{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "2978da26",
   "metadata": {},
   "source": [
    "### Jan 22nd\n",
    "\n",
    "-  Implemented trials_fetch() to query the ClinicalTrials.gov v2 API with automatic pagination.\n",
    "-  Added filtering support via advanced query syntax:\n",
    "    -  phase\n",
    "\t-  country\n",
    "\t-  date range (from_date, to_date) with selectable date_filter field."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "67efd660",
   "metadata": {
    "vscode": {
     "languageId": "r"
    }
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m\u001b[36mℹ\u001b[39m Loading \u001b[34mtidytrials\u001b[39m\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "List of 2\n",
      " $ studies:List of 10\n",
      "  ..$ :List of 5\n",
      "  .. ..$ protocolSection:List of 13\n",
      "  .. .. ..$ identificationModule      :List of 5\n",
      "  .. .. .. ..$ nctId         : chr \"NCT05368103\"\n",
      "  .. .. .. ..$ orgStudyIdInfo:List of 1\n",
      "  .. .. .. .. ..$ id: chr \"HZNP-DAX-201\"\n",
      "  .. .. .. ..$ organization  :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"Amgen\"\n",
      "  .. .. .. .. ..$ class   : chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ briefTitle    : chr \"Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata\"\n",
      "  .. .. .. ..$ officialTitle : chr \"A Phase 2A, Open Label, Proof of Concept Trial of Daxdilimab for the Treatment of Moderate To Severe Alopecia Areata\"\n",
      "  .. .. ..$ statusModule              :List of 14\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2024-12\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"COMPLETED\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-04-27\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2023-08-07\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2024-01-26\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2022-04-11\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2022-05-05\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-05-10\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ resultsFirstSubmitDate     : chr \"2024-12-12\"\n",
      "  .. .. .. ..$ resultsFirstSubmitQcDate   : chr \"2024-12-12\"\n",
      "  .. .. .. ..$ resultsFirstPostDateStruct :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-01-07\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2024-12-12\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-01-07\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 2\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"Amgen\"\n",
      "  .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 2\n",
      "  .. .. .. ..$ briefSummary       : chr \"The purpose of this study is to assess the preliminary efficacy, safety, tolerability, PK, and PD of Daxdilimab\"| __truncated__\n",
      "  .. .. .. ..$ detailedDescription: chr \"Approximately 30 participants will be enrolled to receive daxdilimab administered subcutaneously over 32 weeks.\"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 1\n",
      "  .. .. .. ..$ conditions:List of 1\n",
      "  .. .. .. .. ..$ : chr \"Alopecia Areata\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 1\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 4\n",
      "  .. .. .. .. ..$ allocation       : chr \"NA\"\n",
      "  .. .. .. .. ..$ interventionModel: chr \"SINGLE_GROUP\"\n",
      "  .. .. .. .. ..$ primaryPurpose   : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo      :List of 1\n",
      "  .. .. .. .. .. ..$ masking: chr \"NONE\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 30\n",
      "  .. .. .. .. ..$ type : chr \"ACTUAL\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 1\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Daxdilimab\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Nine sets of Daxdilimab injections over a total of 32 weeks.\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Daxdilimab\"\n",
      "  .. .. .. ..$ interventions:List of 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Daxdilimab\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Daxdilimab will be administered subcutaneously as two injections for each dose.\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Daxdilimab\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"HZN-7734\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percent Change From Baseline in SALT Score at Week 24\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline to Week 24\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 17\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percent Change From Baseline in SALT Score at Weeks 12, 16, 20, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline to Weeks 12, 16, 20, 28, 32, and 36\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Achieved a ≥ 50% Reduction in SALT Score From Baseline at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline to Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 10 at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 20 at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 30 at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 50 at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percent Change From Baseline in SALT Score at Weeks 40, 44, and 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline to Weeks 40, 44, and 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Achieved a ≥ 50% Reduction in SALT Score From Baseline at Weeks 40, 44, and 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline to Weeks 40, 44, and 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 10 at Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 20 at Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 30 at Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 50 at Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Serum Concentration of Daxdilimab\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Blood samples were collected at the visits and time points specified.\\n\\nAll post-baseline concentrations below\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline: 2 hours post-dose; Weeks 4-32: Pre-dose; Weeks 36-48: Any time during the visit.\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percent Change From Baseline in Plasmacytoid Dendritic Cell (pDC) Levels\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Blood samples were collected at the visits and timepoints specified and analyzed using flow cytometry.\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline to Weeks 4, 12, 24, 32, 36 and 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of Participants Who Experienced an Anti-drug Antibody (ADA) Response\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The number of participants who experienced an ADA response was defined as participants with ADA positive post-b\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline and Weeks 4, 8, 12, 24, and 36: Pre-dose\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of Participants Who Experienced a Treatment-emergent Adverse Event (TEAE)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"A TEAE was any untoward medical occurrence in a participant that was not present prior to treatment but appeare\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Day 1 to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of Participants Who Experienced an Adverse Event of Special Interest (AESI)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"An AESI was defined as a serious or non-serious adverse event of scientific and medical interest specific to un\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Day 1 to Week 48\"\n",
      "  .. .. ..$ eligibilityModule         :List of 6\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Inclusion Criteria:\\n\\n1. Willing and able to give informed consent.\\n2. Willing and able to comply with the pr\"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"ALL\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"18 Years\"\n",
      "  .. .. .. ..$ maximumAge         : chr \"65 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 2\n",
      "  .. .. .. .. ..$ : chr \"ADULT\"\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 2\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"MD\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Amgen\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"STUDY_DIRECTOR\"\n",
      "  .. .. .. ..$ locations       :List of 13\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Burke Pharmaceutical Research\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hot Springs\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Arkansas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"71913\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -93.1\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"First OC Dermatology Research, Inc.\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Fountain Valley\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"92708\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 33.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -118\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"ForCare Clinical Research\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Tampa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Florida\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"33613\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 27.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -82.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"DS Research\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Louisville\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Kentucky\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40241\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -85.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Progressive Clinical Research, P.A.\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"San Antonio\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Texas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"78213\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 29.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -98.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Dermatology Specialists of Spokane\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Spokane\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Washington\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"99202\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -117\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Enverus Medical Research\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Surrey\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"British Columbia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"V3V 0C6\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 49.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -123\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Dr Dusan Sajic Medicine Professional Corporation\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guelph\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"N1L 0B7\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -80.3\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Lynderm Research Inc.\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Markham\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"L3P 1X3\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.3\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The Centre for Clinical Trials\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Oakville\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"L6J 7W5\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"SKiN Centre for Dermatology\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Peterborough\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"K9J 5K2,\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 44.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -78.3\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Innovaderm Research\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Montreal\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Quebec\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"H2X 2V1\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -73.6\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centre de Recherche Saint-Louis (Quebec)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Québec\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"G1W 4R4\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 46.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -71.2\n",
      "  .. .. ..$ referencesModule          :List of 1\n",
      "  .. .. .. ..$ seeAlsoLinks:List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"AmgenTrials clinical trials website\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"http://www.amgentrials.com\"\n",
      "  .. .. ..$ ipdSharingStatementModule :List of 1\n",
      "  .. .. .. ..$ ipdSharing: chr \"NO\"\n",
      "  .. ..$ resultsSection :List of 5\n",
      "  .. .. ..$ participantFlowModule        :List of 4\n",
      "  .. .. .. ..$ preAssignmentDetails: chr \"Of the 55 participants who were screened for enrolment in the trial, 25 were screen failures. A total of 30 par\"| __truncated__\n",
      "  .. .. .. ..$ recruitmentDetails  : chr \"A total of 30 participants were enrolled at 5 trial centers located in the United States and 7 trial centers in\"| __truncated__\n",
      "  .. .. .. ..$ groups              :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG000\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. ..$ periods             :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ title        : chr \"Overall Study\"\n",
      "  .. .. .. .. .. ..$ milestones   :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"STARTED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"30\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"Received Daxdilimab\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"30\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"22\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"NOT COMPLETED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"8\"\n",
      "  .. .. .. .. .. ..$ dropWithdraws:List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Withdrawal by Subject\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Lost to Follow-up\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Lack of Efficacy\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. ..$ baselineCharacteristicsModule:List of 4\n",
      "  .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG000\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. ..$ measures             :List of 5\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ title         : chr \"Age, Continuous\"\n",
      "  .. .. .. .. .. ..$ paramType     : chr \"MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType: chr \"STANDARD_DEVIATION\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure : chr \"years\"\n",
      "  .. .. .. .. .. ..$ classes       :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"42.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"13.83\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Sex: Female, Male\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Female\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"20\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Male\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"10\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Ethnicity (NIH/OMB)\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 3\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Hispanic or Latino\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Not Hispanic or Latino\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"28\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Unknown or Not Reported\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Race/Ethnicity, Customized\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Asian\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Black or African American\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"White\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"20\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Other\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ title         : chr \"Severity of Alopecia Tool (SALT) Score\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ paramType     : chr \"MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType: chr \"STANDARD_DEVIATION\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure : chr \"score on a scale\"\n",
      "  .. .. .. .. .. ..$ classes       :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"74.4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"15.72\"\n",
      "  .. .. ..$ outcomeMeasuresModule        :List of 1\n",
      "  .. .. .. ..$ outcomeMeasures:List of 18\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"PRIMARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percent Change From Baseline in SALT Score at Week 24\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Standard Deviation\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent change in score on a scale\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline to Week 24\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-12.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"35.15\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percent Change From Baseline in SALT Score at Weeks 12, 16, 20, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Standard Deviation\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent change in score on a scale\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline to Weeks 12, 16, 20, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 6\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 12\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-5.4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"21.57\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 16\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-8.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"26.58\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 20\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-10.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"30.10\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 28\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-16.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"34.35\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 32\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-17.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"37.16\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 36\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-18.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"37.22\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Achieved a ≥ 50% Reduction in SALT Score From Baseline at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline to Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 7\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 12\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"3.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"17.2\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 16\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"10.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"2.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"26.5\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 20\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"13.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"3.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"30.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 24\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"20.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"7.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"38.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 28\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"20.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"7.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"38.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 32\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"20.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"7.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"38.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 36\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"20.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"7.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"38.6\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 10 at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 7\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 12\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"11.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 16\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"11.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 20\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"11.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 24\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"3.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"17.2\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 28\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"6.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"22.1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 32\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"10.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"2.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"26.5\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 36\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"13.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"3.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"30.7\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 20 at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 7\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 12\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"11.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 16\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"11.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 20\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"6.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"22.1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 24\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"13.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"3.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"30.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 28\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 32\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 36\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 30 at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 7\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 12\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"6.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"22.1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 16\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"10.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"2.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"26.5\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 20\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"10.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"2.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"26.5\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 24\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 28\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 32\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 36\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"20.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"7.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"38.6\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 50 at Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Weeks 12, 16, 20, 24, 28, 32, and 36\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 7\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 12\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 16\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"23.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"9.9\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"42.3\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 20\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"26.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"12.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"45.9\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 24\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"26.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"12.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"45.9\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 28\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"30.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"14.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"49.4\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 32\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"30.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"14.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"49.4\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 36\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"30.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"14.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"49.4\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percent Change From Baseline in SALT Score at Weeks 40, 44, and 48\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Standard Deviation\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent change in score on a scale\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline to Weeks 40, 44, and 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 40\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-19.4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"37.72\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 44\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-20.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"40.67\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 48\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"-22.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"41.43\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Achieved a ≥ 50% Reduction in SALT Score From Baseline at Weeks 40, 44, and 48\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline to Weeks 40, 44, and 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 40\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"20.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"7.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"38.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 44\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"26.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"12.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"45.9\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 48\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"23.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"9.9\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"42.3\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 10 at Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 40\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"10.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"2.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"26.5\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 44\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"10.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"2.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"26.5\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 48\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"13.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"3.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"30.7\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 20 at Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 40\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 44\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 48\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 30 at Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 40\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"20.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"7.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"38.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 44\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"20.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"7.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"38.6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 48\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"5.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"34.7\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percentage of Participants Who Had an Absolute SALT Score ≤ 50 at Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The SALT score determined the degree of hair loss based on the percentage of scalp surface area involved on the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Weeks 40, 44 and 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 40\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"26.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"12.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"45.9\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 44\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"30.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"14.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"49.4\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 48\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"23.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"9.9\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"42.3\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Serum Concentration of Daxdilimab\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Blood samples were collected at the visits and time points specified.\\n\\nAll post-baseline concentrations below\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Pharmacokinetic (PK) Analysis Set: Included all participants who received any dose of daxdilimab and had at lea\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Standard Deviation\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"ng/mL\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline: 2 hours post-dose; Weeks 4-32: Pre-dose; Weeks 36-48: Any time during the visit.\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Baseline\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0.640\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"1.354\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 4\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6.698\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"3.514\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 8\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8.823\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"4.439\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 12\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"28\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"9.978\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"5.569\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 16\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"9.582\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"5.410\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 20\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"9.473\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"5.616\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 24\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"25\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"10.322\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"6.154\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 28\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"24\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"10.595\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"6.663\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 32\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"25\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"10.638\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"6.549\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 36\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"25\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"10.480\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"6.074\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 40\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"25\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3.543\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"2.878\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 44\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"22\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1.309\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"1.218\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 48\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"22\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0.430\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"0.465\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Percent Change From Baseline in Plasmacytoid Dendritic Cell (pDC) Levels\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Blood samples were collected at the visits and timepoints specified and analyzed using flow cytometry.\"\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab. Only participants with eval\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"MEDIAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Full Range\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percent change in pDC levels\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline to Weeks 4, 12, 24, 32, 36 and 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 4\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"23\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-88.89\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-100\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"-16.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 12\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"21\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-87.50\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-100\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"33.3\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 24\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"18\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-85.71\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-100\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"-50\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 32\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"18\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-85.71\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-100\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"33.3\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 36\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"18\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-82.86\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-96.6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"66.7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Week 48\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-40.00\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-90.5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"200\"\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Number of Participants Who Experienced an Anti-drug Antibody (ADA) Response\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The number of participants who experienced an ADA response was defined as participants with ADA positive post-b\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline and Weeks 4, 8, 12, 24, and 36: Pre-dose\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Number of Participants Who Experienced a Treatment-emergent Adverse Event (TEAE)\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"A TEAE was any untoward medical occurrence in a participant that was not present prior to treatment but appeare\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Day 1 to Week 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 2\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"TEAEs\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"23\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Serious TEAEs\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Number of Participants Who Experienced an Adverse Event of Special Interest (AESI)\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"An AESI was defined as a serious or non-serious adverse event of scientific and medical interest specific to un\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety Analysis Set: Included all participants who received any dose of daxdilimab.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Day 1 to Week 48\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. ..$ adverseEventsModule          :List of 5\n",
      "  .. .. .. ..$ frequencyThreshold: chr \"5\"\n",
      "  .. .. .. ..$ timeFrame         : chr \"Day 1 to Week 48\"\n",
      "  .. .. .. ..$ description       : chr \"All-cause mortality is reported for all participants enrolled in the study. Serious adverse events and other ad\"| __truncated__\n",
      "  .. .. .. ..$ eventGroups       :List of 1\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG000\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Daxdilimab 300 mg\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants received 300 mg daxdilimab as two subcutaneous (SC) injections every 4 weeks (Q4W) for 32 weeks. P\"| __truncated__\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 0\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 30\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 0\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 30\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 17\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 30\n",
      "  .. .. .. ..$ otherEvents       :List of 12\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Diarrhoea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Fatigue\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Injection site reaction\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 6\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Seasonal allergy\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Immune system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"COVID-19\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Nasopharyngitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 5\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Upper respiratory tract infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 5\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Arthralgia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Musculoskeletal and connective tissue disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dizziness\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Cough\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pruritus\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Skin and subcutaneous tissue disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 24.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 30\n",
      "  .. .. ..$ moreInfoModule               :List of 2\n",
      "  .. .. .. ..$ certainAgreement:List of 4\n",
      "  .. .. .. .. ..$ piSponsorEmployee   : logi FALSE\n",
      "  .. .. .. .. ..$ restrictionType     : chr \"OTHER\"\n",
      "  .. .. .. .. ..$ restrictiveAgreement: logi TRUE\n",
      "  .. .. .. .. ..$ otherDetails        : chr \"The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after co\"| __truncated__\n",
      "  .. .. .. ..$ pointOfContact  :List of 4\n",
      "  .. .. .. .. ..$ title       : chr \"Study Director\"\n",
      "  .. .. .. .. ..$ organization: chr \"Amgen Inc.\"\n",
      "  .. .. .. .. ..$ email       : chr \"medinfo@amgen.com\"\n",
      "  .. .. .. .. ..$ phone       : chr \"866-572-6436\"\n",
      "  .. ..$ documentSection:List of 1\n",
      "  .. .. ..$ largeDocumentModule:List of 1\n",
      "  .. .. .. ..$ largeDocs:List of 2\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ typeAbbrev : chr \"Prot\"\n",
      "  .. .. .. .. .. ..$ hasProtocol: logi TRUE\n",
      "  .. .. .. .. .. ..$ hasSap     : logi FALSE\n",
      "  .. .. .. .. .. ..$ hasIcf     : logi FALSE\n",
      "  .. .. .. .. .. ..$ label      : chr \"Study Protocol\"\n",
      "  .. .. .. .. .. ..$ date       : chr \"2022-01-07\"\n",
      "  .. .. .. .. .. ..$ uploadDate : chr \"2024-12-12T20:34\"\n",
      "  .. .. .. .. .. ..$ filename   : chr \"Prot_000.pdf\"\n",
      "  .. .. .. .. .. ..$ size       : int 7980389\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ typeAbbrev : chr \"SAP\"\n",
      "  .. .. .. .. .. ..$ hasProtocol: logi FALSE\n",
      "  .. .. .. .. .. ..$ hasSap     : logi TRUE\n",
      "  .. .. .. .. .. ..$ hasIcf     : logi FALSE\n",
      "  .. .. .. .. .. ..$ label      : chr \"Statistical Analysis Plan\"\n",
      "  .. .. .. .. .. ..$ date       : chr \"2022-04-18\"\n",
      "  .. .. .. .. .. ..$ uploadDate : chr \"2024-12-12T20:34\"\n",
      "  .. .. .. .. .. ..$ filename   : chr \"SAP_001.pdf\"\n",
      "  .. .. .. .. .. ..$ size       : int 1363092\n",
      "  .. ..$ derivedSection :List of 2\n",
      "  .. .. ..$ miscInfoModule       :List of 1\n",
      "  .. .. .. ..$ versionHolder: chr \"2026-01-22\"\n",
      "  .. .. ..$ conditionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000506\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Alopecia Areata\"\n",
      "  .. .. .. ..$ ancestors:List of 5\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000505\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Alopecia\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007039\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hypotrichosis\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006201\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hair Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012871\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Skin Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D017437\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Skin and Connective Tissue Diseases\"\n",
      "  .. ..$ hasResults     : logi TRUE\n",
      "  ..$ :List of 3\n",
      "  .. ..$ protocolSection:List of 12\n",
      "  .. .. ..$ identificationModule      :List of 5\n",
      "  .. .. .. ..$ nctId         : chr \"NCT04765514\"\n",
      "  .. .. .. ..$ orgStudyIdInfo:List of 1\n",
      "  .. .. .. .. ..$ id: chr \"IIT-0012\"\n",
      "  .. .. .. ..$ organization  :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"AHS Cancer Control Alberta\"\n",
      "  .. .. .. .. ..$ class   : chr \"OTHER\"\n",
      "  .. .. .. ..$ briefTitle    : chr \"Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients\"\n",
      "  .. .. .. ..$ officialTitle : chr \"A Randomized Controlled Trial of Chemo-Radiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail Patie\"| __truncated__\n",
      "  .. .. ..$ statusModule              :List of 11\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2025-06\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"RECRUITING\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-07-27\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2032-06\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2032-06\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2021-01-12\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2021-02-19\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2021-02-21\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2025-06-10\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-06-12\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 2\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"AHS Cancer Control Alberta\"\n",
      "  .. .. .. .. ..$ class: chr \"OTHER\"\n",
      "  .. .. ..$ oversightModule           :List of 4\n",
      "  .. .. .. ..$ oversightHasDmc     : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi FALSE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. .. ..$ isUsExport          : logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 1\n",
      "  .. .. .. ..$ briefSummary: chr \"Currently, the optimal treatment regimen for elderly Glioblastoma (GBM) patients with poor performance status (\"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 1\n",
      "  .. .. .. ..$ conditions:List of 1\n",
      "  .. .. .. .. ..$ : chr \"Glioblastoma Multiforme\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 1\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 4\n",
      "  .. .. .. .. ..$ allocation       : chr \"RANDOMIZED\"\n",
      "  .. .. .. .. ..$ interventionModel: chr \"PARALLEL\"\n",
      "  .. .. .. .. ..$ primaryPurpose   : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo      :List of 1\n",
      "  .. .. .. .. .. ..$ masking: chr \"NONE\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 121\n",
      "  .. .. .. .. ..$ type : chr \"ESTIMATED\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 2\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Standard Arm: TMZ with concurrent RT (combined modality arm)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"ACTIVE_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Patients will receive a total of 21 days of Temozolomide (TMZ), with 15 days of TMZ administered daily with con\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Combination Product: Chemo-Radiotherapy consisting of 40 Gy in 15 daily fractions with concurrent temozolomide.\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Biomarker based treatment\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"MGMT (+) Temozolomide monotherapy: Patients will receive Temozolomide (TMZ) at a dose of 75 mg/m2 daily for 21 \"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Other: Biomarker based treatment (Temozolomide monotherapy or Radiotherapy monotherapy)\"\n",
      "  .. .. .. ..$ interventions:List of 2\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"OTHER\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Biomarker based treatment (Temozolomide monotherapy or Radiotherapy monotherapy)\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Temozolomide or Radiotherapy\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biomarker based treatment\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"COMBINATION_PRODUCT\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Chemo-Radiotherapy consisting of 40 Gy in 15 daily fractions with concurrent temozolomide.\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Temozolomide will be administered at a dose of 75 mg/m2 daily for a total of 21 days. This will be followed by \"| __truncated__\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Standard Arm: TMZ with concurrent RT (combined modality arm)\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Overall survival\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Time between randomization and death due to any cause. Patients without an event will be censored the last time\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Through study completion, an average of 2 years.\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 6\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Progression-free survival\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Time between randomization and radiographic progression based on RANO criteria or death due to any cause. Patie\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Median, 6-month, 1-year, and 2-year rates will be measured.\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Frequency of Adverse Events related to the treatment administered\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adverse events related to the treatment(s) administered will be recorded from screening until one month post ad\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"From screening until one month post adjuvant treatment.\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Health Related Quality of Life (EORTC QLQ-C30)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Throughout study completion, up to 5 years.\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Health Related Quality of Life (EORTC QLQ-BN20)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Throughout study completion, up to 5 years.\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Cost effectiveness\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Assessed by the incremental cost-effectiveness ratio (ICER), calculated as: Cost per life-year gained = (Differ\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Upon study completion, an average of 5 years\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Cognitive and mental function\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Assessed by Montreal Cognitive Assessment (MoCA). This assessment was designed as a rapid screening instrument \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Throughout study completion, up to 5 years.\"\n",
      "  .. .. ..$ eligibilityModule         :List of 5\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Inclusion Criteria:\\n\\n1. Newly-diagnosed, histologically proven, intracranial glioblastoma with maximal safe r\"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"MALE\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"65 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 1\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 1\n",
      "  .. .. .. ..$ locations:List of 2\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Tom Baker Cancer Centre\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Calgary\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Alberta\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 2\n",
      "  .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Gerald Lim, MD\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"1-403-521-3095\"\n",
      "  .. .. .. .. .. .. .. ..$ email: chr \"Gerald.Lim@albertahealthservices.ca\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Gerald Lim, MD\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"PRINCIPAL_INVESTIGATOR\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -114\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Cross Cancer Institute\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Edmonton\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Alberta\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"T6G 1Z2\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 2\n",
      "  .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Wilson Roa, MD, FRCPC\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"780-432-8783\"\n",
      "  .. .. .. .. .. .. .. ..$ email: chr \"Wilson.Roa@ahs.ca\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Wilson Roa, MSc, MD, FRCPC\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"PRINCIPAL_INVESTIGATOR\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 53.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -113\n",
      "  .. .. ..$ ipdSharingStatementModule :List of 1\n",
      "  .. .. .. ..$ ipdSharing: chr \"NO\"\n",
      "  .. ..$ derivedSection :List of 2\n",
      "  .. .. ..$ miscInfoModule       :List of 1\n",
      "  .. .. .. ..$ versionHolder: chr \"2026-01-22\"\n",
      "  .. .. ..$ conditionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005909\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Glioblastoma\"\n",
      "  .. .. .. ..$ ancestors:List of 9\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001254\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Astrocytoma\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005910\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Glioma\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D018302\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms, Neuroepithelial\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D017599\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neuroectodermal Tumors\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009373\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms, Germ Cell and Embryonal\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009370\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms by Histologic Type\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009369\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009375\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms, Glandular and Epithelial\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009380\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms, Nerve Tissue\"\n",
      "  .. ..$ hasResults     : logi FALSE\n",
      "  ..$ :List of 3\n",
      "  .. ..$ protocolSection:List of 13\n",
      "  .. .. ..$ identificationModule      :List of 6\n",
      "  .. .. .. ..$ nctId           : chr \"NCT05139017\"\n",
      "  .. .. .. ..$ orgStudyIdInfo  :List of 1\n",
      "  .. .. .. .. ..$ id: chr \"2140-003\"\n",
      "  .. .. .. ..$ secondaryIdInfos:List of 5\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"VLS-101\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"OTHER\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"Velos Bio\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"MK-2140-003\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"OTHER\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"MSD\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"waveLINE-003\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"OTHER\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"MSD\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"2022-502646-27-00\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"REGISTRY\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"EU CT\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"U1111-1285-0898\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"REGISTRY\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"UTN\"\n",
      "  .. .. .. ..$ organization    :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"Merck Sharp & Dohme LLC\"\n",
      "  .. .. .. .. ..$ class   : chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ briefTitle      : chr \"A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or\"| __truncated__\n",
      "  .. .. .. ..$ officialTitle   : chr \"A Phase 2/3 Multicenter, Open-label, Randomized, Active-Control Study of Zilovertamab Vedotin (MK-2140) in Comb\"| __truncated__\n",
      "  .. .. ..$ statusModule              :List of 11\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2026-01\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"RECRUITING\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-01-14\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2027-09-24\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2027-09-24\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2021-11-11\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2021-11-29\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2021-12-01\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2026-01-15\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2026-01-20\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 2\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"Merck Sharp & Dohme LLC\"\n",
      "  .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 1\n",
      "  .. .. .. ..$ briefSummary: chr \"The purpose of this Phase 2/3, randomized, multisite, open-label, dose confirmation, and expansion study is to \"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 1\n",
      "  .. .. .. ..$ conditions:List of 2\n",
      "  .. .. .. .. ..$ : chr \"DLBCL\"\n",
      "  .. .. .. .. ..$ : chr \"Diffuse Large B-Cell Lymphoma\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 2\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. .. ..$ : chr \"PHASE3\"\n",
      "  .. .. .. ..$ designInfo    :List of 5\n",
      "  .. .. .. .. ..$ allocation                  : chr \"RANDOMIZED\"\n",
      "  .. .. .. .. ..$ interventionModel           : chr \"SEQUENTIAL\"\n",
      "  .. .. .. .. ..$ interventionModelDescription: chr \"In Part 1, Dose Confirmation will be determined by modified toxicity probability interval (mTPI) design, where \"| __truncated__\n",
      "  .. .. .. .. ..$ primaryPurpose              : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo                 :List of 1\n",
      "  .. .. .. .. .. ..$ masking: chr \"NONE\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 290\n",
      "  .. .. .. .. ..$ type : chr \"ESTIMATED\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 6\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"ZV + R-GemOx (Part 1)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Participants in this arm will receive doses of ZV (from 1.5 mg/Kg up to 2.5 mg/Kg) plus Rituximab 375 mg/m\\\\^2,\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 5\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Zilovertamab vedotin\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Rituximab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Gemcitabine\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Oxaliplatin\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Granulocyte Colony-Stimulating Factor (G-CSF)\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"ZV + R-GemOx (Part 2)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Using the recommended Phase 2 dose (RP2D) dose of ZV plus R-GemOx from Part 1, participants will receive ZV plu\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 5\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Zilovertamab vedotin\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Rituximab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Gemcitabine\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Oxaliplatin\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Granulocyte Colony-Stimulating Factor (G-CSF)\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"R-GemOx (active control for Part 2)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"ACTIVE_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Participants will receive R-GemOx given intravenously on Day 1 of repeated 21-day cycles. Treatment will contin\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Rituximab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Gemcitabine\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Oxaliplatin\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"ZV + BR (Part 2)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Using RP2D from Part 1, participants will receive ZV plus Rituximab 375 mg/m\\\\^2, given intravenously on Day 1 \"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 4\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Zilovertamab vedotin\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Rituximab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Bendamustine\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Granulocyte Colony-Stimulating Factor (G-CSF)\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Bendamustine Rituximab (BR)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"ACTIVE_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Participants will receive Rituximab 375 mg/m\\\\^2, given intravenously on Day 1 Bendamustine 90 mg/m\\\\^2 given i\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Rituximab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Bendamustine\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"ZV + BR (Part 1)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Participants in this arm will receive doses of ZV (from 1.5 mg/Kg up to 2.5 mg/Kg) plus Rituximab 375 mg/m\\\\^2,\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 4\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Zilovertamab vedotin\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Rituximab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Bendamustine\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Granulocyte Colony-Stimulating Factor (G-CSF)\"\n",
      "  .. .. .. ..$ interventions:List of 6\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Zilovertamab vedotin\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Intravenous (IV) Infusion 1.5 mg/kg, 1.75 mg/kg, 2.0 mg/kg, 2.25 mg/kg, 2.5 mg/kg\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 4\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + BR (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + BR (Part 2)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 2)\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"MK-2140\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"VLS-101\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Rituximab\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"IV Infusion 375 mg/m\\\\^2\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 6\n",
      "  .. .. .. .. .. .. ..$ : chr \"Bendamustine Rituximab (BR)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"R-GemOx (active control for Part 2)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + BR (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + BR (Part 2)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 2)\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Rituxan®/mabthera\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Truxima® (rituximab-abbs)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"RUXIENCE®, RIABNI®\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Gemcitabine\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"IV Infusion 1000 mg/m\\\\^2\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"R-GemOx (active control for Part 2)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 2)\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Gemzar®\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Oxaliplatin\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"IV Infusion 100 mg/m\\\\^2\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"R-GemOx (active control for Part 2)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 2)\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Eloxatin®\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Bendamustine\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"IV Infusion 90 mg/m\\\\^2\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Bendamustine Rituximab (BR)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + BR (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + BR (Part 2)\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Bendeka®\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Treanda®\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Belrapzo®\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Granulocyte Colony-Stimulating Factor (G-CSF)\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Prophylactic G-CSF will be administered at each cycle of zilovertamab vedotin as per the institutional guidelines.\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 4\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + BR (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + BR (Part 2)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 1)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ZV + R-GemOx (Part 2)\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 5\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants who experienced dose-limiting toxicities (DLTs) in Part 1\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The CTCAE, Version 5.0 will be used to grade the severity of AEs in this study. DLTs will be reported for Part \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to ~6 weeks\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants who experienced an adverse event (AE)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medic\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to ~68 months\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants who discontinued study treatment due to an AE\"\n",
      "  .. .. .. .. .. ..$ description: chr \"An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medic\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to ~68months\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Overall survival (OS)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"OS, defined as the time from randomization to death due to any cause will be reported.\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to ~35 months\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Progression-free survival (PFS)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"PFS, defined as the time from randomization to the first documented disease progression per Lugano response cri\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to ~26 months\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 2\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Objective response rate (ORR)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"ORR, defined as the percentage of participants who achieve a complete response (CR) or partial response (PR) pe\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to ~26 months\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Duration of response (DOR)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"DOR, defined as the time from the first documented evidence of CR or PR until disease progression or death due \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to ~26 months\"\n",
      "  .. .. ..$ eligibilityModule         :List of 5\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Inclusion Criteria:\\n\\n* Has a histologically confirmed diagnosis of Diffuse Large B-Cell Lymphoma (DLBCL).\\n* \"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"ALL\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"18 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 2\n",
      "  .. .. .. .. ..$ : chr \"ADULT\"\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 3\n",
      "  .. .. .. ..$ centralContacts :List of 1\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ name : chr \"Toll Free Number\"\n",
      "  .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ phone: chr \"1-888-577-8839\"\n",
      "  .. .. .. .. .. ..$ email: chr \"Trialsites@msd.com\"\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"Medical Director\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Merck Sharp & Dohme LLC\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"STUDY_DIRECTOR\"\n",
      "  .. .. .. ..$ locations       :List of 114\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Glendale\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Arizona\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"85304\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"602-978-6255\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 33.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -112\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Bass Medical Group ( Site 0166)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Walnut Creek\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"94598\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"888-577-8839\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -122\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Innovative Clinical Research Institute ( Site 0122)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Whittier\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"90603\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34\n",
      "  .. .. .. .. .. .. ..$ lon: num -118\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Boca Raton Regional Hospital- Lynn Cancer Institute ( Site 0163)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Boca Raton\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Florida\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"33486\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"561-955-4145\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 26.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -80.1\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clermont Oncology Center ( Site 0174)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Clermont\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Florida\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"34711\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"352-242-1366\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -81.8\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Saint Elizabeth Medical Center Edgewood ( Site 0165)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Edgewood\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Kentucky\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"41017\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"859-301-2000\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39\n",
      "  .. .. .. .. .. .. ..$ lon: num -84.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"University of Kentucky Chandler Medical Center ( Site 0158)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lexington\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Kentucky\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40536\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"859-257-3379\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38\n",
      "  .. .. .. .. .. .. ..$ lon: num -84.5\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0133)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Louisville\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Kentucky\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40207\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"502-629-3681\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -85.8\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"University of Maryland ( Site 0123)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Baltimore\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Maryland\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"21201\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"410-328-7996\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -76.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Dana-Farber Cancer Institute-Lymphoma ( Site 0111)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Boston\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Massachusetts\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"02215\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"617-632-2305\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -71.1\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"University of Massachusetts Medical School ( Site 0119)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Worcester\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Massachusetts\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"01655\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"774-455-4446\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -71.8\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Corewell Health ( Site 0162)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Grand Rapids\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Michigan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"49503\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"616-486-6180\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43\n",
      "  .. .. .. .. .. .. ..$ lon: num -85.7\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"St. Vincent Frontier Cancer Center-Research ( Site 0108)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Billings\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Montana\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"59102\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"406-238-6290\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -109\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Comprehensive Cancer Centers of Nevada ( Site 0168)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Las Vegas\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Nevada\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"89169\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"702-952-3400\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 36.2\n",
      "  .. .. .. .. .. .. ..$ lon: num -115\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Atlantic Health System ( Site 0116)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Morristown\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New Jersey\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"07960\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -74.5\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"New York Medical College ( Site 0113)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Valhalla\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New York\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"10595\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"888-577-8839\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -73.8\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0156)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nashville\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Tennessee\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"37232\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 36.2\n",
      "  .. .. .. .. .. .. ..$ lon: num -86.8\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Blue Ridge Cancer Care ( Site 0169)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Roanoke\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Virginia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"24014\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"540-982-0237\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.9\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Italiano de Buenos Aires ( Site 2203)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ciudad Autonoma de Buenos Aires\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Buenos Aires\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"C1199ABB\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Argentina\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+541149590200\"\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Instituto de Investigaciones Clínicas Mar del Plata ( Site 2205)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Mar del Plata\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Buenos Aires\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"B7600FZO\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Argentina\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+542234963224\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -38\n",
      "  .. .. .. .. .. .. ..$ lon: num -57.6\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Aleman ( Site 2200)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Buenos Aites\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Buenos Aires F.D.\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"C1118AAT\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Argentina\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+541148277000\"\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Privado Universitario de Córdoba ( Site 2202)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Córdoba\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Córdoba Province\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"X5016KEH\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Argentina\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+543514688200\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -31.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -64.2\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Instituto Alexander Fleming ( Site 2201)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"CABA\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"C1426ANZ\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Argentina\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+541132218900\"\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Townsville University Hospital ( Site 1800)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Douglas\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Queensland\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"4814\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+61744333549\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -19.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 147\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Grampians Health ( Site 1802)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ballarat\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Victoria\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3350\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+61353208500\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -37.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 144\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Royal Perth Hospital-Haematology ( Site 1801)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Perth\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Western Australia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"6000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+61892242405\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -32\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Erasto Gaertner ( Site 2302)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Curitiba\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Paraná\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"81520-060\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+5541999846033\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -25.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -49.3\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Liga Norte Riograndense Contra o Câncer ( Site 2305)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Natal\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Rio Grande do Norte\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"59062-000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+55 (84) 99927-8442\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -5.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -35.2\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Paulistano ( Site 2300)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"São Paulo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"01321-001\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+551131411083\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -23.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -46.6\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pesquisa Clínica do Serviço de Hematologia do Hospital das Clínicas da FMUSP ( Site 2306)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"São Paulo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"05403-010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+55 (11) 97545-8304\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -23.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -46.6\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0200)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toronto\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"M5G 2M9\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.4\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"IC La Serena Research ( Site 2405)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"La Serena\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Coquimbo Region\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1720430\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+56958646664\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -29.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -71.3\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Oncocentro Valdivia ( Site 2407)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Valdivia\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Los Ríos Region\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"5112129\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+56958537020\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -39.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -73.2\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"FALP-UIDO ( Site 2400)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santiago\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Region M. de Santiago\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7500921\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+562 2606 2355\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -70.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clínica Inmunocel ( Site 2404)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santiago\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Region M. de Santiago\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7580206\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+56224376600\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -70.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clínica RedSalud Vitacura ( Site 2409)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santiago\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Region M. de Santiago\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7650018\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"56223954044\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -70.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Bradfordhill ( Site 2403)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santiago\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Region M. de Santiago\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"8420383\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+56229490970\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -70.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Biocenter ( Site 2401)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Concepción\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Región del Biobío\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"4070196\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+56412858421\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -36.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -73\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Beijing Cancer hospital ( Site 3000)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Beijing\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Beijing Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"100142\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+8601088196698\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Chongqing University Cancer Hospital-Medical Oncology ( Site 3025)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chongqing\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Chongqing Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"400030\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"02365075696\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 29.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 107\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Chongqing University Three Gorges Hospital ( Site 3026)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chongqing\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Chongqing Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"404199\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 29.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 107\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Sun Yat-sen University Cancer Center-Internal Medicine ( Site 3001)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Guangdong\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"510060\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+86-020-87343272\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 23.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Zhujiang Hospital ( Site 3002)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Guangdong\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"510280\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+86-020-61643888\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 23.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First Affiliated Hospital of Henan University of Science &Technology ( Site 3029)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Luoyang\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Henan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"471003\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 112\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Henan Cancer Hospital-hematology department ( Site 3013)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Zhengzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Henan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"450008\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0371-65588007\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 3017)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wuhan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Hubei\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"430048\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"027-85726685\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First Affiliated Hospital of Nanchang University ( Site 3004)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nanchang\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Jiangxi\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"330006\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Jiangxi Provincial Cancer Hospital ( Site 3005)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nanchang\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Jiangxi\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"330029\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"079188329441\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First Hospital of Jilin University-Hematology ( Site 3012)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Changchun\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Jilin\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"130021\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"13756948057\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 125\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fudan University Shanghai Cancer Center ( Site 3009)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Shanghai\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Shanghai Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"200032\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"021 6417 5589\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 31.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 121\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"West China Hospital of Sichuan University-Head and Neck Oncology ( Site 3016)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chengdu\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Sichuan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"610041\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+8618980601027\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 104\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Sichuan Cancer hospital-Oncology ( Site 3021)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chengdu\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Sichuan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"610042\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+8613668112022\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 104\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Zhejiang Cancer Hospital ( Site 3014)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Zhejiang\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"310000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0571 8812 2222\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First Affiliated Hospital Zhejiang University School of Medicine ( Site 3027)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Zhejiang\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"310003\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0571-87236114\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Pablo Tobon Uribe ( Site 0804)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Medellín\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Antioquia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"50034\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Colombia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"6044459753\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 6.25\n",
      "  .. .. .. .. .. .. ..$ lon: num -75.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0801)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bogotá\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Bogota D.C.\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"110131\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Colombia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"3044921963\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 4.61\n",
      "  .. .. .. .. .. .. ..$ lon: num -74.1\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Instituto Médico de Alta Tecnologia S.A.S ( Site 0803)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Montería\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Departamento de Córdoba\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"230002\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Colombia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"3135342052\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 8.75\n",
      "  .. .. .. .. .. .. ..$ lon: num -75.9\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Oncologos del Occidente ( Site 0800)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Pereira\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Risaralda Department\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"660001\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Colombia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+57 3187715522\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 4.81\n",
      "  .. .. .. .. .. .. ..$ lon: num -75.7\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fundacion Valle del Lili ( Site 0802)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cali\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Valle del Cauca Department\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"760032\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Colombia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+576023319090\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 3.43\n",
      "  .. .. .. .. .. .. ..$ lon: num -76.5\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Metropolitano - Sede Lindora ( Site 2500)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santa Ana\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Provincia de San José\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"10903\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Costa Rica\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+506 8497 8912\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 9.93\n",
      "  .. .. .. .. .. .. ..$ lon: num -84.2\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"CIMCA ( Site 2501)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"San José\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"10103\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Costa Rica\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+506 6041 6775\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 9.93\n",
      "  .. .. .. .. .. .. ..$ lon: num -84.1\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"centre hospitalier lyon sud-Service Hématologie ( Site 0702)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Pierre-Bénite\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Rhone\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"69310\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 4.82\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pitie Salpetriere University Hospital-Clinical haematology ( Site 0700)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Paris\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"75013\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+33142162330\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.35\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Evangelismos General Hospital of Athens ( Site 0900)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Athens\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Attica\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"106 76\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Greece\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0030 2132041721\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.7\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Regional General Hospital of Athens \\\"Laiko\\\" ( Site 0901)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Athens\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Attica\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"115 26\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Greece\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0030 2136060981\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.7\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"University Hospital of Alexandroupolis ( Site 0903)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Alexandroupoli\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"East Macedonia and Thrace\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"681 00\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Greece\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0030 2551353739\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 25.9\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"MEDI-K ( Site 2602)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guatemala City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"01009\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Guatemala\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+502 5366 8125\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 14.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -90.5\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Private Practice- Dr. Rixci Augusto Lenin Ramírez ( Site 2601)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guatemala City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"01010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Guatemala\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+502 3014 7611\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 14.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -90.5\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"CELAN,S.A ( Site 2603)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guatemala City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Guatemala\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+502 5200 2329\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 14.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -90.5\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Queen Mary Hospital ( Site 3100)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hong Kong\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"000000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hong Kong\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+85222553838\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 22.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Princess Margaret Hospital ( Site 3101)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hong Kong\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hong Kong\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+85229901111\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 22.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Emek Medical Center-Hematology Unit ( Site 1102)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Afula\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1834111\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 35.3\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Carmel Hospital ( Site 1103)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Haifa\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3436212\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 35\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hadassah Medical Center ( Site 1100)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Jerusalem\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"9112001\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 31.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 35.2\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1203)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Rozzano\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Milano\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"20089\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0282244080\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 9.16\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"IRCCS - AOU di Bologna-Istituto di Ematologia \\\"L. e A. Seragnoli\\\" ( Site 1200)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bologna\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40138\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 44.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 11.3\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1202)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Napoli\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80131\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"390815903382\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 14.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fondazione Policlinico Universitario Agostino Gemelli IRCCS -ISTITUTO DI EMATOLOGIA ( Site 1204)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Roma\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"00168\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45\n",
      "  .. .. .. .. .. .. ..$ lon: num 11.1\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Health Pharma Professional Research S.A. de C.V: ( Site 2700)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Mexico City\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Mexico City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"03100\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Mexico\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"5575864856\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 19.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -99.1\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Medivest Centro de Investigación Integral ( Site 2704)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chihuahua City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"31203\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Mexico\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+526144130886\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -106\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centro de Infusion Superare ( Site 2701)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Mexico City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"03104\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Mexico\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"5552646440\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 19.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -99.1\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Aotearoa Clinical Trials ( Site 0501)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Auckland\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"2025\"\n",
      "  .. .. .. .. .. ..$ country : chr \"New Zealand\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+64 9 277 1660\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -36.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 175\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clínicas AUNA Sede Chiclayo ( Site 2803)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chiclayo\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lambayeque\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"14001\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Peru\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"51 74748333 Ext 7832\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -6.77\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.9\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clínica San Felipe ( Site 2805)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lima\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"15072\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Peru\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"511 2039900 Ext 131\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -12\n",
      "  .. .. .. .. .. .. ..$ lon: num -77\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Nacional Edgardo Rebagliati Martins ( Site 2802)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lima\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"15072\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Peru\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+51991895682\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -12\n",
      "  .. .. .. .. .. .. ..$ lon: num -77\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Nacional Dos De Mayo ( Site 2804)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lima\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"15087\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Peru\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+51944464618\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -12\n",
      "  .. .. .. .. .. .. ..$ lon: num -77\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pratia MCM Krakow ( Site 1303)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Krakow\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lesser Poland Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"30-727\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0048602338290\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 19.9\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Specjalistyczny Szpital im. Dr Alfreda Sokolowskiego w Walbrzychu ( Site 1305)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wałbrzych\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lower Silesian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"58-309\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+48746489966\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 16.3\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site 1301)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wroclaw\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lower Silesian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"50-367\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 17\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centrum Onkologii Ziemi Lubelskiej-Oddzial Hematologii i Transplantacji Szpiku ( Site 1304)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lublin\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lublin Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"20-090\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 22.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( Site 1300)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Warsaw\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Masovian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"02-781\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"0048225462366\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 52.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 21\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Szpitale Pomorskie Sp. z o. o.-Hematology and Bone Marrow Transplantation Department ( Site 1302)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Gdynia\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Pomeranian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"81-519\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 54.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.5\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku ( Site 1309)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Słupsk\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Pomeranian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"76-200\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"59 84 60 390\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 54.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 17\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pratia Onkologia Katowice ( Site 1306)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Katowice\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Silesian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40-519\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+48600388282\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 19\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Seoul National University Hospital-Oncology ( Site 0302)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Seoul\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"03080\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Korea\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Study Coordinator\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"82220723559\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 127\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Samsung Medical Center ( Site 0300)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Seoul\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"06351\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Korea\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 127\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 0400)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bangkok\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Bangkok\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"10700\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Thailand\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 13.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 101\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Chulalongkorn University ( Site 0402)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Pathumwan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Bangkok\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"10330\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Thailand\"\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Maharaj Nakorn Chiang Mai Hospital ( Site 0401)\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chiang Mai\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"50200\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Thailand\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 18.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 99\n",
      "  .. .. .. .. .. [list output truncated]\n",
      "  .. .. ..$ referencesModule          :List of 1\n",
      "  .. .. .. ..$ seeAlsoLinks:List of 2\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"Merck Clinical Trials Information\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://www.merckclinicaltrials.com/\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"Plain Language Summary\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://msd.trialsummaries.com/Study/StudyDetails?id=26287&tenant=MT_MSD_9011\"\n",
      "  .. .. ..$ ipdSharingStatementModule :List of 3\n",
      "  .. .. .. ..$ ipdSharing : chr \"YES\"\n",
      "  .. .. .. ..$ description: chr \"https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf\"\n",
      "  .. .. .. ..$ url        : chr \"https://externaldatasharing-msd.com/\"\n",
      "  .. ..$ derivedSection :List of 3\n",
      "  .. .. ..$ miscInfoModule          :List of 1\n",
      "  .. .. .. ..$ versionHolder: chr \"2026-01-22\"\n",
      "  .. .. ..$ conditionBrowseModule   :List of 2\n",
      "  .. .. .. ..$ meshes   :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D016403\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphoma, Large B-Cell, Diffuse\"\n",
      "  .. .. .. ..$ ancestors:List of 10\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D016393\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphoma, B-Cell\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008228\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphoma, Non-Hodgkin\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008223\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphoma\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009370\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms by Histologic Type\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009369\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008232\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphoproliferative Disorders\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008206\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphatic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006425\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hemic and Lymphatic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007160\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immunoproliferative Disorders\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007154\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immune System Diseases\"\n",
      "  .. .. ..$ interventionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 5\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000069283\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Rituximab\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000093542\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Gemcitabine\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000077150\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Oxaliplatin\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000069461\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Bendamustine Hydrochloride\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D016179\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Granulocyte Colony-Stimulating Factor\"\n",
      "  .. .. .. ..$ ancestors:List of 37\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D058846\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Antibodies, Monoclonal, Murine-Derived\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000911\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Antibodies, Monoclonal\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000906\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Antibodies\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007136\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immunoglobulins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007162\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immunoproteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001798\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Blood Proteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011506\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Proteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000602\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Amino Acids, Peptides, and Proteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012712\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Serum Globulins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005916\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Globulins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006571\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003841\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Deoxycytidine\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003562\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Cytidine\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011741\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pyrimidine Nucleosides\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011743\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pyrimidines\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006573\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, 1-Ring\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D056831\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Coordination Complexes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009930\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Organic Chemicals\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002087\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Butyrates\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000144\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Acids, Acyclic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002264\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Carboxylic Acids\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009588\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Nitrogen Mustard Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009150\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Mustard Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006846\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons, Halogenated\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006838\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001562\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Benzimidazoles\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006574\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, 2-Ring\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000072471\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, Fused-Ring\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003115\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Colony-Stimulating Factors\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006023\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Glycoproteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006001\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Glycoconjugates\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002241\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Carbohydrates\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D016298\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hematopoietic Cell Growth Factors\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D016207\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Cytokines\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D036341\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Intercellular Signaling Peptides and Proteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D010455\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Peptides\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001685\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Biological Factors\"\n",
      "  .. ..$ hasResults     : logi FALSE\n",
      "  ..$ :List of 3\n",
      "  .. ..$ protocolSection:List of 13\n",
      "  .. .. ..$ identificationModule      :List of 6\n",
      "  .. .. .. ..$ nctId           : chr \"NCT05664737\"\n",
      "  .. .. .. ..$ orgStudyIdInfo  :List of 1\n",
      "  .. .. .. .. ..$ id: chr \"CA056-015\"\n",
      "  .. .. .. ..$ secondaryIdInfos:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"2022-502328-35\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"OTHER\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"EU CTR\"\n",
      "  .. .. .. ..$ organization    :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. ..$ class   : chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ briefTitle      : chr \"A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety a\"| __truncated__\n",
      "  .. .. .. ..$ officialTitle   : chr \"A Phase 2, Study for the Treatment of Anemia With Alpha (α)-Thalassemia to Determine the Efficacy and Safety of\"| __truncated__\n",
      "  .. .. ..$ statusModule              :List of 11\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2025-08\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"RECRUITING\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-12-09\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2027-07-16\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2034-08-14\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2022-12-09\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2022-12-22\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-12-27\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2025-08-19\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-08-20\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 2\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 1\n",
      "  .. .. .. ..$ briefSummary: chr \"The purpose of the study is to evaluate the efficacy and safety of luspatercept plus best supportive care (BSC)\"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 2\n",
      "  .. .. .. ..$ conditions:List of 1\n",
      "  .. .. .. .. ..$ : chr \"Anemia\"\n",
      "  .. .. .. ..$ keywords  :List of 9\n",
      "  .. .. .. .. ..$ : chr \"Luspatercept\"\n",
      "  .. .. .. .. ..$ : chr \"BMS-986346\"\n",
      "  .. .. .. .. ..$ : chr \"ACE-536\"\n",
      "  .. .. .. .. ..$ : chr \"α-thalassemia\"\n",
      "  .. .. .. .. ..$ : chr \"Alpha Thalassemia\"\n",
      "  .. .. .. .. ..$ : chr \"Reblozyl\"\n",
      "  .. .. .. .. ..$ : chr \"Transfusions\"\n",
      "  .. .. .. .. ..$ : chr \"Non-transfusion dependent\"\n",
      "  .. .. .. .. ..$ : chr \"RBC transfusion dependent\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 1\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 4\n",
      "  .. .. .. .. ..$ allocation       : chr \"RANDOMIZED\"\n",
      "  .. .. .. .. ..$ interventionModel: chr \"PARALLEL\"\n",
      "  .. .. .. .. ..$ primaryPurpose   : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo      :List of 2\n",
      "  .. .. .. .. .. ..$ masking  : chr \"QUADRUPLE\"\n",
      "  .. .. .. .. .. ..$ whoMasked:List of 4\n",
      "  .. .. .. .. .. .. ..$ : chr \"PARTICIPANT\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"CARE_PROVIDER\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"INVESTIGATOR\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"OUTCOMES_ASSESSOR\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 249\n",
      "  .. .. .. .. ..$ type : chr \"ESTIMATED\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 4\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Transfusion Dependent (TD): Luspatercept + Best supportive care (BSC)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Luspatercept\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Adult TD Cohort: Placebo + BSC\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"PLACEBO_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Placebo\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Non-transfusion Dependent (NTD): Luspatercept + BSC\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Luspatercept\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Adult NTD Cohort: Placebo + BSC\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"PLACEBO_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Placebo\"\n",
      "  .. .. .. ..$ interventions:List of 2\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Luspatercept\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Specified dose on specified days\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Non-transfusion Dependent (NTD): Luspatercept + BSC\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Transfusion Dependent (TD): Luspatercept + Best supportive care (BSC)\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"BMS-986346\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"ACE-536\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"REBLOZYL\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Placebo\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Specified dose on specified days\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Adult NTD Cohort: Placebo + BSC\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Adult TD Cohort: Placebo + BSC\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 5\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with ≥ 50% reduction from baseline in RBC transfusion burden with a reduction of at leas\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with an increase from baseline of ≥ 1.0 grams (g)/decilitre (dL) in mean hemoglobin (Hb)\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 24\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Dose-limiting toxicities (DLTs) defined as observance of ≥ Grade 3-related hemolytic crises or ≥ Grade 3-relate\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 3\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with adverse events (AEs)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to 8.5 years\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Pharmacokinetics (PK): Serum concentration of Luspatercept\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 102\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 64\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with ≥ 33% reduction from baseline in RBC transfusion burden with a reduction of at leas\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The longest duration with ≥ 50% reduction from baseline in RBC transfusion burden with a reduction of at least 2 units\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of RBC transfusion units from week 1 to week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult and Adolescent TD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in hemoglobin in the absence of transfusion at Week 24\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult and Adolescent NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 24\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The longest duration of an increase from baseline of ≥ 1.0 g/dL in mean hemoglobin values starting from Week 13\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Time Duration with an increase from baseline of ≥ 1.0 g/dL in hemoglobin values in the absence of transfusion within 48 weeks\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with an increase from baseline of ≥1.0 g/dL in mean Hb values over the continuous 12- we\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 24\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"≥ 3 Increase from Baseline in Functional Assessment of Cancer Therapy Anemia Fatigue Subscale (FACT-An FS) Scor\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 24\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with AEs\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult and Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to 5 years\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with laboratory abnormalities\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to 5 Years\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with immunogenicity\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to 5 Years\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with ≥ 50% reduction from baseline in RBC transfusion burden during any continuous 24-we\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with ≥ 33% reduction from baseline in RBC transfusion burden during any continuous 12-we\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with ≥ 33% reduction from baseline in RBC transfusion burden from Week 13 to Week 24 and\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with ≥ 33% reduction from baseline in RBC transfusion burden from Week 1 to Week 24 and \"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with ≥ 50% reduction from baseline in RBC transfusion burden from Week 13 to Week 24 and\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with ≥ 50% reduction from baseline in RBC transfusion burden from Week 1 to Week 24 and \"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in total RBC units transfused from Week 1 to Week 24, Week 25 to Week 48, and Week 1 to Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The longest duration of RBC transfusion-free period for participants who achieve transfusion-free period of ≥ 12 weeks\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The longest duration of reduction in transfusion burden for participants who achieve a response (rolling 12-wee\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Time from first dose to first day of response (rolling 12-week and 24-week response, both for ≥ 33% and ≥ 50% reduction)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in number of transfusion events at Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants who achieve RBC transfusion-free period of any continuous ≥ 12 weeks during treatment\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult and Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants who achieve RBC transfusion-free period of any continuous ≥ 24 weeks during treatment\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult and Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Time to first transfusion\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult and Adolescent NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of transfusions\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Within 48 Weeks\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of transfusion visits/units\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Within 48 Weeks\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in mean hemoglobin values over the continuous 12-week interval from Week 13 to Week 24 and\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants achieving an increase from baseline of ≥1.0g/dL or ≥1.5g/dL in mean Hb values in absence\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Time from first to last Hb measurement with increase from baseline by ≥ 1.0 g/dL\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Time to the first increase from baseline of ≥ 1.0 g/dL in mean Hb value\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants who achieve an increase in mean Hb of >10g/dL values during any continuous 12-week and 2\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in self-reported health-related quality of life (HRQoL) assessed by physical component sum\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in non-transfusion dependent β-thalassemia patient-reported outcome (NTDT-PRO) Tiredness/w\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in FACT-An FS Score at Week 24 and Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in Functional Assessment of Cancer Therapy Anemia Anemia Subscale (FACT-An AS) at Week 24 and Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with at least one hemolytic crisis\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Rate of hemolytic crises\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Time to first hemolytic crisis\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Time to second hemolytic crisis\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in hemolysis markers at Week 24 and Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts:\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change from baseline in the 6-minute walk test (6MWT) distance at Week 24 and Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Pharmacokinetics (PK): Serum concentration of Luspatercept\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult and Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 108\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percent Change from Baseline in Biomarkers for Erythropoiesis at Week 84\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\\n\\nThe biomarkers for erythropoiesis to be evaluated include Hb variants including hem\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 84\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percent Change from Baseline in Biomarkers and Parameters for Iron Homeostasis at Week 84\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\\n\\nThe biomarkers and parameters for iron homeostasis to be evaluated include hepcidin\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 84\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change in mean corpuscular volume (MCV) at Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change in mean corpuscular hemoglobin (MCH) at Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change in nucleated red blood cells (nRBC) at Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change in red blood cells (RBC) at Week 48\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adult TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The longest duration with reduction from baseline in the RBC transfusion burden\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The number of participants with ≥ 50% reduction from baseline in RBC transfusion burden during an continuous 12\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The number of participants with ≥ 33% reduction from baseline in RBC transfusion burden during an continuous 24 weeks\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants achieving an increase from baseline of ≥1.0g/dL in mean Hb values in absence of transfus\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 24\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Cumulative time (in weeks) with an increase from baseline of ≥1.0g/dL in mean Hb values in absence of RBC trans\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants who achieve an increase in mean Hb of >10g/dL values during any continuous 12-week inter\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The longest duration with an increase from baseline of ≥1.0g/dL in mean Hb values in absence of transfusions\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent NTD Cohort\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of participants with antidrug antibody (ADA)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Mean change in biomarkers for hemolysis\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\\n\\nBiomarkers for hemolysis to be evaluated include total/direct/indirect bilirub\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Mean change in biomarkers and parameters for iron homeostasis\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\\n\\nThe biomarkers and parameters for iron homeostasis to be evaluated include ser\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to 1 Year\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Hematologic assessments\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\\n\\nThe hematologic assessments to be evaluated are red blood cell count, hemoglob\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The change from baseline in the number of health care resource utilization (HCRU)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Mean change from baseline in Pediatric Quality of Life Inventory (PedsQL) domain scores\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Mean change from baseline EQ-5D-5L utility index\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Mean change from baseline visual analogue scale (VAS) scores\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Adolescent TD and NTD Cohorts\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to Week 48\"\n",
      "  .. .. ..$ eligibilityModule         :List of 5\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Key Inclusion Criteria:\\n\\n* Adult participant≥ 18 years with documented diagnosis of A-Thal HbH disease with T\"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"ALL\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"12 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 3\n",
      "  .. .. .. .. ..$ : chr \"CHILD\"\n",
      "  .. .. .. .. ..$ : chr \"ADULT\"\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 3\n",
      "  .. .. .. ..$ centralContacts :List of 2\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ name : chr \"BMS Study Connect Contact Center www.BMSStudyConnect.com\"\n",
      "  .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ phone: chr \"855-907-3286\"\n",
      "  .. .. .. .. .. ..$ email: chr \"Clinical.Trials@bms.com\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ name: chr \"First line of the email MUST contain the NCT# and Site #.\"\n",
      "  .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"STUDY_DIRECTOR\"\n",
      "  .. .. .. ..$ locations       :List of 36\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0008\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Halifax\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Nova Scotia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"B3K 6R8\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 44.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -63.6\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Sun Yat-sen Memorial Hospital, Sun Yat-Sen University\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"GD\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"510120\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Jian-Pei Fang, Site 0029\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+862081332199\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 23.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Nanfang Hospital of Southern Medical University\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"GD\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"510515\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Ling Jiang, Site 0015\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+8613602791429\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 23.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First People's Hospital of Foshan\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Foshan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Guangdong\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"528000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Ying Zhao, Site 0013\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 23\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Maoming People's Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Maoming Shi\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Guangdong\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"525000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Ying Dong, Site 0017\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Shenzhen Second People's Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Shenzhen Shi\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Guangdong\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"518025\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Xin Du, Site 0030\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Liuzhou People's Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Liuchow\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Guangxi\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"545006\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Qin Liu, Site 0023\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"8613978020485\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 24.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 109\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"People's Liberation Army The 923rd Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nanning\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"GX\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"530021\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Xiaolin Yin, Site 0014\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+8613321717899\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 22.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 108\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0011\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Haikou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Hainan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"570203\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 20\n",
      "  .. .. .. .. .. .. ..$ lon: num 110\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0012\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kunming\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Yunnan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"650032\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 25\n",
      "  .. .. .. .. .. .. ..$ lon: num 103\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hainan General Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Haikou\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"570311\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Guyun Wang, Site 0002\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+8613006021266\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 20\n",
      "  .. .. .. .. .. .. ..$ lon: num 110\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First Affiliated Hospital of Guangxi Medical University\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nanning\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"530021\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Yongrong Lai, Site 0016\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+07715356746\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 22.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 108\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0005\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Thessaloniki\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"B\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"546 42\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Greece\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 22.9\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0007\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Larissa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"E\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"412 21\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Greece\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 22.4\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0018\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Rio\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"G\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"265 04\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Greece\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 21.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0006\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Athens\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"115 27\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Greece\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0009\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Goudi\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"11527\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Greece\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0025\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hong Kong\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"HK\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hong Kong\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 22.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0024\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hong Kong Island\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hong Kong\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 22.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0022\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cagliari\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"CA\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"09121\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 9.12\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0026\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Genova\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"GE\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"16128\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 11.9\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0020\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Orbassano\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"TO\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"10043\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45\n",
      "  .. .. .. .. .. .. ..$ lon: num 7.54\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0028\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Napoli\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80131\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 14.5\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"\\\"Universita degli Studi della Campania \\\"\\\"Luigi Vanvitelli\\\"\\\" - AOU - Clinica Pediatrica\\\"\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Napoli\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80138\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Silverio Perrotta, Site 0019\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+0390815665421 0 000\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 14.5\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Sultanah Aminah\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Johor Bahru\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80100\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Malaysia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Christopher Chin Keong Liam, Site 0033\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+60127069245\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 1.47\n",
      "  .. .. .. .. .. .. ..$ lon: num 104\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0032\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kuala Lumpur\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"50586\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Malaysia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Site 0032\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 3.14\n",
      "  .. .. .. .. .. .. ..$ lon: num 102\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0035\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Al-Ahsa\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"31982\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Saudi Arabia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Site 0035\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0034\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Riyadh\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"11411\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Saudi Arabia\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Site 0034\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 24.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 46.7\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0036\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Singapore\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"229899\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Singapore\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Site 0036\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 1.29\n",
      "  .. .. .. .. .. .. ..$ lon: num 104\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"Kaohsiung Medical University Chung-Ho Memorial Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kaohsiung City\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"KHH\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"807\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Taiwan\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Shyh-Shin Chiou, Site 0010\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 22.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"National Taiwan University Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nan Gang Qu\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"TPE\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"10002\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Taiwan\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Meng-Yao Lu, Site 0004\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"+88622312345671713\"\n",
      "  .. .. .. .. ..$ :List of 8\n",
      "  .. .. .. .. .. ..$ facility: chr \"China Medical University Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Taichung\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"TXG\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40447\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Taiwan\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Ching-Tien Peng, Site 0003\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"886422052121ext4636\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 24.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 121\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Siriraj Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bangkok\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"10700\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Thailand\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ name : chr \"Vip Viprakasit, Site 0001\"\n",
      "  .. .. .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. .. .. ..$ phone: chr \"6624122113\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 13.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 101\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0031\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Mueang Phitsanulok\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"65000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Thailand\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Site 0031\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0027\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Altındağ\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"06230\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Turkey (Türkiye)\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Site 0027\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 37.7\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0021\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Topkapı\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"34093\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Turkey (Türkiye)\"\n",
      "  .. .. .. .. .. ..$ contacts:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ name: chr \"Site 0021\"\n",
      "  .. .. .. .. .. .. .. ..$ role: chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 38.7\n",
      "  .. .. ..$ referencesModule          :List of 2\n",
      "  .. .. .. ..$ references  :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"37606495\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"DERIVED\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Diamantidis MD, Pitsava S, Zayed O, Argyrakouli I, Karapiperis K, Chatzoulis C, Alexiou E, Manafas A, Tsangalas\"| __truncated__\n",
      "  .. .. .. ..$ seeAlsoLinks:List of 2\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"BMS Clinical Trial Information\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"BMS Clinical Trial Patient Recruiting\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://www.bmsclinicaltrials.com/us/en/clinical-trials/NCT05664737.html\"\n",
      "  .. .. ..$ ipdSharingStatementModule :List of 6\n",
      "  .. .. .. ..$ ipdSharing    : chr \"YES\"\n",
      "  .. .. .. ..$ description   : chr \"BMS will provide access to individual anonymized participant data upon request from qualified researchers, and \"| __truncated__\n",
      "  .. .. .. ..$ infoTypes     :List of 3\n",
      "  .. .. .. .. ..$ : chr \"STUDY_PROTOCOL\"\n",
      "  .. .. .. .. ..$ : chr \"SAP\"\n",
      "  .. .. .. .. ..$ : chr \"CSR\"\n",
      "  .. .. .. ..$ timeFrame     : chr \"See Plan Description\"\n",
      "  .. .. .. ..$ accessCriteria: chr \"See Plan Description\"\n",
      "  .. .. .. ..$ url           : chr \"https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosure-commitment.html\"\n",
      "  .. ..$ derivedSection :List of 3\n",
      "  .. .. ..$ miscInfoModule          :List of 1\n",
      "  .. .. .. ..$ versionHolder: chr \"2026-01-22\"\n",
      "  .. .. ..$ conditionBrowseModule   :List of 2\n",
      "  .. .. .. ..$ meshes   :List of 2\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000740\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Anemia\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D017085\"\n",
      "  .. .. .. .. .. ..$ term: chr \"alpha-Thalassemia\"\n",
      "  .. .. .. ..$ ancestors:List of 8\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006402\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hematologic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006425\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hemic and Lymphatic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013789\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Thalassemia\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000745\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Anemia, Hemolytic, Congenital\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000743\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Anemia, Hemolytic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006453\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hemoglobinopathies\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D030342\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Genetic Diseases, Inborn\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009358\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Congenital, Hereditary, and Neonatal Diseases and Abnormalities\"\n",
      "  .. .. ..$ interventionBrowseModule:List of 1\n",
      "  .. .. .. ..$ meshes:List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"C000621232\"\n",
      "  .. .. .. .. .. ..$ term: chr \"luspatercept\"\n",
      "  .. ..$ hasResults     : logi FALSE\n",
      "  ..$ :List of 5\n",
      "  .. ..$ protocolSection:List of 12\n",
      "  .. .. ..$ identificationModule      :List of 5\n",
      "  .. .. .. ..$ nctId         : chr \"NCT05407675\"\n",
      "  .. .. .. ..$ orgStudyIdInfo:List of 1\n",
      "  .. .. .. .. ..$ id: chr \"CA099-003\"\n",
      "  .. .. .. ..$ organization  :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. ..$ class   : chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ briefTitle    : chr \"A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolu\"| __truncated__\n",
      "  .. .. .. ..$ officialTitle : chr \"A Phase 1/2 Study of BMS-986408 Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Par\"| __truncated__\n",
      "  .. .. ..$ statusModule              :List of 14\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2025-09\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"COMPLETED\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-08-02\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2024-08-22\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-07-24\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2022-06-02\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2022-06-02\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-06-07\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ resultsFirstSubmitDate     : chr \"2025-08-19\"\n",
      "  .. .. .. ..$ resultsFirstSubmitQcDate   : chr \"2025-09-16\"\n",
      "  .. .. .. ..$ resultsFirstPostDateStruct :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-10-03\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2025-09-16\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-10-03\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 2\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi FALSE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 1\n",
      "  .. .. .. ..$ briefSummary: chr \"The primary purpose of this study is to characterize the safety profile of BMS-986408 as monotherapy and in com\"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 2\n",
      "  .. .. .. ..$ conditions:List of 1\n",
      "  .. .. .. .. ..$ : chr \"Advanced Solid Tumors\"\n",
      "  .. .. .. ..$ keywords  :List of 4\n",
      "  .. .. .. .. ..$ : chr \"Cancer\"\n",
      "  .. .. .. .. ..$ : chr \"Oncology\"\n",
      "  .. .. .. .. ..$ : chr \"Phase 1\"\n",
      "  .. .. .. .. ..$ : chr \"Solid Tumor\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 2\n",
      "  .. .. .. .. ..$ : chr \"PHASE1\"\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 4\n",
      "  .. .. .. .. ..$ allocation       : chr \"NON_RANDOMIZED\"\n",
      "  .. .. .. .. ..$ interventionModel: chr \"SEQUENTIAL\"\n",
      "  .. .. .. .. ..$ primaryPurpose   : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo      :List of 1\n",
      "  .. .. .. .. .. ..$ masking: chr \"NONE\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 68\n",
      "  .. .. .. .. ..$ type : chr \"ACTUAL\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 7\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Part 1: BMS-986408 Monotherapy\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: BMS-986408\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Part 2: BMS-986408 in combination with nivolumab\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: BMS-986408\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Nivolumab\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Part 2: BMS-986408 in combination with nivolumab and ipilimumab\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: BMS-986408\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Nivolumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Ipilimumab\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Part 2: BMS-986408 in combination with nivolumab and chemotherapy\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: BMS-986408\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Nivolumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Platinum-doublet chemotherapy\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Part 2: BMS-986408 in combination with rabeprazole\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: BMS-986408\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Rabeprazole\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Part 3: BMS-986408 in combination with nivolumab\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: BMS-986408\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Nivolumab\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ label            : chr \"Part 3: BMS-986408 in combination with nivolumab and chemotherapy\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: BMS-986408\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Nivolumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: Platinum-doublet chemotherapy\"\n",
      "  .. .. .. ..$ interventions:List of 5\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"BMS-986408\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Specified dose on specified days\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 7\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 1: BMS-986408 Monotherapy\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with nivolumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with nivolumab and chemotherapy\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with nivolumab and ipilimumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with rabeprazole\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 3: BMS-986408 in combination with nivolumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 3: BMS-986408 in combination with nivolumab and chemotherapy\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Nivolumab\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Specified dose on specified days\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 5\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with nivolumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with nivolumab and chemotherapy\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with nivolumab and ipilimumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 3: BMS-986408 in combination with nivolumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 3: BMS-986408 in combination with nivolumab and chemotherapy\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Opdivo\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"BMS-936558\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Ipilimumab\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Specified dose on specified days\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with nivolumab and ipilimumab\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Yervoy\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"BMS-734016\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Platinum-doublet chemotherapy\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Specified dose on specified days\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with nivolumab and chemotherapy\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 3: BMS-986408 in combination with nivolumab and chemotherapy\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"PDCT\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"carbplatin, paclitaxel, pemetrexed, cisplatin\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Rabeprazole\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Specified dose on specified days\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Part 2: BMS-986408 in combination with rabeprazole\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 3\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of Participants With Dose Limiting Toxicities (DLTs)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"A Dose-Limiting Toxicity (DLT) is defined as a treatment-related adverse event that meets specific severity cri\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"From first dose (Day 1) till 28 days\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of Participants With Adverse Events\"\n",
      "  .. .. .. .. .. ..$ description: chr \"An adverse event (AE) is defined as any new untoward medical occurrence or worsening of a pre-existing medical \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"From first dose (Day 1) till 30 days after the last dose (Up to approximately 13 months) for Group A to C and f\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Number of Participants Who Died\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"From first dose (Day 1) until 100 days after the last dose (Up to approximately 15 months)\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 5\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Maximum Observed Plasma Concentration (Cmax) of BMS-986408\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Blood samples were collected to assess pharmacokinetic parameters\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Day 1 and 15 of Cycle 1 (Each cycle is of 28 days)\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Time to Maximum Observed Plasma Concentration (Tmax) of BMS-986408\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Blood samples were collected to assess pharmacokinetic parameters\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Day 1 and 15 of Cycle 1 (Each cycle is of 28 days)\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Area Under the Plasma Concentration-time Curve From Time 0 to Time of Last Quantifiable Concentration [AUC(0-T)]\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Blood samples were collected to assess pharmacokinetic parameters.\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Day 1 and 15 of Cycle 1 (Each cycle is of 28 days)\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Objective Response Rate (ORR) Per RECIST v1.1\"\n",
      "  .. .. .. .. .. ..$ description: chr \"ORR is defined as the percentage of participants whose best overall response (BOR) is either CR or PR per respo\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"From randomization to the date of objectively documented progression per RECIST v1.1 or the date of subsequent \"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Duration of Response Per RECIST v1.1\"\n",
      "  .. .. .. .. .. ..$ description: chr \"DOR for a participant with a best overall response (BOR) of CR or PR is defined as the time between the date of\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"From randomization to the date of objectively documented progression per RECIST v1.1 or the date of subsequent \"| __truncated__\n",
      "  .. .. ..$ eligibilityModule         :List of 5\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Inclusion Criteria:\\n\\n* Participants with a histologically or cytologically confirmed, advanced, unresectable/\"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"ALL\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"18 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 2\n",
      "  .. .. .. .. ..$ : chr \"ADULT\"\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 2\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"STUDY_DIRECTOR\"\n",
      "  .. .. .. ..$ locations       :List of 18\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0010\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Boston\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Massachusetts\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"02215\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -71.1\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0001\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hackensack\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New Jersey\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"07601\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -74\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0003\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Houston\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Texas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"77030\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 29.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -95.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0007\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Edmonton\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Alberta\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"T6G 1Z2\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 53.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -113\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0011\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hamilton\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"L8V5C2\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0005\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ottawa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"K1H 8L6\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -75.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0006\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toronto\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"M5G 2M9\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0015\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bordeaux\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Aquitaine\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"33076\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 44.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -0.58\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0014\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Villejuif\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Paris\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"94800\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.36\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0018\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Marseille\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"13385\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 5.38\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0019\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toulouse\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"31059\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 1.44\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0024\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Málaga\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Andalusia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"29010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 36.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -4.42\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0025\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Madrid\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Madrid, Comunidad de\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"28009\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -3.7\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0022\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Madrid\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"28040\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -3.7\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0023\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Madrid\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"28050\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -3.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0021\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Sankt Gallen\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Canton of St. Gallen\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"9007\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Switzerland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 9.37\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0012\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Basel\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"4031\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Switzerland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 7.57\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Local Institution - 0020\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Geneva\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1205\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Switzerland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 46.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 6.15\n",
      "  .. .. ..$ referencesModule          :List of 1\n",
      "  .. .. .. ..$ seeAlsoLinks:List of 2\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"BMS Clinical Trial Information\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"BMS Clinical Trial Patient Recruiting\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://www.BMSClinicalTrials.com\"\n",
      "  .. ..$ resultsSection :List of 5\n",
      "  .. .. ..$ participantFlowModule        :List of 3\n",
      "  .. .. .. ..$ preAssignmentDetails: chr \"Participants were not enrolled in Part 3.\"\n",
      "  .. .. .. ..$ groups              :List of 13\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG000\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG001\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG002\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG003\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG004\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG005\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG006\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG007\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG008\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG009\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG010\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG011\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG012\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. ..$ periods             :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ title        : chr \"Overall Study\"\n",
      "  .. .. .. .. .. ..$ milestones   :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"STARTED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"NOT COMPLETED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. ..$ dropWithdraws:List of 8\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Withdrawal by Subject\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Site terminated by sponsor\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Disease Progression\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Physician Decision\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Other reasons\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Death\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Adverse Event\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Ongoing Treatment\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. ..$ baselineCharacteristicsModule:List of 3\n",
      "  .. .. .. ..$ groups  :List of 14\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG000\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG001\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG002\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG003\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG004\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG005\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG006\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG007\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG008\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG009\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG010\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG011\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG012\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG013\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Total\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Total of all reporting groups\"\n",
      "  .. .. .. ..$ denoms  :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ counts:List of 14\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"68\"\n",
      "  .. .. .. ..$ measures:List of 4\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ title         : chr \"Age, Continuous\"\n",
      "  .. .. .. .. .. ..$ paramType     : chr \"MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType: chr \"STANDARD_DEVIATION\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure : chr \"years\"\n",
      "  .. .. .. .. .. ..$ classes       :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"58.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"10.02\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"57.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"15.41\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"62.3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"13.15\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"57.4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"12.57\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"67.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"13.08\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"52.5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"10.08\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"67.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"6.44\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"70.5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"12.02\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"68.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"6.63\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"55.9\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"10.61\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"62.9\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"9.11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"57.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"13.86\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"70.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Could not be estimated due to insufficient number of participants\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"60.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"11.50\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Sex: Female, Male\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Female\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"33\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Male\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"35\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Ethnicity (NIH/OMB)\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 3\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Hispanic or Latino\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Not Hispanic or Latino\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"10\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"55\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Unknown or Not Reported\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Race (NIH/OMB)\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 7\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"American Indian or Alaska Native\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Asian\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Native Hawaiian or Other Pacific Islander\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Black or African American\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"White\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"48\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"More than one race\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Unknown or Not Reported\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 14\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG013\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"10\"\n",
      "  .. .. ..$ outcomeMeasuresModule        :List of 1\n",
      "  .. .. .. ..$ outcomeMeasures:List of 8\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"PRIMARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Number of Participants With Dose Limiting Toxicities (DLTs)\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"A Dose-Limiting Toxicity (DLT) is defined as a treatment-related adverse event that meets specific severity cri\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Participants were DLT evaluable if they received ≥75% of planned BMS-986408 doses without a DLT or had a DLT af\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"From first dose (Day 1) till 28 days\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"9\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"PRIMARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Number of Participants With Adverse Events\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"An adverse event (AE) is defined as any new untoward medical occurrence or worsening of a pre-existing medical \"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety population included all participants who received at least 1 dose of study intervention\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"From first dose (Day 1) till 30 days after the last dose (Up to approximately 13 months) for Group A to C and f\"| __truncated__\n",
      "  .. .. .. .. .. ..$ groups               :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Any Adverse Events\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Any Drug-related AEs\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Serious Adverse Events\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"AEs leading to Discontinuation\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Maximum Observed Plasma Concentration (Cmax) of BMS-986408\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Blood samples were collected to assess pharmacokinetic parameters\"\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"PK evaluable population included all treated participants who have any available concentration-time data. Only \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"GEOMETRIC_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Geometric Coefficient of Variation\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"nanogram per mililitre (ng/mL)\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Day 1 and 15 of Cycle 1 (Each cycle is of 28 days)\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Cycle 1 Day 1\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2.49\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"61.05\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.86\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"37.36\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8.56\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"35.16\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"15.00\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"45.02\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"15.99\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"64.67\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5.57\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"34.38\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"9.98\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"21.58\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11.20\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"12.62\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"37.65\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"19.43\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"41.43\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5.07\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"36.26\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"10.71\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"46.81\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"15.50\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Cycle 1 Day 15\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 10\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"9.32\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"63.71\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"17.66\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"36.70\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"22.19\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"51.79\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"62.97\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"80.05\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"41.27\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"26.51\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"33.14\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"61.85\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"67.55\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"40.90\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30.10\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"28.43\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"39.76\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"61.55\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"32.92\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Time to Maximum Observed Plasma Concentration (Tmax) of BMS-986408\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Blood samples were collected to assess pharmacokinetic parameters\"\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"PK evaluable population included all treated participants who have any available concentration-time data. Only \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"GEOMETRIC_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Geometric Coefficient of Variation\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"hours\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Day 1 and 15 of Cycle 1 (Each cycle is of 28 days)\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Cycle 1 Day 1\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2.52\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"42.77\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.62\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"23.00\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.22\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"39.23\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.28\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"43.77\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5.38\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"20.62\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"3.08\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3.57\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"27.06\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.17\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3.19\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"37.90\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.84\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"21.23\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3.90\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"48.23\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.75\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"22.10\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5.97\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Cycle 1 Day 15\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 10\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2.56\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"90.49\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.02\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"62.27\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.72\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"89.13\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3.12\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"62.02\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2.96\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"115.92\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3.71\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"59.62\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2.45\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"28.62\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2.10\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2.83\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"41.44\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4.14\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"2.57\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Area Under the Plasma Concentration-time Curve From Time 0 to Time of Last Quantifiable Concentration [AUC(0-T)]\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Blood samples were collected to assess pharmacokinetic parameters.\"\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"PK evaluable population included all treated participants who have any available concentration-time data. Only \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"GEOMETRIC_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Geometric Coefficient of Variation\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"ng*h/mL\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Day 1 and 15 of Cycle 1 (Each cycle is of 28 days)\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Cycle 1 Day 1\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"28.20\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"195.49\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"78.06\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"26.21\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"127.52\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"37.45\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"190.26\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"65.52\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"263.11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"46.78\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"21.59\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"39.75\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"47.81\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"25.65\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"45.09\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"177.07\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"37.21\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"275.58\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"34.92\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"72.34\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"26.97\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"132.88\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"64.47\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"255.90\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Cycle 1 Day 15\"\n",
      "  .. .. .. .. .. .. .. ..$ denoms    :List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 10\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"188.79\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"74.03\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"251.19\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"83.24\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"435.29\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"48.55\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1252.68\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"74.84\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"492.07\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"124.61\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"178.12\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"67.11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"377.22\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"38.40\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"170.18\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment: chr \"Not applicable as only 1 participant analyzed\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"360.41\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"132.44\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"736.15\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"131.38\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Objective Response Rate (ORR) Per RECIST v1.1\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"ORR is defined as the percentage of participants whose best overall response (BOR) is either CR or PR per respo\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety population included all participants who received at least 1 dose of study intervention.\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"NUMBER\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"percentage of participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"From randomization to the date of objectively documented progression per RECIST v1.1 or the date of subsequent \"| __truncated__\n",
      "  .. .. .. .. .. ..$ groups               :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"70.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"45.9\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"41.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"28.5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"70.8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"60.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"52.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"84.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"16.7\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"64.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"41.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"36.9\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"52.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"97.5\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Duration of Response Per RECIST v1.1\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"DOR for a participant with a best overall response (BOR) of CR or PR is defined as the time between the date of\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety population included all participants who received at least 1 dose of study intervention. Only confirmed \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"MEDIAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"95% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"months\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"From randomization to the date of objectively documented progression per RECIST v1.1 or the date of subsequent \"| __truncated__\n",
      "  .. .. .. .. .. ..$ groups               :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 1\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment   : chr \"Not estimable due to insufficient number of events.\"\n",
      "  .. .. .. .. ..$ :List of 10\n",
      "  .. .. .. .. .. ..$ type                 : chr \"PRIMARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Number of Participants Who Died\"\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety population included all participants who received at least 1 dose of study intervention\"\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"From first dose (Day 1) until 100 days after the last dose (Up to approximately 15 months)\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 13\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"11\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 13\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG005\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG006\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG007\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG010\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. ..$ adverseEventsModule          :List of 6\n",
      "  .. .. .. ..$ frequencyThreshold: chr \"5\"\n",
      "  .. .. .. ..$ timeFrame         : chr \"All-cause mortality was collected from Day 1 and up to 107 weeks. Serious adverse events, other AEs were collec\"| __truncated__\n",
      "  .. .. .. ..$ description       : chr \"Safety population included all participants who received at least 1 dose of study intervention.\"\n",
      "  .. .. .. ..$ eventGroups       :List of 13\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG000\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 (Group A) BMS-986408 0.75 mg QD\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced solid tumors received 0.75 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 3\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 3\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 2\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 3\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 3\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 3\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG001\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 (Group A) BMS-986408 1.5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 4\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 6\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 1\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 6\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 6\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 6\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG002\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 (Group A) BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced solid tumors received 3 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 3\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 7\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 2\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 7\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 6\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 7\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG003\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 (Group A) BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced solid tumors received 5 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 6\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 11\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 7\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 11\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 11\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 11\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG004\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 (Group A) BMS-986408 7.25 mg QD\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced solid tumors received 7.25 mg tablets of BMS-986408 once daily (QD).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 0\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 3\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 2\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 3\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 3\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 3\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG005\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 (Group B) BMS-986408 1.5 mg BID\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced solid tumors received 1.5 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 3\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 4\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 3\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 4\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 4\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 4\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG006\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 (Group B) BMS-986408 2.25 mg BID\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced solid tumors received 2.25 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 4\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 5\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 4\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 5\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 5\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 5\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG007\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 (Group B) BMS-986408 3.75 mg BID\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced solid tumors received 3.75 mg tablets of BMS-986408 twice in a day (BID).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 2\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 2\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 2\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 2\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 2\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 2\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG008\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 Group C BMS-986408 3 mg QD\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 3\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 6\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 4\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 6\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 6\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 6\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG009\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 1 Group C BMS-986408 5 mg QD\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 4\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 7\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 3\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 7\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 7\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 7\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG010\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 2 Group D BMS-986408 1.5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 3\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 8\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 3\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 8\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 8\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 8\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG011\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 2 Group D BMS-986408 3 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 2\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 5\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 3\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 5\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 5\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 5\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG012\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part 2 Group D BMS-986408 5 mg QD + NIVO 480 mg Q4W\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants with advanced, unresectable/metastatic solid malignancy of the following histologies: HNSCC, NSCLC\"| __truncated__\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 0\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 1\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 1\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 1\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 1\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 1\n",
      "  .. .. .. ..$ seriousEvents     :List of 45\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Anaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Aplasia pure red cell\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Bone marrow failure\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Immune-mediated pancytopenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Normocytic anaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Vision blurred\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Eye disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Constipation\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Diarrhoea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Haemorrhoidal haemorrhage\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Large intestine perforation\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Vomiting\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Asthenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Chest pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Fatigue\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pyrexia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Haemophagocytic lymphohistiocytosis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Immune system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Osteomyelitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pneumonia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Sepsis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Wound infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Spinal fracture\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Injury, poisoning and procedural complications\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Blood bilirubin increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"General physical condition abnormal\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dehydration\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hyponatraemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Flank pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Musculoskeletal and connective tissue disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Malignant neoplasm progression\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Neoplasms benign, malignant and unspecified (incl cysts and polyps)\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Brain oedema\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Cerebrovascular accident\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Acute kidney injury\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Renal and urinary disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Ureteric rupture\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Renal and urinary disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Urinary retention\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Renal and urinary disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Urinary tract obstruction\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Renal and urinary disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pelvic pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Reproductive system and breast disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dyspnoea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dyspnoea exertional\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Haemoptysis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Lung disorder\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pleurisy\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pulmonary haemorrhage\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Diabetic foot\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Skin and subcutaneous tissue disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Assisted suicide\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Surgical and medical procedures\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Embolism arterial\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Vascular disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. ..$ otherEvents       :List of 178\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Anaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Aplasia pure red cell\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Disseminated intravascular coagulation\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Lymphopenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Normocytic anaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Thrombocytopenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Palpitations\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Cardiac disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Sinus tachycardia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Cardiac disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Ear discomfort\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Ear and labyrinth disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Tinnitus\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Ear and labyrinth disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Adrenal insufficiency\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Endocrine disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hyperthyroidism\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Endocrine disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hypothyroidism\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Endocrine disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Diplopia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Eye disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dry eye\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Eye disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Photophobia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Eye disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Vision blurred\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Eye disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Visual impairment\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Eye disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal distension\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal pain lower\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal pain upper\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Ascites\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Colitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Constipation\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Diarrhoea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 8\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 5\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dry mouth\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dyspepsia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dysphagia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Flatulence\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Gastrointestinal pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Gastrooesophageal reflux disease\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Gingival swelling\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Haematemesis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Melaena\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Nausea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 8\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Odynophagia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Regurgitation\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Vomiting\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Asthenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Chest pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Chills\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Facial pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Fatigue\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 5\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Gait disturbance\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Malaise\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Non-cardiac chest pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Oedema peripheral\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Peripheral swelling\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pyrexia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 5\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Xerosis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Bronchitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"COVID-19\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Candida infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Ear infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Fungal oesophagitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hordeolum\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Oral candidiasis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Osteomyelitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pneumonia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Purulent discharge\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Rash pustular\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Rhinolaryngitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Sinusitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Urinary tract infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Wound infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Fibula fracture\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Injury, poisoning and procedural complications\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Infusion related reaction\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Injury, poisoning and procedural complications\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Alanine aminotransferase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Amylase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Aspartate aminotransferase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Blood albumin decreased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Blood alkaline phosphatase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Blood bilirubin increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Blood creatinine increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Blood fibrinogen decreased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"C-reactive protein increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Electrocardiogram QT prolonged\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Gamma-glutamyltransferase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"General physical condition abnormal\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Heart rate increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Lipase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Lymphocyte count decreased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Neutrophil count decreased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Platelet count decreased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Troponin I increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Troponin T increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Troponin increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Urine analysis abnormal\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Weight decreased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"White blood cell count decreased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Appetite disorder\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Decreased appetite\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dehydration\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Folate deficiency\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hypercalcaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hyperferritinaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA 27.0\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 13\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 11\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG004\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 3\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG005\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG006\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG007\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 2\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG008\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 6\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG009\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 7\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG010\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 8\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG011\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 5\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG012\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 1\n",
      "  .. .. .. .. .. [list output truncated]\n",
      "  .. .. ..$ moreInfoModule               :List of 2\n",
      "  .. .. .. ..$ certainAgreement:List of 4\n",
      "  .. .. .. .. ..$ piSponsorEmployee   : logi FALSE\n",
      "  .. .. .. .. ..$ restrictionType     : chr \"OTHER\"\n",
      "  .. .. .. .. ..$ restrictiveAgreement: logi TRUE\n",
      "  .. .. .. .. ..$ otherDetails        : chr \"Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications re\"| __truncated__\n",
      "  .. .. .. ..$ pointOfContact  :List of 4\n",
      "  .. .. .. .. ..$ title       : chr \"Bristol-Myers Squibb Study Director\"\n",
      "  .. .. .. .. ..$ organization: chr \"Bristol-Myers Squibb\"\n",
      "  .. .. .. .. ..$ email       : chr \"Clinical.Trials@bms.com\"\n",
      "  .. .. .. .. ..$ phone       : chr \"Please email\"\n",
      "  .. ..$ documentSection:List of 1\n",
      "  .. .. ..$ largeDocumentModule:List of 1\n",
      "  .. .. .. ..$ largeDocs:List of 1\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ typeAbbrev : chr \"Prot_SAP\"\n",
      "  .. .. .. .. .. ..$ hasProtocol: logi TRUE\n",
      "  .. .. .. .. .. ..$ hasSap     : logi TRUE\n",
      "  .. .. .. .. .. ..$ hasIcf     : logi FALSE\n",
      "  .. .. .. .. .. ..$ label      : chr \"Study Protocol and Statistical Analysis Plan\"\n",
      "  .. .. .. .. .. ..$ date       : chr \"2023-12-11\"\n",
      "  .. .. .. .. .. ..$ uploadDate : chr \"2025-08-19T00:23\"\n",
      "  .. .. .. .. .. ..$ filename   : chr \"Prot_SAP_000.pdf\"\n",
      "  .. .. .. .. .. ..$ size       : int 15702451\n",
      "  .. ..$ derivedSection :List of 3\n",
      "  .. .. ..$ miscInfoModule          :List of 2\n",
      "  .. .. .. ..$ versionHolder     : chr \"2026-01-22\"\n",
      "  .. .. .. ..$ submissionTracking:List of 1\n",
      "  .. .. .. .. ..$ firstMcpInfo:List of 1\n",
      "  .. .. .. .. .. ..$ postDateStruct:List of 2\n",
      "  .. .. .. .. .. .. ..$ date: chr \"2025-09-08\"\n",
      "  .. .. .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ conditionBrowseModule   :List of 1\n",
      "  .. .. .. ..$ meshes:List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009369\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms\"\n",
      "  .. .. ..$ interventionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 6\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000077594\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Nivolumab\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000074324\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Ipilimumab\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D017239\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Paclitaxel\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000068437\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pemetrexed\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002945\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Cisplatin\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D064750\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Rabeprazole\"\n",
      "  .. .. .. ..$ ancestors:List of 40\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D061067\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Antibodies, Monoclonal, Humanized\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000911\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Antibodies, Monoclonal\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000906\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Antibodies\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007136\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immunoglobulins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007162\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immunoproteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001798\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Blood Proteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011506\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Proteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000602\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Amino Acids, Peptides, and Proteins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012712\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Serum Globulins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005916\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Globulins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D043823\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Taxoids\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D043822\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Cyclodecanes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003516\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Cycloparaffins\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006840\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons, Alicyclic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006844\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons, Cyclic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006838\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009930\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Organic Chemicals\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D004224\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Diterpenes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013729\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Terpenes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006147\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Guanine\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007042\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hypoxanthines\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011688\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Purinones\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011687\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Purines\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006574\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, 2-Ring\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000072471\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, Fused-Ring\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006571\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005971\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Glutamates\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D024342\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Amino Acids, Acidic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000596\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Amino Acids\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000600\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Amino Acids, Dicarboxylic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D017606\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Chlorine Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007287\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Inorganic Chemicals\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D017672\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Nitrogen Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D017671\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Platinum Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D053799\"\n",
      "  .. .. .. .. .. ..$ term: chr \"2-Pyridinylmethylsulfinylbenzimidazoles\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013454\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Sulfoxides\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013457\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Sulfur Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011725\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pyridines\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006573\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, 1-Ring\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001562\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Benzimidazoles\"\n",
      "  .. ..$ hasResults     : logi TRUE\n",
      "  ..$ :List of 5\n",
      "  .. ..$ protocolSection:List of 13\n",
      "  .. .. ..$ identificationModule      :List of 7\n",
      "  .. .. .. ..$ nctId           : chr \"NCT05546476\"\n",
      "  .. .. .. ..$ orgStudyIdInfo  :List of 1\n",
      "  .. .. .. .. ..$ id: chr \"C3651003\"\n",
      "  .. .. .. ..$ secondaryIdInfos:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"2023-510446-24-00\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"REGISTRY\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"CTIS (EU)\"\n",
      "  .. .. .. ..$ organization    :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"Pfizer\"\n",
      "  .. .. .. .. ..$ class   : chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ briefTitle      : chr \"Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15\"\n",
      "  .. .. .. ..$ officialTitle   : chr \"A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABIL\"| __truncated__\n",
      "  .. .. .. ..$ acronym         : chr \"PROACC-1\"\n",
      "  .. .. ..$ statusModule              :List of 13\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2025-05\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"COMPLETED\"\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-11-21\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2024-03-13\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-04-23\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2022-08-12\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2022-09-15\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-09-19\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ resultsFirstSubmitDate     : chr \"2025-03-11\"\n",
      "  .. .. .. ..$ resultsFirstSubmitQcDate   : chr \"2025-04-23\"\n",
      "  .. .. .. ..$ resultsFirstPostDateStruct :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-04-29\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2025-05-29\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-05-31\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 2\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"Pfizer\"\n",
      "  .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 2\n",
      "  .. .. .. ..$ briefSummary       : chr \"Study to evaluate the efficacy, safety and tolerability of ponsegromab compared to placebo in patients with can\"| __truncated__\n",
      "  .. .. .. ..$ detailedDescription: chr \"A 12 week double blind study to evaluate the efficacy, safety and tolerability of ponsegromab compared to place\"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 2\n",
      "  .. .. .. ..$ conditions:List of 6\n",
      "  .. .. .. .. ..$ : chr \"Non-small Cell Lung Cancer\"\n",
      "  .. .. .. .. ..$ : chr \"Pancreatic Cancer\"\n",
      "  .. .. .. .. ..$ : chr \"Colorectal Cancer\"\n",
      "  .. .. .. .. ..$ : chr \"Loss of Appetite\"\n",
      "  .. .. .. .. ..$ : chr \"Fatigue\"\n",
      "  .. .. .. .. ..$ : chr \"Cachexia\"\n",
      "  .. .. .. ..$ keywords  :List of 6\n",
      "  .. .. .. .. ..$ : chr \"cancer\"\n",
      "  .. .. .. .. ..$ : chr \"anorexia\"\n",
      "  .. .. .. .. ..$ : chr \"cachexia\"\n",
      "  .. .. .. .. ..$ : chr \"weight loss\"\n",
      "  .. .. .. .. ..$ : chr \"loss of appetite\"\n",
      "  .. .. .. .. ..$ : chr \"fatigue\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 1\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 4\n",
      "  .. .. .. .. ..$ allocation       : chr \"RANDOMIZED\"\n",
      "  .. .. .. .. ..$ interventionModel: chr \"SEQUENTIAL\"\n",
      "  .. .. .. .. ..$ primaryPurpose   : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo      :List of 3\n",
      "  .. .. .. .. .. ..$ masking           : chr \"QUADRUPLE\"\n",
      "  .. .. .. .. .. ..$ maskingDescription: chr \"Double-blind for 12-week double-blind treatment period followed by an up to 1 year optional open-label treatment period\"\n",
      "  .. .. .. .. .. ..$ whoMasked         :List of 4\n",
      "  .. .. .. .. .. .. ..$ : chr \"PARTICIPANT\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"CARE_PROVIDER\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"INVESTIGATOR\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"OUTCOMES_ASSESSOR\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 187\n",
      "  .. .. .. .. ..$ type : chr \"ACTUAL\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 4\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Double-Blind ponsegromab Treatment low dose followed by Open Label ponsegromab Treatment\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"ponsegromab low dose subcutaneous injection every 4 weeks\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: ponsegromab\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Double-Blind Placebo Treatment followed by Open-Label ponsegromab Treatment\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"PLACEBO_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Match placebo subcutaneous injection every 4 weeks\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Placebo for ponsegromab\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Double-Blind ponsegromab Treatment medium dose followed by Open Label ponsegromab Treatment\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"ponsegromab medium dose subcutaneous injection every 4 weeks\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: ponsegromab\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Double-Blind ponsegromab Treatment high dose followed by Open Label ponsegromab Treatment\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"ponsegromab high dose subcutaneous injection every 4 weeks\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: ponsegromab\"\n",
      "  .. .. .. ..$ interventions:List of 2\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"ponsegromab\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Double-Blind ponsegromab Treatment followed by Open Label ponsegromab Treatment\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Double-Blind ponsegromab Treatment high dose followed by Open Label ponsegromab Treatment\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Double-Blind ponsegromab Treatment low dose followed by Open Label ponsegromab Treatment\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Double-Blind ponsegromab Treatment medium dose followed by Open Label ponsegromab Treatment\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Placebo for ponsegromab\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Double-Blind placebo Treatment followed by Open Label ponsegromab Treatment\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Double-Blind Placebo Treatment followed by Open-Label ponsegromab Treatment\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Change From Baseline in Body Weight at Week 12\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Body weight was measured in kilograms using a calibrated weighing scale. Baseline was defined as the last avera\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 12\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 12\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Change From Baseline in Physical Activity at Week 12\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Physical activity was monitored using accelerometry (wearable digital sensors). Physical activity was categoriz\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Change From Baseline in Mean Activity Level During Maximum 6 Minutes at Week 12\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Physical activity was monitored using accelerometry (wearable digital sensors). In this outcome measure mean ac\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Change From Baseline in Total Vector Magnitude at Week 12\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Total vector magnitude is a measure of overall physical activity. Baseline was defined as the mean taken over t\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Change From Baseline in Gait at Week 12\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Gait was monitored using accelerometry (wearable digital sensors). Analysis was performed using MMRM model. Gai\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Change From Baseline in Functional Assessment of Anorexia-Cachexia Therapy- Anorexia and Cachexia Subsc\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"FAACT-ACS is a 12-item symptom-specific subscale to measure participants' concerns about their anorexia (appeti\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline (prior to dose on Day 1), Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Change From Baseline in FAACT- 5-Item Anorexia Symptom Scale (5IASS) at Week 12\"\n",
      "  .. .. .. .. .. ..$ description: chr \"FAACT-5IASS is a 5-item subscale to measure participants' perceptions of anorexia (appetite) concerns for past \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline (prior to dose on Day 1), Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Change From Baseline in Cancer-Related Cachexia Symptom Diary (CRCSD) Scores at Week 12: Appetite, Naus\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"The CRCSD is a daily, self-reported questionnaire that measured severity of symptoms related to cancer cachexia\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Median Change From Baseline in CRCSD Scores at Week 12: Vomiting Frequency\"\n",
      "  .. .. .. .. .. ..$ description: chr \"The CRCSD is a daily, self-reported questionnaire that measured severity of symptoms related to cancer cachexia\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Number of Participants With Treatment Emergent Adverse Events (TEAE)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"An adverse event (AE) was defined as any untoward medical occurrence in a participant administered a pharmaceut\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"From start of study drug on Day 1 maximum up to 4 weeks post last dose on Week 12 (maximum up to approximately Week 16)\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Number of Participants With Incidence of Laboratory Test Abnormalities\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Laboratory test abnormality parameters included: hematology- hemoglobin (gram per deciliter \\\\[g/dL\\\\]), hemato\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Day 1 up to Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Number of Participants With Post-Baseline Vital Signs Meeting the Predefined Criteria\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Vital signs criteria included: supine systolic blood pressure (SBP) \\\\<90 millimeters of mercury (mmHg), increa\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Day 1 up to Week 12\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Part A: Number of Participants With Clinically Significant Echocardiogram (ECG) Abnormalities\"\n",
      "  .. .. .. .. .. ..$ description: chr \"ECG parameters included heart rate (HR), PR interval, QT interval, QTc corrected using Fridericia's formula (QT\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Day 1 up to Week 12\"\n",
      "  .. .. ..$ eligibilityModule         :List of 5\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Key Inclusion Criteria:\\n\\n* Documented active diagnosis of non-small cell lung, pancreatic, colorectal cancer\\\"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"ALL\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"18 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 2\n",
      "  .. .. .. .. ..$ : chr \"ADULT\"\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 2\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"Pfizer CT.gov Call Center\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Pfizer\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"STUDY_DIRECTOR\"\n",
      "  .. .. .. ..$ locations       :List of 78\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CARTI Conway\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Conway\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Arkansas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"72034\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 35.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -92.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CARTI Cancer Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Little Rock\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Arkansas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"72205\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -92.3\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CARTI North Little Rock\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"North Little Rock\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Arkansas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"72117\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -92.3\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CARTI Stuttgart\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Stuttgart\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Arkansas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"72160\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -91.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pacific Cancer Medical Center INC\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Anaheim\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"92801\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 33.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -118\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Beverly Hills Cancer Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Beverly Hills\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"90211\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -118\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Emad Ibrahim,MD,INC.\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Redlands\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"92373\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -117\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Providence Medical Foundation\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santa Rosa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"95403\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -123\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"IU Health Arnett Cancer Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lafayette\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Indiana\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"47904\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -86.9\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pennington Biomedical Research Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Baton Rouge\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Louisiana\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"70808\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -91.2\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Tandem Clinical Research\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Marrero\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Louisiana\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"70072\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 29.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -90.1\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Bozeman Health Deaconess Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bozeman\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Montana\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"59715\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -111\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Oregon Health and Science University: Center for Health and Healing 1\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Portland\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Oregon\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"97239\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -123\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Oregon Health and Science University: Center for Health and Healing 2\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Portland\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Oregon\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"97239\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -123\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Oregon Health and Science University\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Portland\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Oregon\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"97239\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -123\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The University of Texas MD Anderson Cancer Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Houston\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Texas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"77030\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 29.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -95.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Carta - Clinical Associates in Research Therapeutics of America, LLC\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"San Antonio\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Texas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"78212\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 29.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -98.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Virginia Mason Medical Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Seattle\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Washington\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"98101\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -122\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Wenatchee Valley Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wenatchee\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Washington\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"98801\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -120\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"St Vincent's Hospital Sydney\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Darlinghurst\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New South Wales\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"2010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 151\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Orange Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Orange\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New South Wales\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"2800\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 149\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Peter MacCallum Cancer Centre\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Melbourne\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Victoria\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -37.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 145\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Western Health-Sunshine & Footscray Hospitals\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"St Albans\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Victoria\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3021\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -37.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 145\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Complex Oncology Center - Burgas\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Burgas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"8000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Bulgaria\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 27.5\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Specialized Hospital for Active Treatment of Oncology - Haskovo\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Haskovo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"6300\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Bulgaria\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 25.6\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Complex Oncology Center - Ruse EOOD\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Rousse\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7002\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Bulgaria\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 26\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Complex Oncology Center - Shumen\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Shumen\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"9700\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Bulgaria\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 26.9\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Multiprofile Hospital for Active Treatment Serdika EOOD\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Sofia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1303\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Bulgaria\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.3\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"MHAT for Women's Health Nadezhda\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Sofia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1330\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Bulgaria\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.3\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"University Multiprofile Hospital for Active Treatment Sofiamed\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Sofia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1797\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Bulgaria\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.3\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Complex Oncology Center - Vratsa\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Vratsa\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Bulgaria\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The Ottawa Hospital - General Campus\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ottawa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"K1H 8L6\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -75.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Princess Margaret Cancer Centre\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toronto\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"M5G 2M9\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CIUSSS- saguenay-Lac-Saint-Jean\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chicoutimi\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Quebec\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"G7H 5H6\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -71.1\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Rimouski\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Quebec\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"G5L 5T1\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -68.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Peking University First Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Beijing\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Beijing Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"100034\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Henan Cancer Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Zhengzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Henan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"450008\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wuhan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Hubei\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"430030\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Changzhou No.2 People's Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Changzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Jiangsu\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"213003\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 31.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First Affiliated Hospital of Nanchang University\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nanchang\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Jiangxi\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"330006\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Qilu Hospital of Shandong University\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Jinan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Shandong\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"250012\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 36.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 117\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Shanghai Changhai Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Shanghai\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Shanghai Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"200433\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 31.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 121\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Shanxi Provincial Cancer Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Taiyuan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Shanxi\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"030013\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Sir Run Run Shaw Hospital of Zhejiang University School of Medicine\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Zhejiang\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"310016\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wenzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Zhejiang\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"325035\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28\n",
      "  .. .. .. .. .. .. ..$ lon: num 121\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Bacs-Kiskun Varmegyei Oktatokorhaz\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kecskemét\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Bács-Kiskun county\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"6000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hungary\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 46.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 19.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Szolnok\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Jász-Nagykun-Szolnok\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"5004\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hungary\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 20.2\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Semmelweis Egyetem\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Budapest\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1083\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hungary\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 19\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Országos Korányi Pulmonológiai Intézet\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Budapest\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1121\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hungary\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 19\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"National Cancer Center Hospital East\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kashiwa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Chiba\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"277-8577\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Japan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 35.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 140\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"National Hospital Organization Shikoku Cancer Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Matsuyama\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ehime\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"791-0280\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Japan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 33.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 133\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hyogo Cancer Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Akashi\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Hyōgo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"673-8558\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Japan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 135\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Kanagawa cancer center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Yokohama\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Kanagawa\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"241-8515\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Japan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 35.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 140\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Aichi Cancer Center Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nagoya\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Nagoya, Aichi\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"464-8681\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Japan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 35.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 137\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Shizuoka Cancer Center\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nagaizumi-cho\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Shizuoka\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"411-8777\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Japan\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"University Hospital,Kyoto Prefectural University of Medicine\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kyoto\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"602-8566\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Japan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 35\n",
      "  .. .. .. .. .. .. ..$ lon: num 136\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"The Cancer Institute Hospital of JFCR\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Tokyo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"135-8550\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Japan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 35.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 140\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o.\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Krakow\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lesser Poland Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"30-348\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 19.9\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Regionalny Szpital Specjalistyczny im. Dr. Wladyslawa Bieganskiego\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Grudziądz\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"86-300\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 53.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.8\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"NZOZ \\\"Vegamed\\\"\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Katowice\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40-060\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 19\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Specjalistyczna Praktyka Lekarska Slawomir Mandziuk\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lublin\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"20-093\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 22.6\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fakultna nemocnica s poliklinikou F. D. Roosevelta Banska Bystrica\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Banská Bystrica\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"975 17\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Slovakia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 19.1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Univerzitna nemocnica Bratislava, Nemocnica Ruzinov\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bratislava\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"826 06\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Slovakia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 17.1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Narodny onkologicky ustav, II. Onkologicka klinika LFUK a NOU\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bratislava\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"833 10\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Slovakia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 17.1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fakultna nemocnica s poliklinikou Nove Zamky\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Nové Zámky\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"940 34\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Slovakia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.2\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Nemocnica na okraji mesta, n.o.\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Partizánske\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"95801\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Slovakia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.4\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fakultna nemocnica Trnava\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Trnava\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"917 75\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Slovakia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 17.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitari General de Catalunya\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Sant Cugat del Vallès\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Barcelona [barcelona]\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"08915\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.09\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Institut Català d'Oncologia - L'Hospitalet\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"L'Hospitalet de Llobregat\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Catalunya [cataluña]\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"08908\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.1\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Son Llàtzer\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Palma\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Illes Balears [islas Baleares]\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"07198\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.65\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fundación Instituto Valenciano de Oncología\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Valencia\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Valenciana, Comunitat\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"46009\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -0.38\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitario HM Sanchinarro\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Madrid\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"28050\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -3.7\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitari i Politecnic La Fe\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Valencia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"46026\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -0.38\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Chi Mei Hospital - Liouying Branch\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Tainan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Tainan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"73657\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Taiwan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 23\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Kaohsiung Medical University Chung-Ho Memorial Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kaohsiung City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80756\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Taiwan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 22.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"China Medical University Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Taichung\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"404332\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Taiwan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 24.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 121\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"National Cheng Kung University Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Tainan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"704\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Taiwan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 23\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Chang Gung Medical Foundation-Linkou Branch\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Taoyuan District\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"333\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Taiwan\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 25\n",
      "  .. .. .. .. .. .. ..$ lon: num 121\n",
      "  .. .. ..$ referencesModule          :List of 2\n",
      "  .. .. .. ..$ references  :List of 2\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"39282907\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"DERIVED\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Groarke JD, Crawford J, Collins SM, Lubaczewski S, Roeland EJ, Naito T, Hendifar AE, Fallon M, Takayama K, Asmi\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"38500292\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"DERIVED\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Groarke JD, Crawford J, Collins SM, Lubaczewski SL, Breen DM, Harrington MA, Jacobs I, Qiu R, Revkin J, Rossule\"| __truncated__\n",
      "  .. .. .. ..$ seeAlsoLinks:List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"To obtain contact information for a study center near you, click here.\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://pmiform.com/clinical-trial-info-request?StudyID=C3651003\"\n",
      "  .. .. ..$ ipdSharingStatementModule :List of 3\n",
      "  .. .. .. ..$ ipdSharing : chr \"YES\"\n",
      "  .. .. .. ..$ description: chr \"Pfizer will provide access to individual de-identified participant data and related study documents (e.g. proto\"| __truncated__\n",
      "  .. .. .. ..$ url        : chr \"https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests\"\n",
      "  .. ..$ resultsSection :List of 5\n",
      "  .. .. ..$ participantFlowModule        :List of 3\n",
      "  .. .. .. ..$ recruitmentDetails: chr \"A total of 187 participants were enrolled in this study. This study had 2 parts: Part A and Part B. On completi\"| __truncated__\n",
      "  .. .. .. ..$ groups            :List of 4\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG000\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part A: Placebo/ Part B: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab subcutaneously (SC) once in eve\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG001\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg/ Part B: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 milligrams (mg) SC Q4W up to 12 weeks (total of\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG002\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg/ Part B: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses). Pa\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"FG003\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg/ Part B: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses). Pa\"| __truncated__\n",
      "  .. .. .. ..$ periods           :List of 2\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ title        : chr \"Period 1: Part A\"\n",
      "  .. .. .. .. .. ..$ milestones   :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"STARTED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"45\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"46\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"46\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"50\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"32\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"32\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"39\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"34\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"NOT COMPLETED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"13\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"14\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"7\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"16\"\n",
      "  .. .. .. .. .. ..$ dropWithdraws:List of 9\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Adverse Event\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Death\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"6\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Lack of Efficacy\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Lost to Follow-up\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Physician Decision\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Progressive disease\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Withdrawal by Subject\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Global deterioration of health status\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"4\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Other: Unspecified\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ title        : chr \"Period 2: Part B\"\n",
      "  .. .. .. .. .. ..$ milestones   :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"STARTED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"26\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"27\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"35\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"29\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"COMPLETED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type        : chr \"NOT COMPLETED\"\n",
      "  .. .. .. .. .. .. .. ..$ achievements:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"26\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"27\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"35\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"29\"\n",
      "  .. .. .. .. .. ..$ dropWithdraws:List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ type   : chr \"Ongoing\"\n",
      "  .. .. .. .. .. .. .. ..$ reasons:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"26\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"27\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"35\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId    : chr \"FG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ numSubjects: chr \"29\"\n",
      "  .. .. ..$ baselineCharacteristicsModule:List of 4\n",
      "  .. .. .. ..$ populationDescription: chr \"Safety analysis set included all participants randomly assigned to study intervention and who took at least 1 d\"| __truncated__\n",
      "  .. .. .. ..$ groups               :List of 5\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG000\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part A: Placebo/ Part B: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG001\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg/ Part B: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses). Pa\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG002\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg/ Part B: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses). Pa\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG003\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg/ Part B: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses). Pa\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id         : chr \"BG004\"\n",
      "  .. .. .. .. .. ..$ title      : chr \"Total\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Total of all reporting groups\"\n",
      "  .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ counts:List of 5\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"45\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"46\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"46\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"50\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. ..$ value  : chr \"187\"\n",
      "  .. .. .. ..$ measures             :List of 4\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ title         : chr \"Age, Continuous\"\n",
      "  .. .. .. .. .. ..$ paramType     : chr \"MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType: chr \"STANDARD_DEVIATION\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure : chr \"Years\"\n",
      "  .. .. .. .. .. ..$ classes       :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"63.2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"11.26\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"70.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"9.38\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"65.9\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"9.61\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"66.1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"9.93\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"66.4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ spread : chr \"10.28\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Sex: Female, Male\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Female\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"17\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"19\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"15\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"18\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"69\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Male\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"28\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"31\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"32\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"118\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Ethnicity (NIH/OMB)\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 3\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Hispanic or Latino\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"9\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Not Hispanic or Latino\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"43\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"42\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"44\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"43\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"172\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Unknown or Not Reported\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ title        : chr \"Race (NIH/OMB)\"\n",
      "  .. .. .. .. .. ..$ paramType    : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure: chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ classes      :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 7\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"American Indian or Alaska Native\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Asian\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"18\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"19\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"18\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"15\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"70\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Native Hawaiian or Other Pacific Islander\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Black or African American\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"White\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"26\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"28\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"35\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"116\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"More than one race\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ title       : chr \"Unknown or Not Reported\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"BG004\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. ..$ outcomeMeasuresModule        :List of 1\n",
      "  .. .. .. ..$ outcomeMeasures:List of 13\n",
      "  .. .. .. .. ..$ :List of 13\n",
      "  .. .. .. .. .. ..$ type                 : chr \"PRIMARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Change From Baseline in Body Weight at Week 12\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Body weight was measured in kilograms using a calibrated weighing scale. Baseline was defined as the last avera\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set included all evaluable participants. For participants who discontinued study intervention\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"MEDIAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"90% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Kilogram\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"45\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"46\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"46\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"50\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment   : chr \"Measure Type = Posterior Median = -0.60 Measure of Dispersion = 90% Credible Interval = -1.50 to 0.24\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment   : chr \"Measure Type = Posterior Median = 0.75 Measure of Dispersion = 90% Credible Interval = 0.06 to 1.44\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment   : chr \"Measure Type = Posterior Median = 1.48 Measure of Dispersion = 90% Credible Interval = 0.87 to 2.08\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"NA\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ comment   : chr \"Measure Type = Posterior Median = 2.39 Measure of Dispersion = 90% Credible Interval = 1.49 to 3.34\"\n",
      "  .. .. .. .. .. ..$ analyses             :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Bayesian Emax model was used for statistical calculation. The posterior medians and 90% credible intervals (5th\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in Posterior Median\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"1.33\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"0.49\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"2.34\"\n",
      "  .. .. .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Bayesian Emax model was used for statistical calculation. The posterior medians and 90% credible intervals (5th\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in Posterior Median\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"2.08\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"1.08\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"3.15\"\n",
      "  .. .. .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Bayesian Emax model was used for statistical calculation. The posterior medians and 90% credible intervals (5th\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in Posterior Median\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"3\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"1.68\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"4.34\"\n",
      "  .. .. .. .. ..$ :List of 13\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Change From Baseline in Physical Activity at Week 12\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Physical activity was monitored using accelerometry (wearable digital sensors). Physical activity was categoriz\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set:all evaluable participants.For participants who discontinued study intervention/received \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"LEAST_SQUARES_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"90% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Minutes per day\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"12\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"17\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"16\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"13\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Time for Sedentary Activity\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-1.42\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-72.77\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"69.92\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"51.93\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-9.88\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"113.75\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-39.33\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-101.94\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"23.29\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-3.37\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-72.89\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"66.14\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Time for Non-Sedentary Physical Activity\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-37.73\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-66.14\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"-9.32\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.03\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-24.88\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"24.95\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-42.09\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-67.63\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"-16.56\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"12.11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-14.87\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"39.10\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Time for Moderate to Vigorous Physical Activity\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-4.45\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-13.91\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"5.02\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"4.07\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-4.18\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"12.32\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.05\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-8.29\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"8.39\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"3.67\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-5.37\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"12.71\"\n",
      "  .. .. .. .. .. ..$ analyses             :List of 9\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Sedentary Activity Time: MMRM model included participant as a random term, and baseline, time (as a factor), ba\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.8260\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"53.36\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-40.89\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"147.60\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Sedentary Activity Time: MMRM model included participant as a random term, and baseline, time (as a factor), ba\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.2540\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"-37.9\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-132.94\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"57.14\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Sedentary Activity Time: MMRM model included participant as a random term, and baseline, time (as a factor), ba\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.4870\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"-1.95\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-101.63\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"97.73\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Non-Sedentary Activity Time: MMRM model included participant as a random term, and baseline, time (as a factor)\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0497\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"37.76\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"0.07\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"75.46\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Non-Sedentary Activity Time: MMRM model included participant as a random term, and baseline, time (as a factor)\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.5745\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"-4.36\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-42.94\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"34.22\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Non-Sedentary Activity Time: MMRM model included participant as a random term, and baseline, time (as a factor)\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0189\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"49.85\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"10.62\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"89.08\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Moderate to Vigorous Physical Activity Time: MMRM model included participant as a random term, and baseline, ti\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.1302\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"8.51\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-4.00\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"21.03\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Moderate to Vigorous Physical Activity Time: MMRM model included participant as a random term, and baseline, ti\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.2780\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"4.49\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-8.18\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"17.16\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Moderate to Vigorous Physical Activity Time: MMRM model included participant as a random term, and baseline, ti\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.1529\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"8.11\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-5.01\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"21.23\"\n",
      "  .. .. .. .. ..$ :List of 13\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Change From Baseline in Mean Activity Level During Maximum 6 Minutes at Week 12\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Physical activity was monitored using accelerometry (wearable digital sensors). In this outcome measure mean ac\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set:all evaluable participants.For participants who discontinued study intervention/received \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"LEAST_SQUARES_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"90% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Arbitrary units per day (au/day)\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"12\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"17\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"16\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"13\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"70.81\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-785.82\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"927.45\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-59.46\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-794.41\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"675.49\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"794.96\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"39.43\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"1550.48\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"256.43\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-561.29\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"1074.16\"\n",
      "  .. .. .. .. .. ..$ analyses             :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.5762\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"-130.27\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-1257.31\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"996.77\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.1486\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"724.14\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-425.81\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1874.09\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.3972\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"185.62\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-997.94\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1369.18\"\n",
      "  .. .. .. .. ..$ :List of 13\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Change From Baseline in Total Vector Magnitude at Week 12\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Total vector magnitude is a measure of overall physical activity. Baseline was defined as the mean taken over t\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set: all evaluable participants. For participants who discontinued study intervention/receive\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"LEAST_SQUARES_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"90% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Total activity counts/100 per day\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"12\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"17\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"16\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"13\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-1919.02\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-3450.37\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"-387.68\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-331.76\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-1679.81\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"1016.29\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-2017.57\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-3387.48\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"-647.65\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"284.15\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-1175.46\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"1743.77\"\n",
      "  .. .. .. .. .. ..$ analyses             :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0985\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"1587.26\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-443.79\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"3618.31\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.5315\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"-98.54\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-2169.67\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1972.58\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0437\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"2203.18\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"84.51\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"4321.85\"\n",
      "  .. .. .. .. ..$ :List of 13\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Change From Baseline in Gait at Week 12\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Gait was monitored using accelerometry (wearable digital sensors). Analysis was performed using MMRM model. Gai\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set:all evaluable participants.For participants who discontinued study intervention/received \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"LEAST_SQUARES_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"90% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Meter per second (m/s)\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"15\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"19\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"18\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"14\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 2\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Gait Speed\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.008\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.042\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.026\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.040\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.023\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.012\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.044\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.019\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.009\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.024\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.042\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"95th percentile of gait speed\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.041\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.064\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.011\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.037\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.059\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.015\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.063\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.033\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.021\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.030\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.072\"\n",
      "  .. .. .. .. .. ..$ analyses             :List of 6\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Gait Speed: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-tim\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.5052\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.046\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"0.045\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Gait Speed: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-tim\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.5599\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"-0.004\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.050\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"0.042\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Gait Speed: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-tim\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.2770\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.017\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.030\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"0.064\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"95th Percentile of Gait Speed: MMRM model included participant as a random term, and baseline, time (as a facto\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.5047\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.071\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"0.070\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"95th Percentile of Gait Speed: MMRM model included participant as a random term, and baseline, time (as a facto\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.7316\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"-0.026\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.097\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"0.045\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"95th Percentile of Gait Speed: MMRM model included participant as a random term, and baseline, time (as a facto\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.4145\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.01\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.063\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"0.082\"\n",
      "  .. .. .. .. ..$ :List of 13\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Change From Baseline in Functional Assessment of Anorexia-Cachexia Therapy- Anorexia and Cachexia Subsc\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description          : chr \"FAACT-ACS is a 12-item symptom-specific subscale to measure participants' concerns about their anorexia (appeti\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set:all evaluable participants.For participants who discontinued study intervention/received \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"LEAST_SQUARES_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"90% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Units on a scale\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline (prior to dose on Day 1), Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"33\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.52\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-1.60\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"2.63\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"4.76\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"2.54\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"6.97\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"1.15\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.90\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"3.20\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"4.63\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"2.40\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"6.85\"\n",
      "  .. .. .. .. .. ..$ analyses             :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0114\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"4.24\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"1.19\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"7.28\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.3600\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.64\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-2.30\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"3.57\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0138\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"4.11\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"1.06\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"7.17\"\n",
      "  .. .. .. .. ..$ :List of 13\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Change From Baseline in FAACT- 5-Item Anorexia Symptom Scale (5IASS) at Week 12\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"FAACT-5IASS is a 5-item subscale to measure participants' perceptions of anorexia (appetite) concerns for past \"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set:all evaluable participants.For participants who discontinued study intervention/received \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"LEAST_SQUARES_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"90% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Units on a scale\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline (prior to dose on Day 1), Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"33\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.15\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.97\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"1.27\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"2.50\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"1.32\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"3.67\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.15\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.94\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"1.24\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"2.45\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"1.28\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"3.62\"\n",
      "  .. .. .. .. .. ..$ analyses             :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0090\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"2.35\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"0.72\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"3.97\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.4987\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-1.55\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.56\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time interactio\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0100\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"2.3\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"0.68\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"3.92\"\n",
      "  .. .. .. .. ..$ :List of 13\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Change From Baseline in Cancer-Related Cachexia Symptom Diary (CRCSD) Scores at Week 12: Appetite, Naus\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description          : chr \"The CRCSD is a daily, self-reported questionnaire that measured severity of symptoms related to cancer cachexia\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set:all evaluable participants.For participants who discontinued study intervention/received \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"LEAST_SQUARES_MEAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"90% Confidence Interval\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Units on a scale\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"24\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"26\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 3\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Appetite\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.23\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.83\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.37\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.20\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.36\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.76\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.23\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.37\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.82\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.69\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.11\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"1.27\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Nausea\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.33\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.82\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.17\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.14\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.32\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.61\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.06\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.43\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.55\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.50\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.98\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"-0.02\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Physical Fatigue\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.27\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.85\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.32\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.39\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.16\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.94\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.38\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.21\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.96\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"-0.06\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"-0.63\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.51\"\n",
      "  .. .. .. .. .. ..$ analyses             :List of 9\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Appetite: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time \"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.1912\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.43\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.38\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.24\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Appetite: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time \"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.1866\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.46\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.39\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.30\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Appetite: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time \"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.0349\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.92\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"0.09\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.75\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Nausea: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time in\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.8754\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.47\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.20\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.14\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Nausea: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time in\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.8205\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.38\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.31\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.08\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Nausea: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-by-time in\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.3375\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"-0.17\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.86\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"0.51\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Physical Fatigue: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.9138\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.66\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.14\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.45\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Physical Fatigue: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.9011\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.64\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.18\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.46\"\n",
      "  .. .. .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. .. .. ..$ groupIds          :List of 2\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. ..$ : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ groupDescription  : chr \"Physical Fatigue: MMRM model included participant as a random term, and baseline, time (as a factor), baseline-\"| __truncated__\n",
      "  .. .. .. .. .. .. .. ..$ nonInferiorityType: chr \"SUPERIORITY\"\n",
      "  .. .. .. .. .. .. .. ..$ pValue            : chr \"=0.6618\"\n",
      "  .. .. .. .. .. .. .. ..$ statisticalMethod : chr \"MMRM analysis; 1-sided\"\n",
      "  .. .. .. .. .. .. .. ..$ paramType         : chr \"Difference in LS Mean\"\n",
      "  .. .. .. .. .. .. .. ..$ paramValue        : chr \"0.21\"\n",
      "  .. .. .. .. .. .. .. ..$ ciPctValue        : chr \"90\"\n",
      "  .. .. .. .. .. .. .. ..$ ciNumSides        : chr \"TWO_SIDED\"\n",
      "  .. .. .. .. .. .. .. ..$ ciLowerLimit      : chr \"-0.61\"\n",
      "  .. .. .. .. .. .. .. ..$ ciUpperLimit      : chr \"1.02\"\n",
      "  .. .. .. .. ..$ :List of 12\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Median Change From Baseline in CRCSD Scores at Week 12: Vomiting Frequency\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"The CRCSD is a daily, self-reported questionnaire that measured severity of symptoms related to cancer cachexia\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Censored analysis set:all evaluable participants.For participants who discontinued study intervention/received \"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"MEDIAN\"\n",
      "  .. .. .. .. .. ..$ dispersionType       : chr \"Inter-Quartile Range\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Units on a scale\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Baseline, Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"24\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"30\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"26\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"27\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.00\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.00\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.00\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId   : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value     : chr \"0.00\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ lowerLimit: chr \"0.0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ upperLimit: chr \"0.0\"\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Number of Participants With Treatment Emergent Adverse Events (TEAE)\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"An adverse event (AE) was defined as any untoward medical occurrence in a participant administered a pharmaceut\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety analysis set included all participants randomly assigned to study intervention and who took at least 1 d\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"From start of study drug on Day 1 maximum up to 4 weeks post last dose on Week 12 (maximum up to approximately Week 16)\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"45\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"46\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"46\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"50\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"36\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"32\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"31\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"37\"\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Number of Participants With Incidence of Laboratory Test Abnormalities\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Laboratory test abnormality parameters included: hematology- hemoglobin (gram per deciliter \\\\[g/dL\\\\]), hemato\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety analysis set included all participants randomly assigned to study intervention and who took at least 1 d\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Day 1 up to Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"37\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"35\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"40\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"41\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"26\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"24\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"29\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"28\"\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Number of Participants With Post-Baseline Vital Signs Meeting the Predefined Criteria\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"Vital signs criteria included: supine systolic blood pressure (SBP) \\\\<90 millimeters of mercury (mmHg), increa\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety analysis set included all participants randomly assigned to study intervention and who took at least 1 d\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Day 1 up to Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"40\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"40\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"44\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"44\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 7\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Supine SBP Value < 90mmHg\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Supine SBP Increase Change >= 30mmHg\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"8\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Supine SBP Decrease Change >= 30mmHg\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"2\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"6\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"5\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Supine DBP Value < 50mmHg\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Supine SBP Increase Change >= 20mmHg\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Supine DBP Decrease Change >= 20mmHg\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"4\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ title     : chr \"Supine Pulse Rate Value > 120mmHg\"\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"3\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"1\"\n",
      "  .. .. .. .. ..$ :List of 11\n",
      "  .. .. .. .. .. ..$ type                 : chr \"SECONDARY\"\n",
      "  .. .. .. .. .. ..$ title                : chr \"Part A: Number of Participants With Clinically Significant Echocardiogram (ECG) Abnormalities\"\n",
      "  .. .. .. .. .. ..$ description          : chr \"ECG parameters included heart rate (HR), PR interval, QT interval, QTc corrected using Fridericia's formula (QT\"| __truncated__\n",
      "  .. .. .. .. .. ..$ populationDescription: chr \"Safety analysis set included all participants randomly assigned to study intervention and who took at least 1 d\"| __truncated__\n",
      "  .. .. .. .. .. ..$ reportingStatus      : chr \"POSTED\"\n",
      "  .. .. .. .. .. ..$ paramType            : chr \"COUNT_OF_PARTICIPANTS\"\n",
      "  .. .. .. .. .. ..$ unitOfMeasure        : chr \"Participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame            : chr \"Day 1 up to Week 12\"\n",
      "  .. .. .. .. .. ..$ groups               :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ id         : chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. ..$ title      : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. .. .. ..$ description: chr \"Part A: Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ denoms               :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. ..$ units : chr \"Participants\"\n",
      "  .. .. .. .. .. .. .. ..$ counts:List of 4\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"45\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"46\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"46\"\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. ..$ value  : chr \"50\"\n",
      "  .. .. .. .. .. ..$ classes              :List of 1\n",
      "  .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. ..$ categories:List of 1\n",
      "  .. .. .. .. .. .. .. .. ..$ :List of 1\n",
      "  .. .. .. .. .. .. .. .. .. ..$ measurements:List of 4\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG000\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG001\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG002\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. .. .. .. .. .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ groupId: chr \"OG003\"\n",
      "  .. .. .. .. .. .. .. .. .. .. .. ..$ value  : chr \"0\"\n",
      "  .. .. ..$ adverseEventsModule          :List of 6\n",
      "  .. .. .. ..$ frequencyThreshold: chr \"5\"\n",
      "  .. .. .. ..$ timeFrame         : chr \"Part A: From start of study drug on Day 1 maximum up to 4 weeks post last dose on Week 12 (maximum up to approx\"| __truncated__\n",
      "  .. .. .. ..$ description       : chr \"Same event may appear as AE and SAE. What is presented are distinct events. Event may be categorized serious in\"| __truncated__\n",
      "  .. .. .. ..$ eventGroups       :List of 4\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG000\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part A: Placebo\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants were randomized to receive placebo matching to Ponsegromab SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 5\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 45\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 11\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 45\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 25\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 45\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG001\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part A: Ponsegromab 100 mg\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants were randomized to receive Ponsegromab 100 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 6\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 46\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 15\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 46\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 19\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 46\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG002\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part A: Ponsegromab 200 mg\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants were randomized to receive Ponsegromab 200 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 6\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 46\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 10\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 46\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 19\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 46\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ id                : chr \"EG003\"\n",
      "  .. .. .. .. .. ..$ title             : chr \"Part A: Ponsegromab 400 mg\"\n",
      "  .. .. .. .. .. ..$ description       : chr \"Participants were randomized to receive Ponsegromab 400 mg SC Q4W up to 12 weeks (total of 3 doses).\"\n",
      "  .. .. .. .. .. ..$ deathsNumAffected : int 9\n",
      "  .. .. .. .. .. ..$ deathsNumAtRisk   : int 50\n",
      "  .. .. .. .. .. ..$ seriousNumAffected: int 20\n",
      "  .. .. .. .. .. ..$ seriousNumAtRisk  : int 50\n",
      "  .. .. .. .. .. ..$ otherNumAffected  : int 24\n",
      "  .. .. .. .. .. ..$ otherNumAtRisk    : int 50\n",
      "  .. .. .. ..$ seriousEvents     :List of 60\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Anaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Febrile neutropenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Thrombocytopenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Cardiopulmonary failure\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Cardiac disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Myocardial infarction\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Cardiac disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Tachycardia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Cardiac disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Anal fistula\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Anal incontinence\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Ascites\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Colitis ischaemic\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Enteritis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Gastrointestinal obstruction\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Ileus\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Rectal obstruction\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Vomiting\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Asthenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"General physical health deterioration\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pyrexia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hyperbilirubinaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Hepatobiliary disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Jaundice cholestatic\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Hepatobiliary disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"COVID-19\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"COVID-19 pneumonia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Infectious pleural effusion\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Intestinal fistula infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Neutropenic sepsis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pelvic abscess\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pneumonia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pneumonia aspiration\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pneumonia bacterial\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Sepsis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Urinary tract infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Anastomotic complication\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Injury, poisoning and procedural complications\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Radiation pneumonitis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Injury, poisoning and procedural complications\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Wound dehiscence\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Injury, poisoning and procedural complications\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Alanine aminotransferase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Aspartate aminotransferase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Electrocardiogram QT prolonged\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hypoglycaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hypoproteinaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Malignant neoplasm progression\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Neoplasms benign, malignant and unspecified (incl cysts and polyps)\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Metastases to central nervous system\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Neoplasms benign, malignant and unspecified (incl cysts and polyps)\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Neoplasm progression\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Neoplasms benign, malignant and unspecified (incl cysts and polyps)\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Ovarian neoplasm\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Neoplasms benign, malignant and unspecified (incl cysts and polyps)\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Cerebral amyloid angiopathy\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Cerebral infarction\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Diplegia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Metabolic encephalopathy\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Paraplegia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Spinal cord compression\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Urinary incontinence\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Renal and urinary disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Acute respiratory failure\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Atelectasis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dyspnoea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Haemoptysis\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hypoxia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Interstitial lung disease\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pleural effusion\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hypotension\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Vascular disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. ..$ otherEvents       :List of 19\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Anaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Blood and lymphatic system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Abdominal pain\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Constipation\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Diarrhoea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 8\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 5\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Nausea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 7\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Vomiting\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Gastrointestinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 5\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Asthenia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Fatigue\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Oedema peripheral\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pyrexia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"General disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 5\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Pneumonia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Upper respiratory tract infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Urinary tract infection\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Infections and infestations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Alanine aminotransferase increased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"White blood cell count decreased\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Investigations\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Decreased appetite\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Hypokalaemia\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Metabolism and nutrition disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 4\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 6\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 6\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Neuropathy peripheral\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Nervous system disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 0\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ term            : chr \"Dyspnoea\"\n",
      "  .. .. .. .. .. ..$ organSystem     : chr \"Respiratory, thoracic and mediastinal disorders\"\n",
      "  .. .. .. .. .. ..$ sourceVocabulary: chr \"MedDRA v26.1\"\n",
      "  .. .. .. .. .. ..$ assessmentType  : chr \"NON_SYSTEMATIC_ASSESSMENT\"\n",
      "  .. .. .. .. .. ..$ stats           :List of 4\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG000\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 2\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 45\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG001\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG002\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 1\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 46\n",
      "  .. .. .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. .. .. ..$ groupId    : chr \"EG003\"\n",
      "  .. .. .. .. .. .. .. ..$ numAffected: int 3\n",
      "  .. .. .. .. .. .. .. ..$ numAtRisk  : int 50\n",
      "  .. .. ..$ moreInfoModule               :List of 2\n",
      "  .. .. .. ..$ certainAgreement:List of 4\n",
      "  .. .. .. .. ..$ piSponsorEmployee   : logi FALSE\n",
      "  .. .. .. .. ..$ restrictionType     : chr \"OTHER\"\n",
      "  .. .. .. .. ..$ restrictiveAgreement: logi TRUE\n",
      "  .. .. .. .. ..$ otherDetails        : chr \"Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone\"| __truncated__\n",
      "  .. .. .. ..$ pointOfContact  :List of 4\n",
      "  .. .. .. .. ..$ title       : chr \"Pfizer ClinicalTrials.gov Call Center\"\n",
      "  .. .. .. .. ..$ organization: chr \"Pfizer Inc.\"\n",
      "  .. .. .. .. ..$ email       : chr \"ClinicalTrials.gov_Inquiries@pfizer.com\"\n",
      "  .. .. .. .. ..$ phone       : chr \"1-800-718-1021\"\n",
      "  .. ..$ documentSection:List of 1\n",
      "  .. .. ..$ largeDocumentModule:List of 1\n",
      "  .. .. .. ..$ largeDocs:List of 2\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ typeAbbrev : chr \"Prot\"\n",
      "  .. .. .. .. .. ..$ hasProtocol: logi TRUE\n",
      "  .. .. .. .. .. ..$ hasSap     : logi FALSE\n",
      "  .. .. .. .. .. ..$ hasIcf     : logi FALSE\n",
      "  .. .. .. .. .. ..$ label      : chr \"Study Protocol\"\n",
      "  .. .. .. .. .. ..$ date       : chr \"2023-06-02\"\n",
      "  .. .. .. .. .. ..$ uploadDate : chr \"2025-03-11T14:38\"\n",
      "  .. .. .. .. .. ..$ filename   : chr \"Prot_000.pdf\"\n",
      "  .. .. .. .. .. ..$ size       : int 3588608\n",
      "  .. .. .. .. ..$ :List of 9\n",
      "  .. .. .. .. .. ..$ typeAbbrev : chr \"SAP\"\n",
      "  .. .. .. .. .. ..$ hasProtocol: logi FALSE\n",
      "  .. .. .. .. .. ..$ hasSap     : logi TRUE\n",
      "  .. .. .. .. .. ..$ hasIcf     : logi FALSE\n",
      "  .. .. .. .. .. ..$ label      : chr \"Statistical Analysis Plan\"\n",
      "  .. .. .. .. .. ..$ date       : chr \"2024-04-07\"\n",
      "  .. .. .. .. .. ..$ uploadDate : chr \"2025-03-11T14:38\"\n",
      "  .. .. .. .. .. ..$ filename   : chr \"SAP_001.pdf\"\n",
      "  .. .. .. .. .. ..$ size       : int 6045974\n",
      "  .. ..$ derivedSection :List of 2\n",
      "  .. .. ..$ miscInfoModule       :List of 3\n",
      "  .. .. .. ..$ versionHolder     : chr \"2026-01-22\"\n",
      "  .. .. .. ..$ removedCountries  :List of 1\n",
      "  .. .. .. .. ..$ : chr \"Czechia\"\n",
      "  .. .. .. ..$ submissionTracking:List of 1\n",
      "  .. .. .. .. ..$ firstMcpInfo:List of 1\n",
      "  .. .. .. .. .. ..$ postDateStruct:List of 2\n",
      "  .. .. .. .. .. .. ..$ date: chr \"2025-03-27\"\n",
      "  .. .. .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ conditionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 8\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002289\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Carcinoma, Non-Small-Cell Lung\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D010190\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pancreatic Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D015179\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Colorectal Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000855\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Anorexia\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005221\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Fatigue\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002100\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Cachexia\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009369\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D015431\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Weight Loss\"\n",
      "  .. .. .. ..$ ancestors:List of 25\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002283\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Carcinoma, Bronchogenic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001984\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Bronchial Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008175\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lung Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012142\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Respiratory Tract Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013899\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Thoracic Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009371\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms by Site\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008171\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lung Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012140\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Respiratory Tract Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D004067\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Digestive System Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D004701\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Endocrine Gland Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D004066\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Digestive System Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D010182\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pancreatic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D004700\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Endocrine System Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007414\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Intestinal Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005770\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Gastrointestinal Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005767\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Gastrointestinal Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003108\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Colonic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007410\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Intestinal Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012002\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Rectal Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012817\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Signs and Symptoms, Digestive\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012816\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Signs and Symptoms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013568\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pathological Conditions, Signs and Symptoms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001836\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Body Weight Changes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001835\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Body Weight\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013851\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Thinness\"\n",
      "  .. ..$ hasResults     : logi TRUE\n",
      "  ..$ :List of 3\n",
      "  .. ..$ protocolSection:List of 13\n",
      "  .. .. ..$ identificationModule      :List of 6\n",
      "  .. .. .. ..$ nctId           : chr \"NCT05070845\"\n",
      "  .. .. .. ..$ orgStudyIdInfo  :List of 1\n",
      "  .. .. .. .. ..$ id: chr \"C1131003\"\n",
      "  .. .. .. ..$ secondaryIdInfos:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"2023-509338-21-00\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"REGISTRY\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"CTIS (EU)\"\n",
      "  .. .. .. ..$ organization    :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"Pfizer\"\n",
      "  .. .. .. .. ..$ class   : chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ briefTitle      : chr \"Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia\"\n",
      "  .. .. .. ..$ officialTitle   : chr \"AN INTERVENTIONAL PHASE 2, OPEN-LABEL, MULTI-CENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADU\"| __truncated__\n",
      "  .. .. ..$ statusModule              :List of 11\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2025-08\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"RECRUITING\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-02-02\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2027-10-01\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2027-10-01\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2021-09-27\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2021-09-27\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2021-10-07\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2025-08-12\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-08-14\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 2\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"Pfizer\"\n",
      "  .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi FALSE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 2\n",
      "  .. .. .. ..$ briefSummary       : chr \"This is a Phase 2, open-label, multicenter, multiple subcutaneous injection, safety and efficacy study of PF-06\"| __truncated__\n",
      "  .. .. .. ..$ detailedDescription: chr \"This study is designed to elucidate the effects of PF-06835375 on platelet counts in participants with moderate\"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 2\n",
      "  .. .. .. ..$ conditions:List of 1\n",
      "  .. .. .. .. ..$ : chr \"Primary Immune Thrombocytopenia\"\n",
      "  .. .. .. ..$ keywords  :List of 2\n",
      "  .. .. .. .. ..$ : chr \"ITP\"\n",
      "  .. .. .. .. ..$ : chr \"platelets\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 1\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 4\n",
      "  .. .. .. .. ..$ allocation       : chr \"NA\"\n",
      "  .. .. .. .. ..$ interventionModel: chr \"SINGLE_GROUP\"\n",
      "  .. .. .. .. ..$ primaryPurpose   : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo      :List of 2\n",
      "  .. .. .. .. .. ..$ masking           : chr \"NONE\"\n",
      "  .. .. .. .. .. ..$ maskingDescription: chr \"open label\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 61\n",
      "  .. .. .. .. ..$ type : chr \"ESTIMATED\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 3\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Open Label PF-06835375 dose 1 Treatment\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"subcutaneous injection once monthly for 3 months\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: PF-06835375\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Open Label PF-06835375 dose 2 Treatment\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"subcutaneous injection once monthly for 4 months\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: PF-06835375\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Open Label PF-06835375 dose 3 Treatment\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"subcutaneous injection once monthly for 4 months\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: PF-06835375\"\n",
      "  .. .. .. ..$ interventions:List of 1\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"PF-06835375\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"CXCR5 inhibitor\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open Label PF-06835375 dose 1 Treatment\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open Label PF-06835375 dose 2 Treatment\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open Label PF-06835375 dose 3 Treatment\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Proportion of participants with change from baseline of platelet counts\"\n",
      "  .. .. .. .. .. ..$ description: chr \"To evaluate absolute value of platelet count of treated participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"baseline through 12 and 16 weeks\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 6\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"proportion of participants with modified overall response (mOR)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"To evaluate the modified overall response of platelet count of treated participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"baseline through 12 and 16 weeks\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"proportion of participants with complete response (CR)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"To evaluate the complete response of platelet count of treated participants\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"baseline through 12 and 16 weeks\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Number of Participants With Treatment Emergent Treatment-Related Adverse Events (AEs)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"baseline through end of study (Week 20 for cohort 1 and Week 24 for cohorts 2 and 3)\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Proportion of participants with change from baseline of platelet counts\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"baseline to Week 20 and Week 24\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Proportion of participants with change from baseline of circulating B cells\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"baseline to Week 20 and Week 24\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Proportion of participants with change from baseline of circulating cTfh cells\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"baseline to Week 20 and Week 24\"\n",
      "  .. .. ..$ eligibilityModule         :List of 6\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Inclusion Criteria:\\n\\n* Diagnosis of Primary ITP. Ongoing ITP (platelet counts \\\\<50 x 109/L) \\\\[No severe ble\"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"ALL\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"18 Years\"\n",
      "  .. .. .. ..$ maximumAge         : chr \"70 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 2\n",
      "  .. .. .. .. ..$ : chr \"ADULT\"\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 3\n",
      "  .. .. .. ..$ centralContacts :List of 1\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ name : chr \"Pfizer CT.gov Call Center\"\n",
      "  .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ phone: chr \"1-800-718-1021\"\n",
      "  .. .. .. .. .. ..$ email: chr \"ClinicalTrials.gov_Inquiries@pfizer.com\"\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"Pfizer CT.gov Call Center\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Pfizer\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"STUDY_DIRECTOR\"\n",
      "  .. .. .. ..$ locations       :List of 28\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"East Carolina University\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Greenville\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"North Carolina\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"27834\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 35.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -77.4\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clinical Research Unit Haematology, Division of Cancer Services, St. George Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kogarah\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New South Wales\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"2217\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -34\n",
      "  .. .. .. .. .. .. ..$ lon: num 151\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Liverpool Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Liverpool\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New South Wales\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"2170\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 151\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"South West Radiology\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Liverpool\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New South Wales\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"2170\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 151\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Slade Pharmacy\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Mount Kuring-Gai\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New South Wales\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"2080\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 151\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Calvary Mater Newcastle\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Waratah\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New South Wales\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"2298\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -32.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 152\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Flinders Medical Centre\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bedford Park\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"South Australia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"5042\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -35\n",
      "  .. .. .. .. .. .. ..$ lon: num 139\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"ICON Cancer Centre - Kurralta Park\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kurralta Park\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"South Australia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"5037\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -35\n",
      "  .. .. .. .. .. .. ..$ lon: num 139\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"The Alfred Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Melbourne\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Victoria\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3004\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -37.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 145\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Royal Perth Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Perth\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Western Australia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"6000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -32\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Unity Health Toronto, St. Michael's Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toronto\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"M5B 1W8\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.4\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"McGill University Health Centre\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Montreal\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Quebec\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"H4A 3J1\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -73.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fakultni nemocnice Hradec Kralove\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hradec Králové\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"500 05\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Czechia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 15.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Vseobecna fakultni nemocnice v Praze\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Prague\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"12808\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Czechia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 14.4\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pécsi Tudományegyetem Klinikai Központ\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Pécs\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Baranya\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7624\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hungary\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 46.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.2\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Somogy Megyei Kaposi Mór Oktató Kórház\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kaposvár\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Somogy County\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7400\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hungary\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 46.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 17.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Semmelweis University\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Budapest\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"1088\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hungary\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 19\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Petz Aladár Egyetemi Oktató Kórház\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Győr\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"9024\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Hungary\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 17.6\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"AIDPORT Sp. z o.o.\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Skórzewo\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Greater Poland Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"60-185\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 52.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 16.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"InterHem\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bialystok\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"15-732\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 53.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 23.2\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Klinika Hematologii i Transplantologii Uniwersyteckie Centrum Kliniczne\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Gdansk\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80-214\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 54.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pratia Onkologia Katowice\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Katowice\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40-519\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 19\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Uniwersytecki Szpital Kliniczny w Poznaniu\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Poznan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"60-569\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 52.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 16.9\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wroclaw\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"50-367\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 17\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Addenbrooke's Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cambridge\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Cambridgeshire\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"CB2 2QQ\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United Kingdom\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 52.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 0.117\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Derriford Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Plymouth\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Devon\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"Pl6 8DH\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United Kingdom\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -4.14\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"The Royal Cornwall Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Truro\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"England\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"TR1 3LJ\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United Kingdom\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -5.05\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hammersmith Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"London\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"W12 0HS\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United Kingdom\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -0.126\n",
      "  .. .. ..$ referencesModule          :List of 1\n",
      "  .. .. .. ..$ seeAlsoLinks:List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"To obtain contact information for a study center near you, click here.\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://pmiform.com/clinical-trial-info-request?StudyID=C1131003\"\n",
      "  .. .. ..$ ipdSharingStatementModule :List of 3\n",
      "  .. .. .. ..$ ipdSharing : chr \"YES\"\n",
      "  .. .. .. ..$ description: chr \"Pfizer will provide access to individual de-identified participant data and related study documents (e.g. proto\"| __truncated__\n",
      "  .. .. .. ..$ url        : chr \"https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests\"\n",
      "  .. ..$ derivedSection :List of 2\n",
      "  .. .. ..$ miscInfoModule       :List of 1\n",
      "  .. .. .. ..$ versionHolder: chr \"2026-01-22\"\n",
      "  .. .. ..$ conditionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D016553\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Purpura, Thrombocytopenic, Idiopathic\"\n",
      "  .. .. .. ..$ ancestors:List of 17\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011696\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Purpura, Thrombocytopenic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011693\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Purpura\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001778\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Blood Coagulation Disorders\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006402\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hematologic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006425\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hemic and Lymphatic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D057049\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Thrombotic Microangiopathies\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013921\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Thrombocytopenia\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001791\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Blood Platelet Disorders\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000095542\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Cytopenia\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006474\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hemorrhagic Disorders\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001327\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Autoimmune Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007154\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immune System Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006470\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hemorrhage\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D010335\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pathologic Processes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013568\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pathological Conditions, Signs and Symptoms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012877\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Skin Manifestations\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012816\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Signs and Symptoms\"\n",
      "  .. ..$ hasResults     : logi FALSE\n",
      "  ..$ :List of 3\n",
      "  .. ..$ protocolSection:List of 12\n",
      "  .. .. ..$ identificationModule      :List of 5\n",
      "  .. .. .. ..$ nctId         : chr \"NCT03947775\"\n",
      "  .. .. .. ..$ orgStudyIdInfo:List of 1\n",
      "  .. .. .. .. ..$ id: chr \"53205\"\n",
      "  .. .. .. ..$ organization  :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"University Health Network, Toronto\"\n",
      "  .. .. .. .. ..$ class   : chr \"OTHER\"\n",
      "  .. .. .. ..$ briefTitle    : chr \"HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL\"\n",
      "  .. .. .. ..$ officialTitle : chr \"A Multicenter, Randomized Controlled Trial of the Efficacy, Safety and Immunogenicity of HPV Vaccination in Pre\"| __truncated__\n",
      "  .. .. ..$ statusModule              :List of 11\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2022-06\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"NOT_YET_RECRUITING\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-09-01\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2026-03-01\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2026-05-01\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2019-05-09\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2019-05-09\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2019-05-13\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2022-06-09\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-06-13\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 3\n",
      "  .. .. .. ..$ responsibleParty:List of 4\n",
      "  .. .. .. .. ..$ type                   : chr \"PRINCIPAL_INVESTIGATOR\"\n",
      "  .. .. .. .. ..$ investigatorFullName   : chr \"Irving Salit\"\n",
      "  .. .. .. .. ..$ investigatorTitle      : chr \"Immunodeficiency Clinic, Toronto General Hospital\"\n",
      "  .. .. .. .. ..$ investigatorAffiliation: chr \"University Health Network, Toronto\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"University Health Network, Toronto\"\n",
      "  .. .. .. .. ..$ class: chr \"OTHER\"\n",
      "  .. .. .. ..$ collaborators   :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ name : chr \"Merck Sharp & Dohme LLC\"\n",
      "  .. .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi FALSE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 2\n",
      "  .. .. .. ..$ briefSummary       : chr \"Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) worldwide. Infection by cert\"| __truncated__\n",
      "  .. .. .. ..$ detailedDescription: chr \"Advances in the treatment of HIV-infected individuals with the advent of the combination antiretroviral therapy\"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 2\n",
      "  .. .. .. ..$ conditions:List of 3\n",
      "  .. .. .. .. ..$ : chr \"Anal Intraepithelial Neoplasia\"\n",
      "  .. .. .. .. ..$ : chr \"Anal Cancer\"\n",
      "  .. .. .. .. ..$ : chr \"Human Papilloma Virus\"\n",
      "  .. .. .. ..$ keywords  :List of 8\n",
      "  .. .. .. .. ..$ : chr \"Men who have sex with men\"\n",
      "  .. .. .. .. ..$ : chr \"Human immunodeficiency virus\"\n",
      "  .. .. .. .. ..$ : chr \"Human papillomavirus\"\n",
      "  .. .. .. .. ..$ : chr \"Vaccine\"\n",
      "  .. .. .. .. ..$ : chr \"Gardasil\"\n",
      "  .. .. .. .. ..$ : chr \"Anal Intraepithelial Neoplasia\"\n",
      "  .. .. .. .. ..$ : chr \"Anal Cancer\"\n",
      "  .. .. .. .. ..$ : chr \"9-valent\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 1\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 5\n",
      "  .. .. .. .. ..$ allocation                  : chr \"RANDOMIZED\"\n",
      "  .. .. .. .. ..$ interventionModel           : chr \"PARALLEL\"\n",
      "  .. .. .. .. ..$ interventionModelDescription: chr \"This will be a randomized, open-label multicentre clinical trial consisting of two arms (immediate versus delay\"| __truncated__\n",
      "  .. .. .. .. ..$ primaryPurpose              : chr \"PREVENTION\"\n",
      "  .. .. .. .. ..$ maskingInfo                 :List of 1\n",
      "  .. .. .. .. .. ..$ masking: chr \"NONE\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 228\n",
      "  .. .. .. .. ..$ type : chr \"ESTIMATED\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 2\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Immediate Vaccination\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Administration of dose #1 of 9-valent HPV vaccination will be given at baseline visit, dose #2 at month 2, and \"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: 9-valent HPV vaccination\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Delayed Vaccination\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"ACTIVE_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Administration of dose #1 of 9-valent HPV vaccination will be given at month 12, dose #2 at month 14, and dose #3 at month 18.\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: 9-valent HPV vaccination\"\n",
      "  .. .. .. ..$ interventions:List of 1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"9-valent HPV vaccination\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Gardasil-9 is a novel, 9-valent HPV recombinant vaccine, which expands the coverage of oncogenic HPV types, wit\"| __truncated__\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Delayed Vaccination\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Immediate Vaccination\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Gardasil-9\"\n",
      "  .. .. ..$ outcomesModule            :List of 3\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The proportion of participants in each arm with biopsy-proven HGAIN (AIN-2/3).\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Secondary Prevention. \\\"Successful treatment\\\" refers to a biopsy-proven HGAIN lesion treated with ablative the\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"24 months, following successful treatment of HGAIN\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"The geometric mean titres (GMT) of antibody to each vaccine type above a pre-specified, validated cut-off. F\"\n",
      "  .. .. .. .. .. ..$ description: chr \"Immunogenicity. or this measure, immunogenicity will be measured as the proportion of participants with GMT of \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"24 months, following successful treatment of HGAIN\"\n",
      "  .. .. .. ..$ otherOutcomes    :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Change in anal carriage of vaccine HPV types. Repeated detection of anal HPV will indicate the duration of carr\"| __truncated__\n",
      "  .. .. .. .. .. ..$ description: chr \"Immunogenicity\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"24 months\"\n",
      "  .. .. ..$ eligibilityModule         :List of 7\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Subject Inclusion Criteria\\n\\n1. Males, aged ≥ 18 years at baseline;\\n2. Physician or laboratory documentation \"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi TRUE\n",
      "  .. .. .. ..$ sex                : chr \"MALE\"\n",
      "  .. .. .. ..$ genderBased        : logi TRUE\n",
      "  .. .. .. ..$ genderDescription  : chr \"History of any sexual activity with men, or both men and women, where sexual activity is defined as oral, vagin\"| __truncated__\n",
      "  .. .. .. ..$ minimumAge         : chr \"18 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 2\n",
      "  .. .. .. .. ..$ : chr \"ADULT\"\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 3\n",
      "  .. .. .. ..$ centralContacts :List of 2\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ name : chr \"Irving Salit, MD\"\n",
      "  .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ phone: chr \"416-340-3697\"\n",
      "  .. .. .. .. .. ..$ email: chr \"irving.salit@uhn.ca\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ name    : chr \"Grecia Higuerey\"\n",
      "  .. .. .. .. .. ..$ role    : chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ phone   : chr \"416-340-4800\"\n",
      "  .. .. .. .. .. ..$ phoneExt: chr \"3026\"\n",
      "  .. .. .. .. .. ..$ email   : chr \"grecia.higuerey@uhnresearch.ca\"\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"Irving Salit, MD\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Toronto General Hospital, University Health Network\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"PRINCIPAL_INVESTIGATOR\"\n",
      "  .. .. .. ..$ locations       :List of 4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"BC Centre for Disease Control\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Vancouver\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"British Columbia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"V5Z 4R4\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 49.2\n",
      "  .. .. .. .. .. .. ..$ lon: num -123\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"University of British Columbia\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Vancouver\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"British Columbia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"V6T 1Z4\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 49.2\n",
      "  .. .. .. .. .. .. ..$ lon: num -123\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Ottawa Hospital Research Institute\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ottawa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"K1Y 4E9\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -75.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"University Health Network - Toronto General Hospital\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toronto\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"M5G 2C4\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.4\n",
      "  .. .. ..$ referencesModule          :List of 1\n",
      "  .. .. .. ..$ references:List of 5\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"9516219\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"BACKGROUND\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining mor\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"18677028\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"BACKGROUND\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, \"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"16280701\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"BACKGROUND\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Chiao EY, Krown SE, Stier EA, Schrag D. A population-based analysis of temporal trends in the incidence of squa\"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"22291111\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"BACKGROUND\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Swedish KA, Factor SH, Goldstone SE. Prevention of recurrent high-grade anal neoplasia with quadrivalent human \"| __truncated__\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"22454089\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"BACKGROUND\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, Huh WK, Sings HL, James MK, Haupt RM; FUTURE I a\"| __truncated__\n",
      "  .. ..$ derivedSection :List of 2\n",
      "  .. .. ..$ miscInfoModule       :List of 1\n",
      "  .. .. .. ..$ versionHolder: chr \"2026-01-22\"\n",
      "  .. .. ..$ conditionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 3\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001005\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Anus Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006716\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Homosexuality\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000163\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Acquired Immunodeficiency Syndrome\"\n",
      "  .. .. .. ..$ ancestors:List of 30\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012004\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Rectal Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D015179\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Colorectal Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007414\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Intestinal Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005770\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Gastrointestinal Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D004067\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Digestive System Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009371\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms by Site\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009369\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D004066\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Digestive System Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005767\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Gastrointestinal Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007410\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Intestinal Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001004\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Anus Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012002\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Rectal Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D019529\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Sexuality\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012725\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Sexual Behavior\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001519\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Behavior\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D015658\"\n",
      "  .. .. .. .. .. ..$ term: chr \"HIV Infections\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000086982\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Blood-Borne Infections\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003141\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Communicable Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007239\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Infections\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D015229\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Sexually Transmitted Diseases, Viral\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012749\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Sexually Transmitted Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D016180\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lentivirus Infections\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012192\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Retroviridae Infections\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012327\"\n",
      "  .. .. .. .. .. ..$ term: chr \"RNA Virus Infections\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D014777\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Virus Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D012897\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Slow Virus Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000091662\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Genital Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000091642\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Urogenital Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007153\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immunologic Deficiency Syndromes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007154\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immune System Diseases\"\n",
      "  .. ..$ hasResults     : logi FALSE\n",
      "  ..$ :List of 3\n",
      "  .. ..$ protocolSection:List of 13\n",
      "  .. .. ..$ identificationModule      :List of 7\n",
      "  .. .. .. ..$ nctId           : chr \"NCT05039619\"\n",
      "  .. .. .. ..$ orgStudyIdInfo  :List of 1\n",
      "  .. .. .. .. ..$ id: chr \"WA42985\"\n",
      "  .. .. .. ..$ secondaryIdInfos:List of 2\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"2021-000097-29\"\n",
      "  .. .. .. .. .. ..$ type: chr \"EUDRACT_NUMBER\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"2023-505825-15-00\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"OTHER\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"EU CT Number\"\n",
      "  .. .. .. ..$ organization    :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"Hoffmann-La Roche\"\n",
      "  .. .. .. .. ..$ class   : chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ briefTitle      : chr \"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class\"| __truncated__\n",
      "  .. .. .. ..$ officialTitle   : chr \"A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, a\"| __truncated__\n",
      "  .. .. .. ..$ acronym         : chr \"POSTERITY\"\n",
      "  .. .. ..$ statusModule              :List of 11\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2026-01\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"RECRUITING\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-05-12\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2027-08-31\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2029-09-28\"\n",
      "  .. .. .. .. ..$ type: chr \"ESTIMATED\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2021-09-01\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2021-09-01\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2021-09-09\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2026-01-05\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2026-01-07\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 3\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"Hoffmann-La Roche\"\n",
      "  .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ collaborators   :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ name : chr \"Genentech, Inc.\"\n",
      "  .. .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 1\n",
      "  .. .. .. ..$ briefSummary: chr \"This phase II, randomized, double-blind, placebo-controlled study is designed to evaluate the safety, efficacy \"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 1\n",
      "  .. .. .. ..$ conditions:List of 1\n",
      "  .. .. .. .. ..$ : chr \"Lupus Nephritis\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 1\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 4\n",
      "  .. .. .. .. ..$ allocation       : chr \"RANDOMIZED\"\n",
      "  .. .. .. .. ..$ interventionModel: chr \"PARALLEL\"\n",
      "  .. .. .. .. ..$ primaryPurpose   : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo      :List of 2\n",
      "  .. .. .. .. .. ..$ masking  : chr \"DOUBLE\"\n",
      "  .. .. .. .. .. ..$ whoMasked:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"PARTICIPANT\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"INVESTIGATOR\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 40\n",
      "  .. .. .. .. ..$ type : chr \"ESTIMATED\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 3\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Blinded Obinutuzumab\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Participants will receive obinutuzumab 1000 milligrams (mg) intravenous (IV) infusions on Day 1, Day 14, Week 2\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 6\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Mycophenolate Mofetil\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Acetaminophen/paracetamol\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Diphenhydramine hydrochloride (HCl)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Methylprednisolone\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Prednisone\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Placebo\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"PLACEBO_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Placebo participants will receive obinutuzumab matched placebo on Day 1, Day 14, Week 24, Week 26 and Week 52.\"\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 6\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Placebo\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Mycophenolate Mofetil\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Acetaminophen/paracetamol\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Diphenhydramine hydrochloride (HCl)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Methylprednisolone\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Prednisone\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Open-Label Obinutuzumab\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Younger participants aged 5 to \\\\<12 will receive obinutuzumab 1000 mg IV infusions on Days 1, 14, Week 24, Wee\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 6\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Mycophenolate Mofetil\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Acetaminophen/paracetamol\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Diphenhydramine hydrochloride (HCl)\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Methylprednisolone\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: Prednisone\"\n",
      "  .. .. .. ..$ interventions:List of 7\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Obinutuzumab\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Obinutuzumab will be administered by IV infusion at a dose of 1000 mg on Day 1, Day 14, Week 24, Week 26 and Week 52.\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Blinded Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open-Label Obinutuzumab\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Gazyva\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Placebo\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Placebo matching obinutuzumab will be administered by IV on Day 1, Day 14, Week 24, Week 26 and Week 52.\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Placebo\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Mycophenolate Mofetil\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Mycophenolate Mofetil (MMF) will be taken by home administration orally at a target dose of 1200 mg/m\\\\^2/day t\"| __truncated__\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Blinded Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open-Label Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Placebo\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Acetaminophen/paracetamol\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Acetaminophen 1000 mg will be administered as pre-medication prior to infusions.\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Blinded Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open-Label Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Placebo\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Diphenhydramine hydrochloride (HCl)\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Diphenhydramine HCl 50 mg will be administered as pre-medication prior to infusions.\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Blinded Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open-Label Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Placebo\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Methylprednisolone\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Methylprednisolone 80 mg IV will be administered as pre-medication prior to infusions.\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Blinded Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open-Label Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Placebo\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"Prednisone\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Oral prednisone or equivalent corticosteroid will be taken by home administration daily to a maximum dose of 60\"| __truncated__\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 3\n",
      "  .. .. .. .. .. .. ..$ : chr \"Blinded Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Open-Label Obinutuzumab\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Placebo\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 2\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants who Achieve a Complete Renal Response (CRR) (AP)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"CRR is defined as achievement of all of the following:\\n\\n* Urinary protein-to-creatinine ratio (UPCR) \\\\<0.5 g\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants with Adverse Events (PP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 26\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants Achieving a CRR (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Weeks 24 and 52\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants who Achieve CRR with Successful Prednisone Taper (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants who Achieve a PRR (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Week 76\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Achieving an Overall Response (CRR or PRR) (AP)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"PRR is defined as:\\n\\nachievement of all of the following:\\n\\n* \\\\>=50% reduction in urinary protein-to-creatin\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Weeks 24, 52, and 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in UPCR (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in eGFR (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Time to Onset of CRR over the Course of 76 weeks (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Up to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants who Experience Treatment Failure (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Week 12 to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in anti-dsDNA titers (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in C3 Complement Levels (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in C4 Complement Levels (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants with Adverse Events According to National Cancer Institute Common Terminology Criter\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Serum Concentrations of Obinutuzumab (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants Achieving B-cell Depletion (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline, Weeks 4, 24, 52 and 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale (PedsQL)-Fatigue Total Score (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change from Baseline in Child Health Questionnaire-Parent Form 28 (CHQ-PF28) Domain Scores (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants with Anti-drug Antibodies (ADA) (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Weeks 0, 24, 52 and 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Relationship Between ADA Status and Percentage of Participants Achieving a CRR (AP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Weeks 24, 52 and 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants Achieving a CRR (PP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Week 76\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Percentage of Participants Achieving an Overall Response (PP)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"PRR is defined as achievement of all of the following:\\n\\n* \\\\>=50% reduction in UPCR from baseline\\n* UPCR \\\\<\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants who Achieve CRR with Successful Prednisone Taper (PP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in eGFR (PP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants Achieving B-cell Depletion (PP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline, Weeks 4, 24, 52 and 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Percentage of Participants with ADAs (PP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Weeks 0, 24, 52 and 76\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ measure  : chr \"Change in anti-dsDNA titers (PP)\"\n",
      "  .. .. .. .. .. ..$ timeFrame: chr \"Baseline to Week 76\"\n",
      "  .. .. ..$ eligibilityModule         :List of 6\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Inclusion Criteria:\\n\\n* Participants who are age 12 to \\\\<18 years at the time of randomization\\n* Participant\"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"ALL\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"5 Years\"\n",
      "  .. .. .. ..$ maximumAge         : chr \"17 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 1\n",
      "  .. .. .. .. ..$ : chr \"CHILD\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 3\n",
      "  .. .. .. ..$ centralContacts :List of 1\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ name : chr \"Reference Study ID Number: WA42985 https://forpatients.roche.com/\"\n",
      "  .. .. .. .. .. ..$ role : chr \"CONTACT\"\n",
      "  .. .. .. .. .. ..$ phone: chr \"888-662-6728 (U.S. and Canada)\"\n",
      "  .. .. .. .. .. ..$ email: chr \"global.rochegenentechtrials@roche.com\"\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"Clinical Trials\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Hoffmann-La Roche\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"STUDY_DIRECTOR\"\n",
      "  .. .. .. ..$ locations       :List of 42\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Loma Linda University health\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Loma Linda\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"92354\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34\n",
      "  .. .. .. .. .. .. ..$ lon: num -117\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"UCSF Benioff Childrens Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"San Francisco\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"94158\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -122\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Children's Hospital Colorado, Anchutz Medical Campus\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Aurora\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Colorado\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80045\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -105\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Emory Children's Center\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Atlanta\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Georgia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"30322\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 33.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -84.4\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Indiana University Health University Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Indianapolis\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Indiana\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"46202\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -86.2\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Louisiana State University\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Shreveport\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Louisiana\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"71103\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -93.8\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hackensack University Medical Center\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hackensack\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New Jersey\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"07601\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -74\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Cohen Children's Medical Center of New York\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Queens\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New York\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"11042\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -73.8\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Cincinnati Childrens Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cincinnati\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ohio\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"45229\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -84.5\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Chldren?s Hospital of Philadelphia\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Philadelphia\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Pennsylvania\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"19104\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40\n",
      "  .. .. .. .. .. .. ..$ lon: num -75.2\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Texas Arthritis Center\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"El Paso\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Texas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"79902\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 31.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -106\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Ser Servicos Especializados Em Reumatologia\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Salvador\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Estado de Bahia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40150-150\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -13\n",
      "  .. .. .. .. .. .. ..$ lon: num -38.5\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centro de Pesquisa São Lucas\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Campinas\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"São Paulo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"13060-904\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -22.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -47.1\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital das Clinicas - FMUSP\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"São Paulo\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"São Paulo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"05403-000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -23.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -46.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Universidade Federal de Sao Paulo - UNIFES\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"São Paulo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"04024-002\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -23.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -46.6\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"The Hospital for Sick Children\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toronto\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"M5G 1X8\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.4\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Sainte-Justine\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Montreal\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Quebec\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"H3T 1C5\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -73.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CH de Bicêtre\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Le Kremlin-Bicêtre\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"94275\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.36\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hôpital Robert Debré\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Paris\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"75019\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.35\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hop Necker Enfants Malades\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Paris\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"75743\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.35\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CHU de Toulouse - Hôpital des Enfants\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toulouse\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"31000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 1.44\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Ospedale Pediatrico Bambino Gesu\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Rome\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lazio\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"00165\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 12.5\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"IRCCS G. Gaslini\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Genoa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Liguria\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"16148\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 44.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 8.94\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clinica Pediatrica II De Marchi\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Milan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lombardy\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"20122\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Italy\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 9.19\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"CREA Hospital Mexico Americano\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guadalajara\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Jalisco\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"44620\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Mexico\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 20.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -103\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clinstile S.A de C.V.\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Mexico City\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Mexico CITY (federal District)\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"06700\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Mexico\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 19.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -99.1\n",
      "  .. .. .. .. ..$ :List of 7\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitario Dr. Jose Eleuterio Gonzalez\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Monterrey\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Nuevo León\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"64460\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Mexico\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 25.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -100\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Instituto de Ginecología y Reproducción\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lima\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Peru\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -12\n",
      "  .. .. .. .. .. .. ..$ lon: num -77\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clinica El Golf\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"ACTIVE_NOT_RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"San Isidro\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"L27 Lima\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Peru\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -12.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -77\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Uniwersyteckie Centrum Kliniczne\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Gdansk\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80-294\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 54.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Szpital Specjalistyczny dla Dzieci i Doroslych\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Torun\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"87-100\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 53\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Saint-Petersburg State\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"St-peterburg\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Sankt-Peterburg\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"194100\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Russia\"\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Red Cross War Memorial Children?s Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cape Town\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7700\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Africa\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Groote Schuur Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cape Town\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7925\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Africa\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Panaroma Medical Center\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Panorama\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7500\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Africa\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -28.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 31.9\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Sant Joan De Deu\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Esplugas de Llobregat\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Barcelona\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"08950\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Ramon y Cajal\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Madrid\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"28034\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -3.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital de La Paz\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Madrid\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"28046\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -3.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitario la Fe: Servicio de Reumatologia Pediatrica\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Valencia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"46026\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -0.38\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Royal Hospital For Children\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"WITHDRAWN\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Glasgow\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"G51 4TF\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United Kingdom\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 55.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -4.26\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Alder Hey Childrens Hospital\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Liverpool\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"L12 2AP\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United Kingdom\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 53.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -2.98\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Great Ormond Street Hospital for Children\"\n",
      "  .. .. .. .. .. ..$ status  : chr \"RECRUITING\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"London\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"WC1N 3JH\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United Kingdom\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -0.126\n",
      "  .. .. ..$ referencesModule          :List of 1\n",
      "  .. .. .. ..$ references:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ pmid    : chr \"37678236\"\n",
      "  .. .. .. .. .. ..$ type    : chr \"DERIVED\"\n",
      "  .. .. .. .. .. ..$ citation: chr \"Dossier C, Bonneric S, Baudouin V, Kwon T, Prim B, Cambier A, Couderc A, Moreau C, Deschenes G, Hogan J. Obinut\"| __truncated__\n",
      "  .. .. ..$ ipdSharingStatementModule :List of 2\n",
      "  .. .. .. ..$ ipdSharing : chr \"YES\"\n",
      "  .. .. .. ..$ description: chr \"For eligible studies, qualified researchers may request access to individual patient level clinical data. See R\"| __truncated__\n",
      "  .. ..$ derivedSection :List of 3\n",
      "  .. .. ..$ miscInfoModule          :List of 1\n",
      "  .. .. .. ..$ versionHolder: chr \"2026-01-22\"\n",
      "  .. .. ..$ conditionBrowseModule   :List of 2\n",
      "  .. .. .. ..$ meshes   :List of 1\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008181\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lupus Nephritis\"\n",
      "  .. .. .. ..$ ancestors:List of 13\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005921\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Glomerulonephritis\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009393\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Nephritis\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007674\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Kidney Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D014570\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Urologic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D052776\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Female Urogenital Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005261\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Female Urogenital Diseases and Pregnancy Complications\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000091642\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Urogenital Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D052801\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Male Urogenital Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008180\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lupus Erythematosus, Systemic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003240\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Connective Tissue Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D017437\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Skin and Connective Tissue Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001327\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Autoimmune Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007154\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immune System Diseases\"\n",
      "  .. .. ..$ interventionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 6\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"C543332\"\n",
      "  .. .. .. .. .. ..$ term: chr \"obinutuzumab\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009173\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Mycophenolic Acid\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000082\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Acetaminophen\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D004155\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Diphenhydramine\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008775\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Methylprednisolone\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011241\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Prednisone\"\n",
      "  .. .. .. ..$ ancestors:List of 25\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002208\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Caproates\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000144\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Acids, Acyclic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002264\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Carboxylic Acids\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009930\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Organic Chemicals\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005227\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Fatty Acids\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008055\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lipids\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000083\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Acetanilides\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000813\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Anilides\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000577\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Amides\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000814\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Aniline Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000588\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Amines\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D005021\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Ethylamines\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001559\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Benzhydryl Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001555\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Benzene Derivatives\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006841\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons, Aromatic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006844\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons, Cyclic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006838\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011239\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Prednisolone\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011246\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pregnadienetriols\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011245\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pregnadienes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011278\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pregnanes\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D013256\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Steroids\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000072473\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Fused-Ring Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011083\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Polycyclic Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011244\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pregnadienediols\"\n",
      "  .. ..$ hasResults     : logi FALSE\n",
      "  ..$ :List of 3\n",
      "  .. ..$ protocolSection:List of 13\n",
      "  .. .. ..$ identificationModule      :List of 6\n",
      "  .. .. .. ..$ nctId           : chr \"NCT05508867\"\n",
      "  .. .. .. ..$ orgStudyIdInfo  :List of 1\n",
      "  .. .. .. .. ..$ id: chr \"4280A-008\"\n",
      "  .. .. .. ..$ secondaryIdInfos:List of 4\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"MK-4280A-008\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"OTHER\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"MSD\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"2023-503615-14-00\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"REGISTRY\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"EU CT\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ id    : chr \"U1111-1287-5864\"\n",
      "  .. .. .. .. .. ..$ type  : chr \"REGISTRY\"\n",
      "  .. .. .. .. .. ..$ domain: chr \"UTN\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"2022-000371-39\"\n",
      "  .. .. .. .. .. ..$ type: chr \"EUDRACT_NUMBER\"\n",
      "  .. .. .. ..$ organization    :List of 2\n",
      "  .. .. .. .. ..$ fullName: chr \"Merck Sharp & Dohme LLC\"\n",
      "  .. .. .. .. ..$ class   : chr \"INDUSTRY\"\n",
      "  .. .. .. ..$ briefTitle      : chr \"A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-\"| __truncated__\n",
      "  .. .. .. ..$ officialTitle   : chr \"A Phase 2 Randomized Clinical Study of MK-4280A (Coformulated Favezelimab [MK-4280] Plus Pembrolizumab [MK-3475\"| __truncated__\n",
      "  .. .. ..$ statusModule              :List of 11\n",
      "  .. .. .. ..$ statusVerifiedDate         : chr \"2026-01\"\n",
      "  .. .. .. ..$ overallStatus              : chr \"COMPLETED\"\n",
      "  .. .. .. ..$ expandedAccessInfo         :List of 1\n",
      "  .. .. .. .. ..$ hasExpandedAccess: logi FALSE\n",
      "  .. .. .. ..$ startDateStruct            :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-10-18\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ primaryCompletionDateStruct:List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2025-09-03\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ completionDateStruct       :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2026-01-08\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ studyFirstSubmitDate       : chr \"2022-08-18\"\n",
      "  .. .. .. ..$ studyFirstSubmitQcDate     : chr \"2022-08-18\"\n",
      "  .. .. .. ..$ studyFirstPostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2022-08-19\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. .. ..$ lastUpdateSubmitDate       : chr \"2026-01-16\"\n",
      "  .. .. .. ..$ lastUpdatePostDateStruct   :List of 2\n",
      "  .. .. .. .. ..$ date: chr \"2026-01-20\"\n",
      "  .. .. .. .. ..$ type: chr \"ACTUAL\"\n",
      "  .. .. ..$ sponsorCollaboratorsModule:List of 2\n",
      "  .. .. .. ..$ responsibleParty:List of 1\n",
      "  .. .. .. .. ..$ type: chr \"SPONSOR\"\n",
      "  .. .. .. ..$ leadSponsor     :List of 2\n",
      "  .. .. .. .. ..$ name : chr \"Merck Sharp & Dohme LLC\"\n",
      "  .. .. .. .. ..$ class: chr \"INDUSTRY\"\n",
      "  .. .. ..$ oversightModule           :List of 3\n",
      "  .. .. .. ..$ oversightHasDmc     : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDrug  : logi TRUE\n",
      "  .. .. .. ..$ isFdaRegulatedDevice: logi FALSE\n",
      "  .. .. ..$ descriptionModule         :List of 1\n",
      "  .. .. .. ..$ briefSummary: chr \"Researchers are looking for a way to treat classical Hodgkin lymphoma (cHL) that is relapsed (the cancer has co\"| __truncated__\n",
      "  .. .. ..$ conditionsModule          :List of 2\n",
      "  .. .. .. ..$ conditions:List of 1\n",
      "  .. .. .. .. ..$ : chr \"Hodgkin Lymphoma\"\n",
      "  .. .. .. ..$ keywords  :List of 3\n",
      "  .. .. .. .. ..$ : chr \"Programmed Cell Death-1 (PD1, PD-1)\"\n",
      "  .. .. .. .. ..$ : chr \"Programmed Cell Death 1 Ligand 1 (PDL1, PD-L1)\"\n",
      "  .. .. .. .. ..$ : chr \"Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)\"\n",
      "  .. .. ..$ designModule              :List of 4\n",
      "  .. .. .. ..$ studyType     : chr \"INTERVENTIONAL\"\n",
      "  .. .. .. ..$ phases        :List of 1\n",
      "  .. .. .. .. ..$ : chr \"PHASE2\"\n",
      "  .. .. .. ..$ designInfo    :List of 4\n",
      "  .. .. .. .. ..$ allocation       : chr \"RANDOMIZED\"\n",
      "  .. .. .. .. ..$ interventionModel: chr \"PARALLEL\"\n",
      "  .. .. .. .. ..$ primaryPurpose   : chr \"TREATMENT\"\n",
      "  .. .. .. .. ..$ maskingInfo      :List of 1\n",
      "  .. .. .. .. .. ..$ masking: chr \"NONE\"\n",
      "  .. .. .. ..$ enrollmentInfo:List of 2\n",
      "  .. .. .. .. ..$ count: int 203\n",
      "  .. .. .. .. ..$ type : chr \"ACTUAL\"\n",
      "  .. .. ..$ armsInterventionsModule   :List of 2\n",
      "  .. .. .. ..$ armGroups    :List of 2\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Favezelimab/Pembrolizumab\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"EXPERIMENTAL\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Participants will receive coformulated favezelimab/pembrolizumab (800 mg/200 mg) by intravenous (IV) infusion o\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Biological: favezelimab/pembrolizumab\"\n",
      "  .. .. .. .. ..$ :List of 4\n",
      "  .. .. .. .. .. ..$ label            : chr \"Chemotherapy (Bendamustine or Gemcitabine)\"\n",
      "  .. .. .. .. .. ..$ type             : chr \"ACTIVE_COMPARATOR\"\n",
      "  .. .. .. .. .. ..$ description      : chr \"Participants will receive physician's choice of EITHER bendamustine by IV infusion at a dose between 90 and 120\"| __truncated__\n",
      "  .. .. .. .. .. ..$ interventionNames:List of 2\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: bendamustine\"\n",
      "  .. .. .. .. .. .. ..$ : chr \"Drug: gemcitabine\"\n",
      "  .. .. .. ..$ interventions:List of 3\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"BIOLOGICAL\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"favezelimab/pembrolizumab\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"Coformulated favezelimab/pembrolizumab (800 mg/200 mg), IV infusion\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Favezelimab/Pembrolizumab\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"MK-4820A\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"bendamustine\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"IV infusion\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Chemotherapy (Bendamustine or Gemcitabine)\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"BENDEKA®\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ type          : chr \"DRUG\"\n",
      "  .. .. .. .. .. ..$ name          : chr \"gemcitabine\"\n",
      "  .. .. .. .. .. ..$ description   : chr \"IV infusion\"\n",
      "  .. .. .. .. .. ..$ armGroupLabels:List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"Chemotherapy (Bendamustine or Gemcitabine)\"\n",
      "  .. .. .. .. .. ..$ otherNames    :List of 1\n",
      "  .. .. .. .. .. .. ..$ : chr \"GEMZAR®\"\n",
      "  .. .. ..$ outcomesModule            :List of 2\n",
      "  .. .. .. ..$ primaryOutcomes  :List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Progression Free Survival (PFS) per Lugano Response Criteria as Assessed by investigator\"\n",
      "  .. .. .. .. .. ..$ description: chr \"PFS is defined as the time from randomization to the first documented disease progression per Lugano criteria 2\"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to approximately 39 months\"\n",
      "  .. .. .. ..$ secondaryOutcomes:List of 5\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Overall Survival (OS)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"OS is defined as the time from randomization to death due to any cause.\"\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to approximately 39 months\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Objective Response Rate (ORR) per Lugano Response Criteria as Assessed by investigator\"\n",
      "  .. .. .. .. .. ..$ description: chr \"ORR is defined as the percentage of participants who achieve a complete response (CR) or partial response (PR) \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to approximately 39 months\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Duration of Response (DOR) per Lugano Response Criteria as Assessed by investigator\"\n",
      "  .. .. .. .. .. ..$ description: chr \"For participants who demonstrate CR or PR per Lugano criteria 2014 as assessed by investigator, DOR is defined \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to approximately 39 months\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of Participants Who Experienced At Least One Adverse Event (AE)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"An AE is any untoward medical occurrence in a clinical study participant temporally associated with the use of \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to approximately 25 months\"\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ measure    : chr \"Number of Participants Who Discontinue Study Treatment Due to an Adverse Event (AE)\"\n",
      "  .. .. .. .. .. ..$ description: chr \"An AE is any untoward medical occurrence in a clinical study participant temporally associated with the use of \"| __truncated__\n",
      "  .. .. .. .. .. ..$ timeFrame  : chr \"Up to approximately 24 months\"\n",
      "  .. .. ..$ eligibilityModule         :List of 5\n",
      "  .. .. .. ..$ eligibilityCriteria: chr \"Inclusion Criteria:\\n\\n* Has histologically confirmed diagnosis of classical Hodgkin lymphoma (cHL) that is 2-f\"| __truncated__\n",
      "  .. .. .. ..$ healthyVolunteers  : logi FALSE\n",
      "  .. .. .. ..$ sex                : chr \"ALL\"\n",
      "  .. .. .. ..$ minimumAge         : chr \"18 Years\"\n",
      "  .. .. .. ..$ stdAges            :List of 2\n",
      "  .. .. .. .. ..$ : chr \"ADULT\"\n",
      "  .. .. .. .. ..$ : chr \"OLDER_ADULT\"\n",
      "  .. .. ..$ contactsLocationsModule   :List of 2\n",
      "  .. .. .. ..$ overallOfficials:List of 1\n",
      "  .. .. .. .. ..$ :List of 3\n",
      "  .. .. .. .. .. ..$ name       : chr \"Medical Director\"\n",
      "  .. .. .. .. .. ..$ affiliation: chr \"Merck Sharp & Dohme LLC\"\n",
      "  .. .. .. .. .. ..$ role       : chr \"STUDY_DIRECTOR\"\n",
      "  .. .. .. ..$ locations       :List of 105\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The University of Arizona Cancer Center - North Campus ( Site 2216)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Tucson\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Arizona\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"85719\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.2\n",
      "  .. .. .. .. .. .. ..$ lon: num -111\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"UCLA Hematology/Oncology - Santa Monica ( Site 2208)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Los Angeles\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"90404\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -118\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Torrance\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"California\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"90502\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 33.8\n",
      "  .. .. .. .. .. .. ..$ lon: num -118\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Moffitt Cancer Center ( Site 2200)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Tampa\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Florida\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"33612\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 27.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -82.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"University of Kentucky Chandler Medical Center ( Site 2201)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lexington\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Kentucky\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"40536\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38\n",
      "  .. .. .. .. .. .. ..$ lon: num -84.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 2210)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Baltimore\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Maryland\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"21201\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -76.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Johns Hopkins University-The Sidney Kimmel Comprehensive Cancer Center ( Site 2206)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Baltimore\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Maryland\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"21231\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -76.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"University of Michigan ( Site 2215)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ann Arbor\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Michigan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"48109\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -83.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Cancer and Hematology Centers of Western Michigan ( Site 2222)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Grand Rapids\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Michigan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"49503\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43\n",
      "  .. .. .. .. .. .. ..$ lon: num -85.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Rutgers Cancer Institute of New Jersey ( Site 2217)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"New Brunswick\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New Jersey\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"08903\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -74.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Roswell Park Cancer Institute ( Site 2220)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Buffalo\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"New York\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"14263\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 42.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -78.9\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"University Hospitals Cleveland Medical Center ( Site 2214)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cleveland\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ohio\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"44106\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -81.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Cleveland Clinic-Taussig Cancer Center ( Site 2203)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cleveland\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ohio\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"44195\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -81.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"AHN West Penn Hospital ( Site 2213)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Pittsburgh\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Pennsylvania\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"15224\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -80\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"UPMC Hillman Cancer Center ( Site 2205)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Pittsburgh\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Pennsylvania\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"15232\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -80\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fred Hutchinson Cancer Center ( Site 2212)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Seattle\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Washington\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"98109\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United States\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 47.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -122\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Aleman-oncohematologic diseases ( Site 2302)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Buenos Aires\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"C1118AAT\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Argentina\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -34.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -58.4\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 2301)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Mendoza\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"M5500AYB\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Argentina\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -32.9\n",
      "  .. .. .. .. .. .. ..$ lon: num -68.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The Townsville Hospital ( Site 0006)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Townsville\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Queensland\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"4814\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -19.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 147\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Royal Adelaide Hospital ( Site 0005)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Adelaide\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"South Australia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"5000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -34.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 139\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Western Health-Sunshine & Footscray Hospitals-Cancer Services-Cancer Research ( Site 0002)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"St Albans\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Victoria\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3021\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -37.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 145\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Royal Perth Hospital-Haematology ( Site 0004)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Perth\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Western Australia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"6000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Australia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -32\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"UZ Leuven-Hematology ( Site 0101)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Leuven\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Vlaams-Brabant\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Belgium\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 4.7\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Namur\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"5530\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Belgium\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 4.87\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0202)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Barretos\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"São Paulo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"14784400\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -20.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -48.6\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Paulistano-Americas Oncologia ( Site 0207)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"São Paulo\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"01321-001\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Brazil\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -23.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -46.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Cross Cancer Institute ( Site 0313)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Edmonton\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Alberta\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"T6G 1Z2\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 53.6\n",
      "  .. .. .. .. .. .. ..$ lon: num -113\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Princess Margaret Cancer Centre ( Site 0310)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toronto\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Ontario\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"M5G 2M9\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -79.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Jewish General Hospital ( Site 0309)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Montreal\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Quebec\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"H3T 1E2\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -73.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"McGill University Health Centre ( Site 0314)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Montreal\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Quebec\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"H4A 3J1\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Canada\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -73.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"FALP-UIDO ( Site 0400)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santiago\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Region M. de Santiago\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7500921\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -70.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Clínica Inmunocel ( Site 0407)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santiago\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Region M. de Santiago\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"7580206\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Chile\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num -33.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -70.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Anhui Provincial Cancer Hospital ( Site 0501)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hefei\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Anhui\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"230031\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 31.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 117\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Beijing Hospital ( Site 0514)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Beijing\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Beijing Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"100005\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Peking University Third Hospital-Hematology ( Site 0519)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Beijing\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Beijing Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"100091\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 116\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First Affiliated hospital of Xiamen University ( Site 0512)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Xiamen\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Fujian\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"361003\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 24.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 118\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Sun Yat-sen University Cancer Center ( Site 0500)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Guangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Guangdong\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"510060\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 23.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Henan Cancer Hospital ( Site 0515)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Zhengzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Henan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"450008\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 34.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0509)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wuhan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Hubei\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"430010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 114\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Xiangya Hospital Central South University ( Site 0513)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Changsha\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Hunan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"410008\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hunan Cancer Hospital ( Site 0503)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Changsha\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Hunan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"410013\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 113\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"The First Hospital of Jilin University-Hematology ( Site 0516)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Changchun\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Jilin\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"130021\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 125\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fudan University Shanghai Cancer Center ( Site 0520)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Shanghai\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Shanghai Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"200032\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 31.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 121\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"West China Hospital of Sichuan University-Head and Neck Oncology ( Site 0502)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Chengdu\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Sichuan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"610041\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 104\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Tianjin Medical University Cancer Institute & Hospital-lymphoma ( Site 0506)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Tianjin\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Tianjin Municipality\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"300060\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 117\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Zhejiang Cancer Hospital ( Site 0510)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hangzhou\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Zhejiang\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"310022\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 30.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 120\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Ningbo First Hospital ( Site 0518)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ningbo\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Zhejiang\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"315010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"China\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 29.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 122\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0901)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Brno\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Brno-mesto\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"625 00\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Czechia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 49.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 16.6\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Fakultni nemocnice Hradec Kralove-IV. interni hematologicka klinika ( Site 0902)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Hradec Králové\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"500 05\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Czechia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 15.8\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0903)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Prague\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"128 08\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Czechia\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 14.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou-haematology ( Site 0707)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Rennes\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Brittany Region\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"35033\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -1.67\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE ( Site 0706)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Toulouse\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Haute-Garonne\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"31059\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 1.44\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 0704)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Limoges\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Haute-Vienne\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"87042\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 1.25\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Institut Curie - site Saint-Cloud ( Site 0708)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Saint-Cloud\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Hauts-de-Seine\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"92210\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.2\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CENTRE LEON BERARD-Medical oncology ( Site 0703)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lyon\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Rhone\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"69008\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 45.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 4.85\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"HENRI MONDOR HOSPITAL ( Site 0702)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Créteil\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Seine-et-Marne\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"94000\"\n",
      "  .. .. .. .. .. ..$ country : chr \"France\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.47\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Klinikum Stuttgart - Katharinenhospital ( Site 0804)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Stuttgart\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Baden-Wurttemberg\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"70174\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Germany\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 9.18\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Universitaetsklinikum Ulm-Department of Internal Medicine III ( Site 0805)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ulm\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Baden-Wurttemberg\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"89081\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Germany\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 48.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 9.99\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Universitaetsklinikum Koeln-Klinik I für Innere Medizin ( Site 0801)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Cologne\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"North Rhine-Westphalia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"50937\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Germany\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 6.95\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Universitaetsklinikum Essen ( Site 0807)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Essen\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"North Rhine-Westphalia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"45147\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Germany\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.5\n",
      "  .. .. .. .. .. .. ..$ lon: num 7.01\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Universitätsklinikum Münster - Albert Schweitzer Campus ( Site 0806)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Münster\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"North Rhine-Westphalia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"48149\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Germany\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 52\n",
      "  .. .. .. .. .. .. ..$ lon: num 7.63\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Universitaetsklinikum Carl Gustav Carus Dresden-University Cancer Center Early Clinical Trial Unit (\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Dresden\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Saxony\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"01307\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Germany\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 13.7\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Universitätsklinikum Leipzig ( Site 0803)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Leipzig\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Saxony\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"04103\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Germany\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.3\n",
      "  .. .. .. .. .. .. ..$ lon: num 12.4\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Rambam Health Care Campus ( Site 1004)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Haifa\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3109601\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 35\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Carmel Hospital ( Site 1007)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Haifa\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"3436212\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 35\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hadassah Medical Center-Hemato-Oncology ( Site 1000)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Jerusalem\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"9112001\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 31.8\n",
      "  .. .. .. .. .. .. ..$ lon: num 35.2\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Rabin Medical Center-Hemato-Oncology ( Site 1001)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Petah Tikva\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"4910021\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 34.9\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Sheba Medical Center-Hemato Oncology ( Site 1005)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ramat Gan\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"5265601\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 34.8\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Sourasky Medical Center ( Site 1002)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Tel Aviv\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"6423906\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Israel\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 32.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 34.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Centro de Infusion Superare ( Site 2503)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Mexico City\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Mexico City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"03100\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Mexico\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 19.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -99.1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Unidad Médica Onco-hematológica ( Site 2507)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Puebla City\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"72424\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Mexico\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 19\n",
      "  .. .. .. .. .. .. ..$ lon: num -98.2\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 1406)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Krakow\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lesser Poland Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"31-826\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 19.9\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckieg-Klinika Hematologii, Nowotworów Krwi i\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Wroclaw\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Lower Silesian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"50-556\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 51.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 17\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Warsaw\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Masovian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"02-781\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 52.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 21\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 1402)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Gdansk\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Pomeranian Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"80-214\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 54.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 18.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Hematologii i Transplantacji S\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kielce\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Świętokrzyskie Voivodeship\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"25-734\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Poland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 20.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Pusan National University Hospital-Internal Medicine ( Site 1704)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Busan\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Pusan-Kwangyokshi\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"49241\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Korea\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 35.1\n",
      "  .. .. .. .. .. .. ..$ lon: num 129\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Seoul National University Hospital ( Site 1701)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Seoul\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"03080\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Korea\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 127\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1702)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Seoul\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"03722\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Korea\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 127\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Asan Medical Center-Department of Oncology ( Site 1703)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Seoul\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"05505\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Korea\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 127\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Samsung Medical Center ( Site 1700)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Seoul\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"06351\"\n",
      "  .. .. .. .. .. ..$ country : chr \"South Korea\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 37.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 127\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitario Marqués de Valdecilla ( Site 1805)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Santander\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Cantabria\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"39008\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.5\n",
      "  .. .. .. .. .. .. ..$ lon: num -3.8\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitari Vall d'Hebron ( Site 1803)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Barcelona\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Catalonia\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"08035\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 2.16\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 1812)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"A Coruña\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"La Coruna\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"15006\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 43.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -8.4\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Insular de Gran Canaria-Oncology ( Site 1807)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Las Palmas de Gran Canaria\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Las Palmas\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"35016\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 28.1\n",
      "  .. .. .. .. .. .. ..$ lon: num -15.4\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital General Universitario de Alicante ( Site 1806)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Alicante\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"03010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38.3\n",
      "  .. .. .. .. .. .. ..$ lon: num -0.481\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitario 12 de Octubre-Hemathology and hemotherapy ( Site 1810)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Madrid\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"28041\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 40.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -3.7\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitario Virgen de la Victoria ( Site 1808)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Málaga\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"29010\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 36.7\n",
      "  .. .. .. .. .. .. ..$ lon: num -4.42\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hospital Universitario de Salamanca - Complejo Asistencial U-Servicio de Hematologia ( Site 1801)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Salamanca\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"37007\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Spain\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 41\n",
      "  .. .. .. .. .. .. ..$ lon: num -5.66\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Skånes Universitetssjukhus Lund ( Site 1901)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Lund\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Skåne County\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"22185\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Sweden\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 55.7\n",
      "  .. .. .. .. .. .. ..$ lon: num 13.2\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1900)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Uppsala\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Uppsala County\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"751 85\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Sweden\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 59.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 17.6\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Ospedale Regionale Bellinzona e Valli-IOSI ( Site 1600)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Bellinzona\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Canton Ticino\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"6501\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Switzerland\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 46.2\n",
      "  .. .. .. .. .. .. ..$ lon: num 9.02\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Mega Medipol-Hematology ( Site 2005)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Stanbul\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Istanbul\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"34214\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Turkey (Türkiye)\"\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 2000)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ankara\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"06100\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Turkey (Türkiye)\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 32.9\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Hacettepe Universite Hastaneleri-Department of Hematology ( Site 2006)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Ankara\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"06230\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Turkey (Türkiye)\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 32.9\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Antalya Egitim ve Arastırma Hastanesi ( Site 2011)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Antalya\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"07100\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Turkey (Türkiye)\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 36.9\n",
      "  .. .. .. .. .. .. ..$ lon: num 30.7\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Ege Universitesi Hastanesi ( Site 2001)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Izmir\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"35100\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Turkey (Türkiye)\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 38.4\n",
      "  .. .. .. .. .. .. ..$ lon: num 27.1\n",
      "  .. .. .. .. ..$ :List of 5\n",
      "  .. .. .. .. .. ..$ facility: chr \"Kocaeli Üniversitesi-Hematology ( Site 2009)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Kocaeli\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"41380\"\n",
      "  .. .. .. .. .. ..$ country : chr \"Turkey (Türkiye)\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 39.6\n",
      "  .. .. .. .. .. .. ..$ lon: num 27.5\n",
      "  .. .. .. .. ..$ :List of 6\n",
      "  .. .. .. .. .. ..$ facility: chr \"Derriford Hospital ( Site 2107)\"\n",
      "  .. .. .. .. .. ..$ city    : chr \"Plymouth\"\n",
      "  .. .. .. .. .. ..$ state   : chr \"Devon\"\n",
      "  .. .. .. .. .. ..$ zip     : chr \"Pl6 8DH\"\n",
      "  .. .. .. .. .. ..$ country : chr \"United Kingdom\"\n",
      "  .. .. .. .. .. ..$ geoPoint:List of 2\n",
      "  .. .. .. .. .. .. ..$ lat: num 50.4\n",
      "  .. .. .. .. .. .. ..$ lon: num -4.14\n",
      "  .. .. .. .. .. [list output truncated]\n",
      "  .. .. ..$ referencesModule          :List of 1\n",
      "  .. .. .. ..$ seeAlsoLinks:List of 2\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"Merck Clinical Trials Information\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://www.merckclinicaltrials.com/\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ label: chr \"Plain Language Summary\"\n",
      "  .. .. .. .. .. ..$ url  : chr \"https://msd.trialsummaries.com/Study/StudyDetails?id=26284&tenant=MT_MSD_9011\"\n",
      "  .. .. ..$ ipdSharingStatementModule :List of 3\n",
      "  .. .. .. ..$ ipdSharing : chr \"YES\"\n",
      "  .. .. .. ..$ description: chr \"https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf\"\n",
      "  .. .. .. ..$ url        : chr \"https://externaldatasharing-msd.com/\"\n",
      "  .. ..$ derivedSection :List of 3\n",
      "  .. .. ..$ miscInfoModule          :List of 1\n",
      "  .. .. .. ..$ versionHolder: chr \"2026-01-22\"\n",
      "  .. .. ..$ conditionBrowseModule   :List of 2\n",
      "  .. .. .. ..$ meshes   :List of 2\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006689\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hodgkin Disease\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"C565324\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Parkinson Disease 4, Autosomal Dominant Lewy Body\"\n",
      "  .. .. .. ..$ ancestors:List of 8\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008223\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphoma\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009370\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms by Histologic Type\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009369\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Neoplasms\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008232\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphoproliferative Disorders\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D008206\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Lymphatic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006425\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hemic and Lymphatic Diseases\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007160\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immunoproliferative Disorders\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D007154\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Immune System Diseases\"\n",
      "  .. .. ..$ interventionBrowseModule:List of 2\n",
      "  .. .. .. ..$ meshes   :List of 3\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"C582435\"\n",
      "  .. .. .. .. .. ..$ term: chr \"pembrolizumab\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000069461\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Bendamustine Hydrochloride\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000093542\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Gemcitabine\"\n",
      "  .. .. .. ..$ ancestors:List of 17\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002087\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Butyrates\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000144\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Acids, Acyclic\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D002264\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Carboxylic Acids\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009930\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Organic Chemicals\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009588\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Nitrogen Mustard Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D009150\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Mustard Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006846\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons, Halogenated\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006838\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Hydrocarbons\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D001562\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Benzimidazoles\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006574\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, 2-Ring\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D000072471\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, Fused-Ring\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006571\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003841\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Deoxycytidine\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D003562\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Cytidine\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011741\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pyrimidine Nucleosides\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D011743\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Pyrimidines\"\n",
      "  .. .. .. .. ..$ :List of 2\n",
      "  .. .. .. .. .. ..$ id  : chr \"D006573\"\n",
      "  .. .. .. .. .. ..$ term: chr \"Heterocyclic Compounds, 1-Ring\"\n",
      "  .. ..$ hasResults     : logi FALSE\n",
      " $ meta   :List of 3\n",
      "  ..$ query          : chr \"cancer\"\n",
      "  ..$ filters        :List of 5\n",
      "  .. ..$ phase      : chr \"Phase 2\"\n",
      "  .. ..$ country    : chr \"Canada\"\n",
      "  .. ..$ from_date  : chr \"2022-01-01\"\n",
      "  .. ..$ to_date    : chr \"2023-01-01\"\n",
      "  .. ..$ date_filter: chr \"StartDate\"\n",
      "  ..$ records_fetched: int 10\n"
     ]
    }
   ],
   "source": [
    "suppressWarnings(devtools::load_all())\n",
    "spec <- list(\n",
    "  query = \"cancer\",\n",
    "  max_records = 10,\n",
    "  phase = \"Phase 2\",\n",
    "  country = \"Canada\",\n",
    "  from_date = \"2022-01-01\",\n",
    "  to_date = \"2023-01-01\",\n",
    "  date_filter = \"StartDate\"\n",
    ")\n",
    "result <- trials_run_spec(spec)\n",
    "str(result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "17c2b760",
   "metadata": {
    "vscode": {
     "languageId": "r"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<strong>$meta</strong> = <dl>\n",
       "\t<dt>$query</dt>\n",
       "\t\t<dd>'cancer'</dd>\n",
       "\t<dt>$filters</dt>\n",
       "\t\t<dd><dl>\n",
       "\t<dt>$phase</dt>\n",
       "\t\t<dd>'Phase 2'</dd>\n",
       "\t<dt>$country</dt>\n",
       "\t\t<dd>'Canada'</dd>\n",
       "\t<dt>$from_date</dt>\n",
       "\t\t<dd>'2022-01-01'</dd>\n",
       "\t<dt>$to_date</dt>\n",
       "\t\t<dd>'2023-01-01'</dd>\n",
       "\t<dt>$date_filter</dt>\n",
       "\t\t<dd>'StartDate'</dd>\n",
       "</dl>\n",
       "</dd>\n",
       "\t<dt>$records_fetched</dt>\n",
       "\t\t<dd>10</dd>\n",
       "</dl>\n"
      ],
      "text/latex": [
       "\\textbf{\\$meta} = \\begin{description}\n",
       "\\item[\\$query] 'cancer'\n",
       "\\item[\\$filters] \\begin{description}\n",
       "\\item[\\$phase] 'Phase 2'\n",
       "\\item[\\$country] 'Canada'\n",
       "\\item[\\$from\\_date] '2022-01-01'\n",
       "\\item[\\$to\\_date] '2023-01-01'\n",
       "\\item[\\$date\\_filter] 'StartDate'\n",
       "\\end{description}\n",
       "\n",
       "\\item[\\$records\\_fetched] 10\n",
       "\\end{description}\n"
      ],
      "text/markdown": [
       "**$meta** = $query\n",
       ":   'cancer'\n",
       "$filters\n",
       ":   $phase\n",
       ":   'Phase 2'\n",
       "$country\n",
       ":   'Canada'\n",
       "$from_date\n",
       ":   '2022-01-01'\n",
       "$to_date\n",
       ":   '2023-01-01'\n",
       "$date_filter\n",
       ":   'StartDate'\n",
       "\n",
       "\n",
       "\n",
       "$records_fetched\n",
       ":   10\n",
       "\n",
       "\n"
      ],
      "text/plain": [
       "$meta\n",
       "$meta$query\n",
       "[1] \"cancer\"\n",
       "\n",
       "$meta$filters\n",
       "$meta$filters$phase\n",
       "[1] \"Phase 2\"\n",
       "\n",
       "$meta$filters$country\n",
       "[1] \"Canada\"\n",
       "\n",
       "$meta$filters$from_date\n",
       "[1] \"2022-01-01\"\n",
       "\n",
       "$meta$filters$to_date\n",
       "[1] \"2023-01-01\"\n",
       "\n",
       "$meta$filters$date_filter\n",
       "[1] \"StartDate\"\n",
       "\n",
       "\n",
       "$meta$records_fetched\n",
       "[1] 10\n",
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "result[2]"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "R",
   "language": "R",
   "name": "ir"
  },
  "language_info": {
   "codemirror_mode": "r",
   "file_extension": ".r",
   "mimetype": "text/x-r-source",
   "name": "R",
   "pygments_lexer": "r",
   "version": "4.5.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
